Submitted URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Effective URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement...
Submission: On February 04 via manual from US — Scanned from DE

Summary

This website contacted 92 IPs in 11 countries across 65 domains to perform 257 HTTP transactions. The main IP is 104.18.14.141, located in and belongs to CLOUDFLARENET, US. The main domain is www.fiercepharma.com. The Cisco Umbrella rank of the primary domain is 116131.
TLS certificate: Issued by Cloudflare Inc ECC CA-3 on July 14th 2021. Valid for: a year.
This is the only time www.fiercepharma.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 2606:4700:303... 13335 (CLOUDFLAR...)
13 104.18.14.141 13335 (CLOUDFLAR...)
1 2a00:1450:400... 15169 (GOOGLE)
1 108.157.4.100 16509 (AMAZON-02)
2 104.16.94.165 13335 (CLOUDFLAR...)
3 45.133.44.4 7018 (ATT-INTER...)
10 142.250.186.162 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
3 2606:4700:10:... 13335 (CLOUDFLAR...)
1 2a00:1450:400... 15169 (GOOGLE)
1 104.16.94.80 13335 (CLOUDFLAR...)
2 2a00:1450:400... 15169 (GOOGLE)
1 54.72.7.92 16509 (AMAZON-02)
2 4 66.155.71.150 13768 (COGECO-PEER1)
1 10 204.180.130.190 53866 (QTS-AS)
1 18.66.242.197 16509 (AMAZON-02)
5 2a00:1450:400... 15169 (GOOGLE)
4 2606:4700::68... 13335 (CLOUDFLAR...)
2 104.111.234.67 16625 (AKAMAI-AS)
1 108.157.4.42 16509 (AMAZON-02)
1 2606:4700::68... 13335 (CLOUDFLAR...)
13 204.180.130.159 53866 (QTS-AS)
1 143.204.103.127 16509 (AMAZON-02)
4 185.239.173.66 55081 (24SHELLS)
2 6 37.252.173.22 29990 (ASN-APPNEX)
3 52.6.171.241 14618 (AMAZON-AES)
1 2a00:1450:400... 15169 (GOOGLE)
1 52.205.167.202 14618 (AMAZON-AES)
1 192.28.147.68 15224 (OMNITURE)
2 45.133.44.3 39572 (ADVANCEDH...)
2 54.229.143.145 16509 (AMAZON-02)
1 143.204.98.81 16509 (AMAZON-02)
1 143.204.98.127 16509 (AMAZON-02)
2 169.197.150.7 398989 (DEEPINTENT)
1 37.252.161.190 29990 (ASN-APPNEX)
1 198.148.27.134 19189 (PULSEPOINT)
8 2602:803:c003... 26667 (RUBICONPR...)
2 147.75.61.140 54825 (PACKET)
1 2.21.111.28 16625 (AKAMAI-AS)
1 18.202.163.212 16509 (AMAZON-02)
1 146.0.227.110 20773 (GODADDY)
1 209.58.175.20 59253 (LEASEWEB-...)
2 204.237.133.116 3257 (GTT-BACKB...)
1 178.250.2.131 44788 (ASN-CRITE...)
1 8.2.111.126 46636 (NATCOWEB)
1 96.46.183.20 7979 (SERVERS-COM)
1 34.107.148.139 15169 (GOOGLE)
1 54.77.120.81 16509 (AMAZON-02)
1 178.162.133.150 60781 (LEASEWEB-...)
1 213.19.147.43 3356 (LEVEL3)
1 51.89.9.252 16276 (OVH)
2 35.244.159.8 15169 (GOOGLE)
1 216.52.2.30 29791 (VOXEL-DOT...)
1 5.178.65.246 50673 (SERVERIUS-AS)
1 185.184.10.30 203690 (RTB-HOUSE...)
11 18.156.195.47 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 34.255.166.68 16509 (AMAZON-02)
10 143.204.98.80 16509 (AMAZON-02)
1 35.165.207.228 16509 (AMAZON-02)
1 2606:4700:303... 13335 (CLOUDFLAR...)
1 52.72.150.209 14618 (AMAZON-AES)
1 1 23.227.139.243 55081 (24SHELLS)
1 193.200.65.5 6681 (GIVEME-CLOUD)
1 37.18.16.23 205675 (HYBRID-AS)
5 54.144.118.149 14618 (AMAZON-AES)
2 3 142.250.185.98 15169 (GOOGLE)
1 35.244.174.68 15169 (GOOGLE)
5 205.162.42.5 53866 (QTS-AS)
1 3 2606:4700:20:... 13335 (CLOUDFLAR...)
1 44.228.48.137 16509 (AMAZON-02)
1 52.41.22.107 16509 (AMAZON-02)
1 1 37.252.172.37 29990 (ASN-APPNEX)
2 8 52.43.149.174 16509 (AMAZON-02)
2 2 52.223.40.198 16509 (AMAZON-02)
2 2 104.36.113.17 62713 (AS-PUBMATIC)
1 178.162.133.149 60781 (LEASEWEB-...)
1 1 198.148.27.139 19189 (PULSEPOINT)
1 69.173.144.138 26667 (RUBICONPR...)
11 2a00:1450:400... 15169 (GOOGLE)
2 204.180.130.165 53866 (QTS-AS)
1 52.43.59.220 16509 (AMAZON-02)
6 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
2 18.66.122.61 16509 (AMAZON-02)
4 142.250.186.66 15169 (GOOGLE)
19 2a00:1450:400... 15169 (GOOGLE)
8 2a00:1450:400... 15169 (GOOGLE)
1 35.83.23.20 16509 (AMAZON-02)
1 2001:4de0:ac1... 20446 (HIGHWINDS3)
2 2a02:2638::3 44788 (ASN-CRITE...)
1 2 2a02:2638:1::13 ()
2 178.250.0.157 ()
1 51.89.20.86 ()
257 92
Apex Domain
Subdomains
Transfer
23 fiercepharma.com
www.fiercepharma.com — Cisco Umbrella Rank: 116131
c405.fiercepharma.com — Cisco Umbrella Rank: 406279 Failed
138 KB
20 googlesyndication.com
1ded3c4c8da534897706a63a9c80e842.safeframe.googlesyndication.com
pagead2.googlesyndication.com — Cisco Umbrella Rank: 100
tpc.googlesyndication.com — Cisco Umbrella Rank: 124
150 KB
19 2mdn.net
s0.2mdn.net — Cisco Umbrella Rank: 255
532 KB
18 doubleclick.net
securepubads.g.doubleclick.net — Cisco Umbrella Rank: 184
stats.g.doubleclick.net — Cisco Umbrella Rank: 96
cm.g.doubleclick.net — Cisco Umbrella Rank: 197
googleads4.g.doubleclick.net — Cisco Umbrella Rank: 274
209 KB
16 omeda.com
olytics.omeda.com — Cisco Umbrella Rank: 30868
cdn.omeda.com — Cisco Umbrella Rank: 47954
oqs.omeda.com — Cisco Umbrella Rank: 33396
165 KB
14 dragonforms.com
sample.dragonforms.com — Cisco Umbrella Rank: 122221
hostedcontent.dragonforms.com — Cisco Umbrella Rank: 88834
89 KB
11 ad.gt
a.ad.gt — Cisco Umbrella Rank: 5184
p.ad.gt — Cisco Umbrella Rank: 5806
ids.ad.gt — Cisco Umbrella Rank: 4690
pixels.ad.gt — Cisco Umbrella Rank: 5709
16 KB
11 yahoo.com
c2shb.ssp.yahoo.com — Cisco Umbrella Rank: 693
1 KB
9 rubiconproject.com
fastlane.rubiconproject.com — Cisco Umbrella Rank: 467
token.rubiconproject.com — Cisco Umbrella Rank: 689
11 KB
8 adnxs.com
ib.adnxs.com — Cisco Umbrella Rank: 241
prebid.adnxs.com — Cisco Umbrella Rank: 1759
secure.adnxs.com — Cisco Umbrella Rank: 404
33 KB
7 spotible.com
ads.spotible.com Failed
creative.spotible.com — Cisco Umbrella Rank: 70958
cdn.spotible.com — Cisco Umbrella Rank: 76793
292 KB
7 crazyegg.com
script.crazyegg.com — Cisco Umbrella Rank: 2008
pagestates-tracking.crazyegg.com — Cisco Umbrella Rank: 3843
assets-tracking.crazyegg.com — Cisco Umbrella Rank: 3846
tracking.crazyegg.com — Cisco Umbrella Rank: 3831
29 KB
7 mediafuse.com
player.mediafuse.com — Cisco Umbrella Rank: 53525
player.hbmp.mediafuse.com — Cisco Umbrella Rank: 36214
ghb.hbmp.mediafuse.com — Cisco Umbrella Rank: 50582
171 KB
6 googletagservices.com
www.googletagservices.com — Cisco Umbrella Rank: 165
149 KB
5 criteo.com
bidder.criteo.com — Cisco Umbrella Rank: 722
gum.criteo.com
mug.criteo.com
2 KB
5 google-analytics.com
www.google-analytics.com — Cisco Umbrella Rank: 42
41 KB
4 b2c.com
api-52-43-59-220.b2c.com
v4-api-52-43-59-220.b2c.com
7 KB
4 pubmatic.com
hbopenbid.pubmatic.com — Cisco Umbrella Rank: 459
image2.pubmatic.com — Cisco Umbrella Rank: 1032
805 B
4 dpmsrv.com
s.dpmsrv.com — Cisco Umbrella Rank: 27632
a.dpmsrv.com — Cisco Umbrella Rank: 23211
42 KB
3 ml314.com
ml314.com — Cisco Umbrella Rank: 1557
in.ml314.com — Cisco Umbrella Rank: 8786
13 KB
3 adtelligent.com
player.adtelligent.com — Cisco Umbrella Rank: 5710
ghb.adtelligent.com — Cisco Umbrella Rank: 5988
sync.adtelligent.com — Cisco Umbrella Rank: 2849
5 KB
3 addtoany.com
static.addtoany.com — Cisco Umbrella Rank: 4404
60 KB
2 criteo.net
static.criteo.net — Cisco Umbrella Rank: 645
56 KB
2 adsrvr.org
match.adsrvr.org — Cisco Umbrella Rank: 329
963 B
2 google.com
adservice.google.com — Cisco Umbrella Rank: 80
671 B
2 google.de
adservice.google.de — Cisco Umbrella Rank: 8028
914 B
2 openx.net
adtelligent-d.openx.net — Cisco Umbrella Rank: 17971
u.openx.net — Cisco Umbrella Rank: 710
514 B
2 sonobi.com
apex.go.sonobi.com — Cisco Umbrella Rank: 1699
sync.go.sonobi.com — Cisco Umbrella Rank: 1044
1 KB
2 a-mo.net
prebid.a-mo.net — Cisco Umbrella Rank: 1204
557 B
2 contextweb.com
bid.contextweb.com — Cisco Umbrella Rank: 2792
bh.contextweb.com — Cisco Umbrella Rank: 577
1 KB
2 deepintent.com
prebid.deepintent.com — Cisco Umbrella Rank: 5893
235 B
2 parsely.com
cdn.parsely.com — Cisco Umbrella Rank: 2931
p1.parsely.com — Cisco Umbrella Rank: 2249
18 KB
2 marketo.net
munchkin.marketo.net — Cisco Umbrella Rank: 3672
6 KB
2 sitescout.com
pixel.sitescout.com — Cisco Umbrella Rank: 3536
191 B
2 basis.net
pixel-a.basis.net — Cisco Umbrella Rank: 16750
132 B
2 gstatic.com
fonts.gstatic.com
54 KB
2 googletagmanager.com
www.googletagmanager.com — Cisco Umbrella Rank: 78
93 KB
2 qtxasset.com
qtxasset.com — Cisco Umbrella Rank: 90567
232 KB
2 blueconic.net
cdn.blueconic.net — Cisco Umbrella Rank: 7691
questex.blueconic.net — Cisco Umbrella Rank: 164216
42 KB
2 googleapis.com
fonts.googleapis.com — Cisco Umbrella Rank: 47
ajax.googleapis.com — Cisco Umbrella Rank: 293
15 KB
1 id5-sync.com
id5-sync.com
538 B
1 jquery.com
code.jquery.com — Cisco Umbrella Rank: 584
29 KB
1 aufp.io
aufp.io — Cisco Umbrella Rank: 6490
3 KB
1 rlcdn.com
idsync.rlcdn.com — Cisco Umbrella Rank: 316
66 B
1 hybrid.ai
dm.hybrid.ai — Cisco Umbrella Rank: 6197
238 B
1 trafmag.com
t.trafmag.com — Cisco Umbrella Rank: 6679
351 B
1 fouanalytics.com
api.fouanalytics.com — Cisco Umbrella Rank: 10665
938 B
1 medidexs.com
sync.medidexs.com — Cisco Umbrella Rank: 33627
20 KB
1 creativecdn.com
prebid-us.creativecdn.com — Cisco Umbrella Rank: 9562
182 B
1 e-planning.net
pbjs.e-planning.net — Cisco Umbrella Rank: 7058
162 B
1 lijit.com
ap.lijit.com — Cisco Umbrella Rank: 690
526 B
1 onetag-sys.com
onetag-sys.com — Cisco Umbrella Rank: 1056
367 B
1 1rx.io
tag.1rx.io — Cisco Umbrella Rank: 1334
176 B
1 yieldmo.com
ads.yieldmo.com — Cisco Umbrella Rank: 670
229 B
1 media.net
prebid.media.net — Cisco Umbrella Rank: 1360
869 B
1 betweendigital.com
ads.betweendigital.com — Cisco Umbrella Rank: 1818
916 B
1 colossusssp.com
colossusssp.com — Cisco Umbrella Rank: 2462
247 B
1 admixer.net
inv-nets.admixer.net — Cisco Umbrella Rank: 2627
510 B
1 servenobid.com
ads.servenobid.com — Cisco Umbrella Rank: 1823
638 B
1 casalemedia.com
htlb.casalemedia.com — Cisco Umbrella Rank: 461
334 B
1 mktoresp.com
294-mqf-056.mktoresp.com — Cisco Umbrella Rank: 163244
311 B
1 zoominfo.com
ws.zoominfo.com — Cisco Umbrella Rank: 9204
1 KB
1 cloudfront.net
d1z2jf7jlzjs58.cloudfront.net
1 KB
1 marketo.com
app-sj10.marketo.com — Cisco Umbrella Rank: 162030
68 KB
1 questexnetwork.com
go.questexnetwork.com
1 KB
257 65
Domain Requested by
19 s0.2mdn.net go.questexnetwork.com
s0.2mdn.net
13 olytics.omeda.com go.questexnetwork.com
www.googletagmanager.com
olytics.omeda.com
sample.dragonforms.com
13 www.fiercepharma.com go.questexnetwork.com
www.fiercepharma.com
11 pagead2.googlesyndication.com olytics.omeda.com
tpc.googlesyndication.com
www.fiercepharma.com
www.googletagservices.com
11 c2shb.ssp.yahoo.com player.mediafuse.com
10 c405.fiercepharma.com cdn.blueconic.net
10 sample.dragonforms.com 1 redirects www.fiercepharma.com
sample.dragonforms.com
code.jquery.com
10 securepubads.g.doubleclick.net www.fiercepharma.com
securepubads.g.doubleclick.net
www.googletagservices.com
8 tpc.googlesyndication.com go.questexnetwork.com
tpc.googlesyndication.com
8 ids.ad.gt 2 redirects www.fiercepharma.com
8 fastlane.rubiconproject.com player.mediafuse.com
6 www.googletagservices.com olytics.omeda.com
securepubads.g.doubleclick.net
6 ib.adnxs.com 2 redirects player.mediafuse.com
www.fiercepharma.com
5 creative.spotible.com securepubads.g.doubleclick.net
creative.spotible.com
www.fiercepharma.com
5 www.google-analytics.com www.googletagmanager.com
www.google-analytics.com
4 hostedcontent.dragonforms.com sample.dragonforms.com
hostedcontent.dragonforms.com
4 googleads4.g.doubleclick.net go.questexnetwork.com
4 ghb.hbmp.mediafuse.com player.hbmp.mediafuse.com
4 script.crazyegg.com www.googletagmanager.com
script.crazyegg.com
3 api-52-43-59-220.b2c.com 1 redirects go.questexnetwork.com
www.fiercepharma.com
3 cm.g.doubleclick.net 2 redirects www.fiercepharma.com
3 a.dpmsrv.com www.fiercepharma.com
s.dpmsrv.com
3 static.addtoany.com www.fiercepharma.com
static.addtoany.com
2 mug.criteo.com www.fiercepharma.com
2 gum.criteo.com 1 redirects
2 static.criteo.net player.mediafuse.com
static.criteo.net
2 cdn.spotible.com www.fiercepharma.com
2 oqs.omeda.com olytics.omeda.com
2 image2.pubmatic.com 2 redirects
2 match.adsrvr.org 2 redirects
2 adservice.google.com securepubads.g.doubleclick.net
2 adservice.google.de securepubads.g.doubleclick.net
2 hbopenbid.pubmatic.com player.mediafuse.com
2 prebid.a-mo.net player.mediafuse.com
2 prebid.deepintent.com player.mediafuse.com
2 ml314.com go.questexnetwork.com
ml314.com
2 munchkin.marketo.net go.questexnetwork.com
munchkin.marketo.net
2 pixel.sitescout.com www.fiercepharma.com
2 pixel-a.basis.net 2 redirects
2 fonts.gstatic.com fonts.googleapis.com
2 www.googletagmanager.com www.fiercepharma.com
sample.dragonforms.com
2 player.mediafuse.com www.fiercepharma.com
2 qtxasset.com www.fiercepharma.com
1 id5-sync.com player.mediafuse.com
1 code.jquery.com sample.dragonforms.com
1 u.openx.net www.fiercepharma.com
1 pixels.ad.gt p.ad.gt
1 v4-api-52-43-59-220.b2c.com www.fiercepharma.com
1 token.rubiconproject.com www.fiercepharma.com
1 bh.contextweb.com 1 redirects
1 sync.go.sonobi.com www.fiercepharma.com
1 secure.adnxs.com 1 redirects
1 p.ad.gt a.ad.gt
1 aufp.io a.ad.gt
1 cdn.omeda.com sample.dragonforms.com
1 idsync.rlcdn.com www.fiercepharma.com
1 dm.hybrid.ai www.fiercepharma.com
1 t.trafmag.com www.fiercepharma.com
1 sync.adtelligent.com 1 redirects
1 in.ml314.com ml314.com
1 api.fouanalytics.com player.hbmp.mediafuse.com
1 a.ad.gt player.hbmp.mediafuse.com
1 sync.medidexs.com player.hbmp.mediafuse.com
1 tracking.crazyegg.com script.crazyegg.com
1 1ded3c4c8da534897706a63a9c80e842.safeframe.googlesyndication.com securepubads.g.doubleclick.net
1 prebid-us.creativecdn.com player.mediafuse.com
1 pbjs.e-planning.net player.mediafuse.com
1 ap.lijit.com player.mediafuse.com
1 adtelligent-d.openx.net player.mediafuse.com
1 onetag-sys.com player.mediafuse.com
1 tag.1rx.io player.mediafuse.com
1 apex.go.sonobi.com player.mediafuse.com
1 ads.yieldmo.com player.mediafuse.com
1 prebid.media.net player.mediafuse.com
1 ads.betweendigital.com player.mediafuse.com
1 colossusssp.com player.mediafuse.com
1 bidder.criteo.com player.mediafuse.com
1 ghb.adtelligent.com player.mediafuse.com
1 inv-nets.admixer.net player.mediafuse.com
1 ads.servenobid.com player.mediafuse.com
1 htlb.casalemedia.com player.mediafuse.com
1 bid.contextweb.com player.mediafuse.com
1 prebid.adnxs.com player.mediafuse.com
1 assets-tracking.crazyegg.com script.crazyegg.com
1 pagestates-tracking.crazyegg.com script.crazyegg.com
1 player.adtelligent.com player.mediafuse.com
1 294-mqf-056.mktoresp.com munchkin.marketo.net
1 p1.parsely.com www.fiercepharma.com
1 stats.g.doubleclick.net www.google-analytics.com
1 cdn.parsely.com d1z2jf7jlzjs58.cloudfront.net
1 ws.zoominfo.com go.questexnetwork.com
1 s.dpmsrv.com go.questexnetwork.com
1 player.hbmp.mediafuse.com player.mediafuse.com
1 d1z2jf7jlzjs58.cloudfront.net www.fiercepharma.com
1 questex.blueconic.net cdn.blueconic.net
1 app-sj10.marketo.com www.fiercepharma.com
1 ajax.googleapis.com www.fiercepharma.com
1 cdn.blueconic.net www.fiercepharma.com
1 fonts.googleapis.com www.fiercepharma.com
1 go.questexnetwork.com
0 ads.spotible.com Failed go.questexnetwork.com
257 101
Subject Issuer Validity Valid
go.questexnetwork.com
Cloudflare Inc ECC CA-3
2021-06-03 -
2022-06-02
a year crt.sh
sni.cloudflaressl.com
Cloudflare Inc ECC CA-3
2021-07-14 -
2022-07-13
a year crt.sh
upload.video.google.com
GTS CA 1C3
2022-01-10 -
2022-04-04
3 months crt.sh
*.blueconic.net
Amazon
2021-08-07 -
2022-09-05
a year crt.sh
player.mediafuse.com
R3
2022-01-15 -
2022-04-15
3 months crt.sh
*.g.doubleclick.net
GTS CA 1C3
2021-12-27 -
2022-03-21
3 months crt.sh
*.google-analytics.com
GTS CA 1C3
2022-01-10 -
2022-04-04
3 months crt.sh
app-sj10.marketo.com
Cloudflare Inc ECC CA-3
2021-06-08 -
2022-06-07
a year crt.sh
*.gstatic.com
GTS CA 1C3
2022-01-10 -
2022-04-04
3 months crt.sh
*.sitescout.com
GeoTrust TLS DV RSA Mixed SHA256 2020 CA-1
2021-12-15 -
2023-01-15
a year crt.sh
*.omeda.com
SSL.com RSA SSL subCA
2021-07-16 -
2022-07-21
a year crt.sh
*.cloudfront.net
Amazon
2021-03-19 -
2022-03-17
a year crt.sh
player.hbmp.mediafuse.com
R3
2021-12-12 -
2022-03-12
3 months crt.sh
*.marketo.net
DigiCert SHA2 Secure Server CA
2021-03-29 -
2022-04-06
a year crt.sh
*.dpmsrv.com
Amazon
2021-05-17 -
2022-06-15
a year crt.sh
zoominfo.com
Cloudflare Inc ECC CA-3
2021-06-04 -
2022-06-03
a year crt.sh
*.parsely.com
Amazon
2021-07-05 -
2022-08-03
a year crt.sh
ghb.hbmp.mediafuse.com
ZeroSSL ECC Domain Secure Site CA
2021-12-08 -
2022-03-08
3 months crt.sh
*.mktoresp.com
DigiCert TLS RSA SHA256 2020 CA1
2021-11-30 -
2022-11-30
a year crt.sh
player.adtelligent.com
R3
2022-01-18 -
2022-04-18
3 months crt.sh
*.ml314.com
Amazon
2021-12-17 -
2023-01-14
a year crt.sh
*.crazyegg.com
DigiCert SHA2 Secure Server CA
2020-07-26 -
2022-07-23
2 years crt.sh
*.deepintent.com
Go Daddy Secure Certificate Authority - G2
2020-04-09 -
2022-06-08
2 years crt.sh
prebid.adnxs.com
GeoTrust TLS RSA CA G1
2020-03-29 -
2022-03-29
2 years crt.sh
*.contextweb.com
DigiCert SHA2 Secure Server CA
2020-05-07 -
2022-05-12
2 years crt.sh
*.rubiconproject.com
DigiCert TLS RSA SHA256 2020 CA1
2021-03-30 -
2022-04-04
a year crt.sh
*.a-mo.net
R3
2021-12-20 -
2022-03-20
3 months crt.sh
san.casalemedia.com
GeoTrust RSA CA 2018
2021-12-12 -
2022-12-13
a year crt.sh
ads.servenobid.com
Amazon
2021-06-28 -
2022-07-27
a year crt.sh
*.admixer.net
Sectigo ECC Domain Validation Secure Server CA
2021-11-16 -
2022-12-17
a year crt.sh
ghb.adtelligent.com
ZeroSSL ECC Domain Secure Site CA
2021-12-08 -
2022-03-08
3 months crt.sh
*.pubmatic.com
DigiCert Baltimore TLS RSA SHA256 2020 CA1
2021-08-04 -
2022-09-04
a year crt.sh
*.criteo.com
DigiCert TLS Hybrid ECC SHA384 2020 CA1
2022-02-04 -
2022-05-03
3 months crt.sh
*.colossusssp.com
Go Daddy Secure Certificate Authority - G2
2021-11-07 -
2022-11-07
a year crt.sh
*.ads.betweendigital.com
Sectigo RSA Domain Validation Secure Server CA
2021-12-15 -
2023-01-15
a year crt.sh
*.media.net
Sectigo RSA Domain Validation Secure Server CA
2021-04-12 -
2022-05-05
a year crt.sh
*.adnxs.com
GeoTrust ECC CA 2018
2021-03-05 -
2022-02-19
a year crt.sh
*.yieldmo.com
Amazon
2021-05-25 -
2022-06-23
a year crt.sh
*.go.sonobi.com
Go Daddy Secure Certificate Authority - G2
2021-12-08 -
2023-01-09
a year crt.sh
*.1rx.io
Sectigo RSA Domain Validation Secure Server CA
2021-06-01 -
2022-07-02
a year crt.sh
*.onetag-sys.com
DigiCert TLS Hybrid ECC SHA384 2020 CA1
2022-01-10 -
2023-01-03
a year crt.sh
*.openx.net
GeoTrust RSA CA 2018
2021-07-08 -
2022-08-08
a year crt.sh
*.lijit.com
Go Daddy Secure Certificate Authority - G2
2021-03-11 -
2022-04-12
a year crt.sh
*.e-planning.net
R3
2021-12-30 -
2022-03-30
3 months crt.sh
*.creativecdn.com
RapidSSL TLS DV RSA Mixed SHA256 2020 CA-1
2021-03-30 -
2022-04-12
a year crt.sh
web.ssp.yahoo.com
DigiCert SHA2 High Assurance Server CA
2021-10-14 -
2022-04-06
6 months crt.sh
*.google.de
GTS CA 1C3
2022-01-10 -
2022-04-04
3 months crt.sh
*.google.com
GTS CA 1C3
2021-12-27 -
2022-03-21
3 months crt.sh
s827.travelagentcentral.com
Amazon
2021-10-12 -
2022-11-10
a year crt.sh
sync.medidexs.com
R3
2022-01-09 -
2022-04-09
3 months crt.sh
*.ad.gt
Amazon
2021-06-09 -
2022-07-08
a year crt.sh
*.hybrid.ai
Sectigo RSA Domain Validation Secure Server CA
2020-07-07 -
2022-10-05
2 years crt.sh
*.spotible.com
Sectigo RSA Domain Validation Secure Server CA
2021-11-02 -
2022-12-03
a year crt.sh
*.rlcdn.com
Sectigo RSA Domain Validation Secure Server CA
2021-02-25 -
2022-03-28
a year crt.sh
aufp.io
Amazon
2021-11-26 -
2022-12-24
a year crt.sh
*.doubleclick.net
GTS CA 1C3
2021-12-27 -
2022-03-21
3 months crt.sh
tpc.googlesyndication.com
GTS CA 1C3
2021-12-27 -
2022-03-21
3 months crt.sh
*.jquery.com
Sectigo RSA Domain Validation Secure Server CA
2021-07-14 -
2022-08-14
a year crt.sh
*.criteo.net
DigiCert TLS Hybrid ECC SHA384 2020 CA1
2022-02-02 -
2022-05-03
3 months crt.sh
*.id5-sync.com
R3
2021-12-20 -
2022-03-20
3 months crt.sh

This page contains 20 frames:

Primary Page: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Frame ID: 24F332D9BDDA766DE27978572A359B7E
Requests: 173 HTTP requests in this frame

Frame: https://pixel.sitescout.com/dmp/asyncPixelSync
Frame ID: E3FF8C3256FBDE18AA3BD60BFD6DDF0D
Requests: 1 HTTP requests in this frame

Frame: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Frame ID: A4064A7C8E646108763DE82D37CCA0FA
Requests: 22 HTTP requests in this frame

Frame: https://static.addtoany.com/menu/sm.23.html
Frame ID: 425FC65DB6C301B34081A2AFBDC65692
Requests: 1 HTTP requests in this frame

Frame: https://1ded3c4c8da534897706a63a9c80e842.safeframe.googlesyndication.com/safeframe/1-0-38/html/container.html
Frame ID: EBA442186F72FABBD7EF3AC90FCF0DEE
Requests: 1 HTTP requests in this frame

Frame: https://ads.spotible.com/tag/universal-tag.js
Frame ID: 65EDE8ADC2DA3DA5AB302604AFA4B1FF
Requests: 2 HTTP requests in this frame

Frame: https://creative.spotible.com/tag/allstream.js
Frame ID: D3DA586635CFE0B7B3E5C4E095C50D88
Requests: 1 HTTP requests in this frame

Frame: https://creative.spotible.com/tag/storage-delegate.html
Frame ID: 5027B0ED53A8E61C4A8F50A892CF71C6
Requests: 1 HTTP requests in this frame

Frame: https://googleads4.g.doubleclick.net/pcs/view?xai=AKAOjssZmLIaiyOrHggyA2VaDhCDRfO8Me9KUzazslZq72JMJ4Q5xabBd3bFXt3y31MYQDD3bRugnuafNSixgEi3zQAohpDEoWPX5Lj14-MnwWvyj3xRjSSv5-LK3vR0CpAhC6UvwHn9NgNyFQ-93vQlZpb4gKe8XBflUJynUGOPWBQEur76WJL7DsoDj3KNizGVQTLJTgac-j6_6dNlR-ioVU5bNJtRQvcxs1-kYYLlwz04P1yStkGlGZdqmCRISRTey-TaLM8h00EYgIbetxBwyFqBOpfEJ0RUk4fLUMqs1lOETVNUduGZdCCofvWqCPwTefWeAptuwaoi-B5AmZTtfJOVy2WolxybQ86f6poZ8U94-2fTX6_zUvIQvrdtpk-7RJwtumdYeIxriHb7imEWpuN-5pPn371MaUJLzTqFMxLu&sig=Cg0ArKJSzIfoXrtHfFWTEAE&uach_m=[UACH]&fbs_aeid=[gw_fbsaeid]&urlfix=1&adurl=
Frame ID: 5B08066C4A0CFE35CF2FF7124F6FA573
Requests: 7 HTTP requests in this frame

Frame: https://googleads4.g.doubleclick.net/pcs/view?xai=AKAOjsvOy3MMD77MU510HagrDKsVKaw6_0P1nZFadeg_wUyplUjC_1SmklPgpLUd2SBcj-L3ZwcnwHxizF9aQPuzeETQwbFq86V5bKFjrtvVXp4vE8h1bzLoEtKwZmGxiKtqSqaqjCN7fHR0dh-8LOdb4UwXf1zSt6NkWul4TtOHJLs_xEXmQH6t1VPrmjDvAYpS0kGWYtsHemsleC15sbe8QhGDySmJlmhP22cmOLH6jrD9s0R-oa4Yhd1N2C_-Foldrfs-9WupSlf_ehEoifVZqFHrS9LTHO1DRwBtsHU-2rf2YL4MuL7GFhOxB7vauLyTtS7_jcx5Jp2ecsbxA1A9t6EzvgzbhG5cGm3RDI1dxW4Ot4vUWfwTiMWdbm-q1Ujx11EclRc_ngD74tOf2DaBmEBGNzMHtas1Q5bgfSPqEgLL&sig=Cg0ArKJSzLsUpTOe8svTEAE&uach_m=[UACH]&fbs_aeid=[gw_fbsaeid]&urlfix=1&adurl=
Frame ID: 235C0215CDD221C7DDD217D3986AE420
Requests: 6 HTTP requests in this frame

Frame: https://googleads4.g.doubleclick.net/pcs/view?xai=AKAOjssQ3qIM3MTLgpAnPyqH9glkPIlBOQ2xJ7EyUbTwTknltySdR0Xpos5n90G8SzkMv8c5RB0lQPW9beNylrjiv-lzbwUc3qST0WZx6Kl22vTQa6XxMw1TxvtA6ynuKwP6Uf_gl4wNs53A_8YbyTzoagHlc2wRxpI8wC8FX_j5pHljq1bXmrnSOA-nvWsMSM8Zc0BiUzITwvlRjsDzhyoUjy-9Q5oUYD6uCYkY_jt1fPn7_sf5OSrwPmWokYvhetP18sisi3zIsOtbm6LR37xECfMJ7uYqUNLun-3HpKqk4ja-AD-egvffCRkPd0_Ap5GmKIqsD87AqSNKXs_74EXW_JynC9t9jGHKmuTlCAiblTS5JcJFLaNKfcU3LmQxsqrmGpeoBv-GpsIEZ7RY_hR2yr7dPFq68lJQIaavzaOeZSoq&sig=Cg0ArKJSzDQRQV8rGlx4EAE&uach_m=[UACH]&fbs_aeid=[gw_fbsaeid]&urlfix=1&adurl=
Frame ID: 798CA3F8AFF6ECDA45AE9AE49BFD87EC
Requests: 6 HTTP requests in this frame

Frame: https://googleads4.g.doubleclick.net/pcs/view?xai=AKAOjst4EPjzZMM8zO3zip9ZvNE9tzlg6obvhASvdTWIUHKGwVgwJT2EW4SieKSm29fYCzY4F5J4pZDhyKNY-Frh6p2_TYu89OwvfhN8zf9vF8R2sQHuIa3SXeIQK9Gt7M7EJ8orM8DGW-LqLIpK7ND5WIZ-D6NMy8JRh22k-VJ7hltv17O8nSPIQtZxmmcq2twROEpp9EXUiqVL21MZtIY6FUwV2B79wQ8kZsHSCuQmxfkBCVyRWiVwH6TWWH9XiuiRHf69K8H4-95GXPIByaiOSmFzLShQfmUFdVmqJW6ANAy3jnQEziTLoMWeXNd_lDahZcb8Yy9Hh97yf6XZDq-EHd6clumpqqGOOE4yASLR5iGDrTJHmuUxwtcC6UcIBIwWQV_Lf3eAtDYBWVzfsYK9uTa3cT3EPESg-IasqhKqNY_e&sig=Cg0ArKJSzEjhADzYpffcEAE&uach_m=[UACH]&fbs_aeid=[gw_fbsaeid]&urlfix=1&adurl=
Frame ID: C3C992C999CF38A5AAA947D65137A18D
Requests: 6 HTTP requests in this frame

Frame: https://s0.2mdn.net/10583188/1640880412777/index.html
Frame ID: 37E3A4DF4094DFE7B2C297981BEB4AA1
Requests: 3 HTTP requests in this frame

Frame: https://s0.2mdn.net/10583188/1640879416687/index.html
Frame ID: 16C4471130E0CB5B1A8356DE92CF1A1B
Requests: 4 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Frame ID: 6EED2426EA10E539FE9F775A565C1D53
Requests: 3 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Frame ID: 888F3EC372D721E3B77E84C0A7451C6D
Requests: 3 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Frame ID: 7FC68F98076B935A6EBB465C177D6073
Requests: 3 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Frame ID: EB7CBBAD3D7C7880643938941E9F13E9
Requests: 3 HTTP requests in this frame

Frame: https://s0.2mdn.net/10583188/1640879416687/index.html
Frame ID: 11AD946476D3E443B4C10E80F1BAD11F
Requests: 4 HTTP requests in this frame

Frame: https://s0.2mdn.net/10583188/1640879416687/index.html
Frame ID: DF244058662EF500205B773B6446EB7A
Requests: 4 HTTP requests in this frame

Screenshot

Page Title

Gilead to fork over $1.25B, pay 3% royalty on blockbuster Biktarvy in GSK patent settlement | FiercePharma

Page URL History Show full URLs

  1. https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxz... Page URL
  2. https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-g... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • addtoany\.com/menu/page\.js

Overall confidence: 100%
Detected patterns
  • adnxs\.(?:net|com)

Overall confidence: 100%
Detected patterns
  • script\.crazyegg\.com/pages/scripts/\d+/\d+\.js

Overall confidence: 100%
Detected patterns
  • 2mdn\.net

Overall confidence: 100%
Detected patterns
  • googletagservices\.com/tag/js/gpt(?:_mobile)?\.js

Overall confidence: 100%
Detected patterns
  • googlesyndication\.com/
  • 2mdn\.net

Overall confidence: 100%
Detected patterns
  • google-analytics\.com/(?:ga|urchin|analytics)\.js

Overall confidence: 100%
Detected patterns
  • googleapis\.com/.+webfont

Overall confidence: 100%
Detected patterns
  • googletagmanager\.com/gtm\.js

Overall confidence: 100%
Detected patterns
  • munchkin\.marketo\.\w+/(?:([\d.]+)/)?munchkin\.js

Overall confidence: 100%
Detected patterns
  • marketo\.\w+/js/forms(?:[\d.]+)/js/forms([\d.]+)\.min\.js

Overall confidence: 100%
Detected patterns
  • https?://[^/]*\.openx\.net

Overall confidence: 100%
Detected patterns
  • adnxs\.com/[^"]*(?:prebid|/pb\.js)

Overall confidence: 100%
Detected patterns
  • https?://[^/]*\.pubmatic\.com

Overall confidence: 100%
Detected patterns
  • https?://[^/]*\.rubiconproject\.com

Overall confidence: 100%
Detected patterns
  • jquery[.-]([\d.]*\d)[^/]*\.js
  • jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

Page Statistics

257
Requests

92 %
HTTPS

25 %
IPv6

65
Domains

101
Subdomains

92
IPs

11
Countries

2801 kB
Transfer

6885 kB
Size

69
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU= Page URL
  2. https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 26
  • https://pixel-a.basis.net/dmp/asyncPixelSync HTTP 301
  • https://pixel.sitescout.com/dmp/asyncPixelSync
Request Chain 27
  • https://pixel-a.basis.net/iap/7f1874304d399254 HTTP 301
  • https://pixel.sitescout.com/iap/7f1874304d399254
Request Chain 28
  • https://sample.dragonforms.com/FiercePharma_short HTTP 302
  • https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short
Request Chain 50
  • https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&q%3DxImp%26v%3D1.x%26cl%3D913%26pixelIndex%3D0%26r%3D447159%26tzOffset%3D0%26url%3Dhttps%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%253Futm_source%253Dnurture-email%2526utm_medium%253Demail%2526utm_campaign%253Djan2022-fp-nurture-email4-what-you-missed%2526mkt_tok%253DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&_=1643944197658 HTTP 307
  • https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fa.dpmsrv.com%2Fdpmpxl%2Findex.php%3Fid%3D%24UID%26q%253DxImp%2526v%253D1.x%2526cl%253D913%2526pixelIndex%253D0%2526r%253D447159%2526tzOffset%253D0%2526url%253Dhttps%25253A%25252F%25252Fwww.fiercepharma.com%25252Fpharma%25252Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%25253Futm_source%25253Dnurture-email%252526utm_medium%25253Demail%252526utm_campaign%25253Djan2022-fp-nurture-email4-what-you-missed%252526mkt_tok%25253DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis%26_%3D1643944197658 HTTP 302
  • https://a.dpmsrv.com/dpmpxl/index.php?id=3035801625078687012&q=xImp&v=1.x&cl=913&pixelIndex=0&r=447159&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&_=1643944197658
Request Chain 120
  • https://sync.adtelligent.com/csync?&redir=https%3A%2F%2Ft.trafmag.com%2Fimages%2Fimages%2F1px-matching-adtelligent.gif%3Fid%3D%7Buid%7D HTTP 302
  • https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=82bfe3fa89b1c5fc
Request Chain 125
  • https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm&ap_id=3035801625078687012&pixelIndex=0&_=1643944197659 HTTP 302
  • https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=3035801625078687012&pixelIndex=0&_=1643944197659&google_gid=CAESEDTbqaQQ_3PSkMAwV2q2IQ0&google_cver=1
Request Chain 135
  • https://secure.adnxs.com/getuid?https://ids.ad.gt/api/v1/match?id=70a36042-ea6e-46be-a9ff-2e7c1131d901&adnxs_id=$UID HTTP 302
  • https://ids.ad.gt/api/v1/match?id=70a36042-ea6e-46be-a9ff-2e7c1131d901&adnxs_id=3035801625078687012
Request Chain 136
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=70a36042-ea6e-46be-a9ff-2e7c1131d901 HTTP 302
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=70a36042-ea6e-46be-a9ff-2e7c1131d901 HTTP 302
  • https://ids.ad.gt/api/v1/t_match?tdid=806389c4-2d34-4560-9cd8-f621883bd145&id=70a36042-ea6e-46be-a9ff-2e7c1131d901
Request Chain 137
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3D70a36042-ea6e-46be-a9ff-2e7c1131d901 HTTP 302
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?ird=1&rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3D70a36042-ea6e-46be-a9ff-2e7c1131d901 HTTP 302
  • https://ids.ad.gt/api/v1/pbm_match?pbm=B700EDD9-77F1-4FB8-A9D9-2197767F6769&id=70a36042-ea6e-46be-a9ff-2e7c1131d901
Request Chain 138
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_cm&google_sc&google_ula=450542624&id=70a36042-ea6e-46be-a9ff-2e7c1131d901 HTTP 302
  • https://ids.ad.gt/api/v1/g_match?id=70a36042-ea6e-46be-a9ff-2e7c1131d901&google_gid=CAESEJOrZg-xVfFp-wAb9ZVWuSE&google_cver=1&google_ula=450542624,0
Request Chain 139
  • https://ids.ad.gt/api/v1/g_hosted?id=70a36042-ea6e-46be-a9ff-2e7c1131d901 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=NzBhMzYwNDItZWE2ZS00NmJlLWE5ZmYtMmU3YzExMzFkOTAx
Request Chain 141
  • https://bh.contextweb.com/bh/rtset?pid=562316&ev=1&rurl=https://ids.ad.gt/api/v1/ppnt_match?uid=%%VGUID%%&id=70a36042-ea6e-46be-a9ff-2e7c1131d901 HTTP 302
  • https://ids.ad.gt/api/v1/ppnt_match?uid=3R3n4DSJqHMl&ev=1&pid=562316&id=70a36042-ea6e-46be-a9ff-2e7c1131d901
Request Chain 142
  • https://ids.ad.gt/api/v1/rub?id=70a36042-ea6e-46be-a9ff-2e7c1131d901 HTTP 302
  • https://token.rubiconproject.com/token?pid=50242&puid=70a36042-ea6e-46be-a9ff-2e7c1131d901&gdpr=0
Request Chain 146
  • https://api-52-43-59-220.b2c.com/api/x?TybpjEJ74q5QaqtF$dXJsJDAkaHR0cHM6Ly93d3cuZmllcmNlcGhhcm1hLmNvbS9waGFybWEvZ2lsZWFkLXRvLWZvcmstb3Zlci0xLTI1LWJpbGxpb24tcGF5LTMtcm95YWx0eS1ibG9ja2J1c3Rlci1iaWt0YXJ2eS1nc2stcGF0ZW50LXNldHRsZW1lbnQ_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~ HTTP 302
  • https://v4-api-52-43-59-220.b2c.com:444/api/4?TybpjEJ74q5QaqtF
Request Chain 258
  • https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Fwww.fiercepharma.com%2F&domain=www.fiercepharma.com&cw=1&pbt=1&lsw=1 HTTP 302
  • https://mug.criteo.com/sid?cpp=OmTaFHxnVGIwc3FlMWpkc2RyMFphd3ZqaVdudlVoYjBPeFZXa0lIVG9oa0ZKTEVSK0RtL3IwR2dHRzJWOGcrM0ZlSkpMQjZrQUVTVm04cnViTlU2MCs3RHJPa2NzcTladkc0OUwzMG9MeTYyOXdiM2hLTHZKOXJYb2J2MDljM0ptT2xvUDJya0RoQ3ZvRVlkbE9VcnNxQXQwMEYwMmtTSytPRkgvRTJXeXc4NVRxbWo3eTlUODdXei9vSlhjVVE0UXdiQnF2UWR2c0ZVTGxQSDh1ZDBsSGp6empXcFoyNkxQSCtSNERBZDhIUUNub1h3ZWV6eFVmN3dGUVBPd05Cbk5OeFo0fA&cppv=2

257 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
go.questexnetwork.com/
670 B
1 KB
Document
General
Full URL
https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
2606:4700:3030::6815:4b21 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4b94a7b0c01e3a2de674cc99e46908a72b0dd71d82049c1d1045511441cd5968
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9

Response headers

date
Fri, 04 Feb 2022 03:09:57 GMT
content-type
text/html
cache-control
private, no-cache, no-store, max-age=0
x-content-type-options
nosniff
vary
Accept-Encoding
cf-cache-status
DYNAMIC
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
6d80b3fcb88a83ac-MXP
content-encoding
gzip
Primary Request gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement
www.fiercepharma.com/pharma/
69 KB
20 KB
Document
General
Full URL
https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
212e3817a65ef556ce2dd27048122a1310b4403a0b608c2728189d86c9de3a72
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://go.questexnetwork.com/

Response headers

date
Fri, 04 Feb 2022 03:09:57 GMT
content-type
text/html; charset=UTF-8
cache-control
max-age=16588800, public
x-drupal-dynamic-cache
MISS
link
<https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement>; rel="canonical" <https://www.fiercepharma.com/node/519456>; rel="shortlink" <https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement>; rel="revision"
x-ua-compatible
IE=edge
content-language
en
x-content-type-options
nosniff
x-frame-options
SAMEORIGIN
expires
Sun, 19 Nov 1978 05:00:00 GMT
last-modified
Fri, 04 Feb 2022 03:09:57 GMT
vary
Cookie,Accept-Encoding
x-generator
Drupal 8 (https://www.drupal.org)
x-drupal-cache
MISS
x-request-id
v-eeaf618e-8567-11ec-8f83-db8b26fc23eb
x-ah-environment
prod
via
varnish
x-cache
MISS
cf-cache-status
MISS
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
6d80b4017f7991fc-FRA
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
css2
fonts.googleapis.com/
7 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css2?family=Overpass:ital,wght@0,400;0,700;0,900;1,400&display=swap
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
16bc5aa9539869018f77eb2a7edc3e56864ce7a05117202d044c7aed8caea080
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Fri, 04 Feb 2022 03:09:58 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
date
Fri, 04 Feb 2022 03:09:58 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Fri, 04 Feb 2022 03:09:58 GMT
css_kVN2rKdhGvoqLDnsAlvvemuiShRpM4Y_yju5_iQ3NVA.css
www.fiercepharma.com/sites/fiercepharma/files/css/
7 KB
2 KB
Stylesheet
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/css/css_kVN2rKdhGvoqLDnsAlvvemuiShRpM4Y_yju5_iQ3NVA.css
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
0430e8666e77465ac8a88c14810567f164a98d29223e337b54e4c50705ad0f7a
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
120911
cf-polished
origSize=7575
x-cache
MISS
cf-bgj
minify
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-a3043964-844d-11ec-94fb-f325f79a3ba9
x-robots-tag
noindex, nofollow
last-modified
Wed, 02 Feb 2022 17:29:01 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css
cache-control
max-age=1209600
cf-ray
6d80b405ca9b91fc-FRA
expires
Wed, 16 Feb 2022 17:29:12 GMT
css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
www.fiercepharma.com/sites/fiercepharma/files/css/
605 KB
55 KB
Stylesheet
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
7533826884f96d6479ad16c923fb9ad6d9dad65930f9e3a4a5c82ebcdfd92f5c
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
840444
cf-polished
origSize=627000
x-cache
HIT
last-modified
Thu, 30 Dec 2021 18:15:55 GMT
x-cache-hits
67
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-ce82ec8e-77c3-11ec-82b5-bf6f4cf2aaa7
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css
cache-control
max-age=1209600
cf-ray
6d80b405ca9c91fc-FRA
expires
Mon, 31 Jan 2022 18:32:20 GMT
questex.js
cdn.blueconic.net/
141 KB
42 KB
Script
General
Full URL
https://cdn.blueconic.net/questex.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
108.157.4.100 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
- /
Resource Hash
365bca218653492c7ccd4b2e285a3242b8f7d76fda1f62cd194eebf8f4a480a3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:02:39 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-permitted-cross-domain-policies
master-only
age
449
x-cache
Hit from cloudfront
content-length
42354
x-xss-protection
1; mode=block
last-modified
Wed, 19 Jan 2022 14:47:53 GMT
server
-
etag
"233e2-5d5f0787c7150-gzip"
vary
Accept-Encoding
content-type
text/javascript; charset=utf-8
via
1.1 b6b3463eedbd4b446fd969736178bf98.cloudfront.net (CloudFront)
cache-control
public, max-age=600, s-maxage=500
x-amz-cf-pop
DUS51-P2
accept-ranges
none
x-robots-tag
noindex, nofollow
x-amz-cf-id
nUPDGfPe6tO8rIW1ZIpa8f-l-qwGkjAROxFwsSLudOTEvVtHAwXfyg==
logo-pharma.svg
www.fiercepharma.com/themes/custom/tektite_fierce/assets/images/logo/
4 KB
2 KB
Image
General
Full URL
https://www.fiercepharma.com/themes/custom/tektite_fierce/assets/images/logo/logo-pharma.svg?v=1.03
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
5f18dc38e84dbadb36b6e7d6da27e45e6fdf4c41ddac6a53452503922e96a73a
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
104167
x-cache
HIT
x-cache-hits
1
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-0a9452a2-1947-11ec-986b-8bfed097753d
x-robots-tag
noindex, nofollow
last-modified
Tue, 31 Aug 2021 05:57:18 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
max-age=1209600
cf-ray
6d80b4067c3e900a-FRA
expires
Tue, 01 Feb 2022 12:27:41 GMT
gild4.png
qtxasset.com/styles/breakpoint_xl_880px_w/s3/fiercepharma/1643750894/gild4.png/
224 KB
225 KB
Image
General
Full URL
https://qtxasset.com/styles/breakpoint_xl_880px_w/s3/fiercepharma/1643750894/gild4.png/gild4.png?VersionId=3yLsad1mYtmplaV2o3PxvvdYzbW8WCCP&itok=AK7LNQpd
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.16.94.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
ece17101fb311cb714783f9252046ab1804818d9c7b99eb235af889ebd352992

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
cf-cache-status
HIT
x-amz-request-id
T93VDG2XF1P7V6XW
cf-polished
origFmt=png, origSize=591922
cf-ray
6d80b406b95a9078-FRA
x-amz-replication-status
COMPLETED
content-disposition
inline; filename="gild4.webp"
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length
229336
x-amz-id-2
uZBlIaF1HhatkMTiNErLSwHD7j1ZxDgcvZeCwoRmwCyh12r3vnalxkTUggf4LTRxHWF/PBbasNk=
last-modified
Tue, 01 Feb 2022 21:29:36 GMT
server
cloudflare
etag
"801b49b13c217ffb227ccb0779e3d4bb"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept
x-amz-version-id
3yLsad1mYtmplaV2o3PxvvdYzbW8WCCP
cache-control
public, max-age=604800
accept-ranges
bytes
content-type
image/webp
cf-bgj
imgq:85,h2pri
Eric_Sag.jpg
qtxasset.com/field/image/
7 KB
8 KB
Image
General
Full URL
https://qtxasset.com/field/image/Eric_Sag.jpg?VersionId=b458ccmSHb78osh3WvQU1RFsMB4jKjsz
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.16.94.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
71e08605c0f27e4c03358bd354623d54585b63c138c75dcc6f455162f86bc827

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
cf-cache-status
HIT
age
324567
cf-polished
qual=85, origFmt=jpeg, origSize=65027
cf-ray
6d80b406b95c9078-FRA
content-disposition
inline; filename="Eric_Sag.webp"
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length
7510
x-amz-id-2
MAdiGVKZTavhrCx6oGc7baqWo38MV3KP0uelXOqevBFG0Vh1aooadMo4BvElktgWKYJBeX08El8=
last-modified
Tue, 12 Apr 2016 20:59:46 GMT
server
cloudflare
etag
"20b03d6da19ef476e3f8d9936f8cbec3"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept
x-amz-request-id
VJ8PT3QNP15K8EBZ
x-amz-version-id
b458ccmSHb78osh3WvQU1RFsMB4jKjsz
accept-ranges
bytes
content-type
image/webp
cf-bgj
imgq:85,h2pri
email-decode.min.js
www.fiercepharma.com/cdn-cgi/scripts/5c5dd728/cloudflare-static/
1 KB
937 B
Script
General
Full URL
https://www.fiercepharma.com/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
2595496fe48df6fcf9b1bc57c29a744c121eb4dd11566466bc13d2e52e6bbcc8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 27 Jan 2022 10:01:18 GMT
server
cloudflare
etag
W/"61f26d6e-4d7"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
x-frame-options
DENY
content-type
application/javascript
cache-control
max-age=172800, public
cf-ray
6d80b4061bef900a-FRA
vary
Accept-Encoding
expires
Sun, 06 Feb 2022 03:09:58 GMT
questex-logo-white.svg
www.fiercepharma.com/themes/custom/tektite/assets/images/
4 KB
2 KB
Image
General
Full URL
https://www.fiercepharma.com/themes/custom/tektite/assets/images/questex-logo-white.svg?v=0.1
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
680030a41d9b8dcd5edc79e159a420da353dd6638a041a6db69eb0df8b5073b2
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
846620
x-cache
HIT
x-cache-hits
3
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-3fa602e8-23aa-11ec-8f9e-075ba2d22459
x-robots-tag
noindex, nofollow
last-modified
Tue, 31 Aug 2021 05:57:18 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
max-age=1209600
cf-ray
6d80b4067c3f900a-FRA
expires
Sun, 23 Jan 2022 11:21:12 GMT
hb_302826_6936.js
player.mediafuse.com/prebidlink/456651/
464 KB
139 KB
Script
General
Full URL
https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.4 Philadelphia, United States, ASN7018 (ATT-INTERNET4, US),
Reverse DNS
Software
nginx /
Resource Hash
75524eb00f5d9b7069c27db2fc8473bfc82dc7cedc3f7cf88c76c833fe1f20dc

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
last-modified
Thu, 03 Feb 2022 19:58:27 GMT
server
nginx
etag
W/"61fc33e3-73e67"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Fri, 04 Feb 2022 04:09:58 GMT
gpt.js
securepubads.g.doubleclick.net/tag/js/
80 KB
27 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/tag/js/gpt.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.186.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s08-in-f2.1e100.net
Software
sffe /
Resource Hash
11b9fc2cd432fa635512188722aa48c09c7a01eefb87302ed7f3215ec7f99ed5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27228
x-xss-protection
0
server
sffe
etag
"1121 / 10 of 1000 / last-modified: 1643929548"
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Fri, 04 Feb 2022 03:09:58 GMT
wrapper_hb_302826_6936.js
player.mediafuse.com/prebidlink/456651/
1 KB
841 B
Script
General
Full URL
https://player.mediafuse.com/prebidlink/456651/wrapper_hb_302826_6936.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.4 Philadelphia, United States, ASN7018 (ATT-INTERNET4, US),
Reverse DNS
Software
nginx /
Resource Hash
6325f7a25c4403ed680a95172069a4571086cbcbf4aac2ea1f028e8ced4818d8

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
last-modified
Thu, 03 Feb 2022 20:31:33 GMT
server
nginx
etag
W/"61fc3ba5-421"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Fri, 04 Feb 2022 04:09:58 GMT
gtm.js
www.googletagmanager.com/
161 KB
56 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82f::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
68b08fd237d8d03f82dcf3f8a30f47bf82361165a777cc94109370f41b24a37a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
br
server
Google Tag Manager
access-control-allow-headers
Cache-Control
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=31536000; includeSubDomains
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
56378
x-xss-protection
0
expires
Fri, 04 Feb 2022 03:09:58 GMT
js_c8LbWbHV1txem3q8oAzuadnL-HiBShaQH_WRviNqT_g.js
www.fiercepharma.com/sites/fiercepharma/files/js/
87 KB
32 KB
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_c8LbWbHV1txem3q8oAzuadnL-HiBShaQH_WRviNqT_g.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b541d631712bc34f7472aabf9cdeaf0fcb2257fd2436ffced1530f5d4f5a0383
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
846620
cf-polished
origSize=89478
x-cache
HIT
last-modified
Thu, 30 Dec 2021 18:15:57 GMT
x-cache-hits
41
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-d25ab1a8-7164-11ec-9e34-1b558f64b334
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
6d80b4065c25900a-FRA
expires
Sun, 23 Jan 2022 15:57:18 GMT
js_hQSXU_zbJqof3y12MhPI7Ysd2kGl33cJXGVpYtnDbf0.js
www.fiercepharma.com/sites/fiercepharma/files/js/
16 KB
7 KB
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_hQSXU_zbJqof3y12MhPI7Ysd2kGl33cJXGVpYtnDbf0.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
8111f22e56354c8880315afdd87fe63c7d82284596f7288969247a118accc642
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
846472
cf-polished
origSize=16281
x-cache
HIT
last-modified
Thu, 30 Dec 2021 18:15:57 GMT
x-cache-hits
17
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-874103aa-7215-11ec-a44a-83c705574550
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
6d80b4066c3a900a-FRA
expires
Mon, 24 Jan 2022 13:02:13 GMT
page.js
static.addtoany.com/menu/
72 KB
26 KB
Script
General
Full URL
https://static.addtoany.com/menu/page.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:47c5 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
f22120d1591b5397235fec8a01ffcc7d45fa6bd0b4cd6f93b8999c9365b359f1
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
via
e1s
x-content-type-options
nosniff
cf-cache-status
HIT
age
87100
p3p
CP="ALL DSP COR CURa ADMa DEVa TAIa PSAa PSDa OUR IND UNI COM NAV INT"
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
last-modified
Wed, 01 Dec 2021 08:23:25 GMT
server
cloudflare
etag
W/"11ee2-5d2116348919c"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
application/javascript; charset=utf-8
vary
Accept-Encoding
cache-control
public, max-age=172800
cf-ray
6d80b406b9e93746-MXP
cf-bgj
minify
js_K8WjWylJMuC9X7UPhFnx2PKpGfKXSmt2neJ09X-RgCQ.js
www.fiercepharma.com/sites/fiercepharma/files/js/
21 KB
8 KB
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_K8WjWylJMuC9X7UPhFnx2PKpGfKXSmt2neJ09X-RgCQ.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
9b17ed6f201a539d617120eb2b829a3a32a661daf2f04893c5978b25dd781034
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
846653
cf-polished
origSize=21128
x-cache
HIT
last-modified
Thu, 30 Dec 2021 18:15:57 GMT
x-cache-hits
16
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-94fea102-6e2b-11ec-8e41-3325e2a98abd
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
6d80b4066c3b900a-FRA
expires
Wed, 19 Jan 2022 13:30:00 GMT
webfont.js
ajax.googleapis.com/ajax/libs/webfont/1.6.26/
13 KB
14 KB
Script
General
Full URL
https://ajax.googleapis.com/ajax/libs/webfont/1.6.26/webfont.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:813::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
81016ac6be850b72df5d4faa0c3cec8e2c1b0ba0045712144a6766adfad40bee
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 21:28:28 GMT
x-content-type-options
nosniff
age
20490
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/hosted-libraries-pushers
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13188
x-xss-protection
0
last-modified
Tue, 03 Mar 2020 19:15:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="hosted-libraries-pushers"
vary
Accept-Encoding
report-to
{"group":"hosted-libraries-pushers","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/hosted-libraries-pushers"}]}
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=31536000, stale-while-revalidate=2592000
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 03 Feb 2023 21:28:28 GMT
js_6txShFh2kqJNyQ8zIiSXaxbK3dpMeRh5Z0PsEAh7qp8.js
www.fiercepharma.com/sites/fiercepharma/files/js/
762 B
723 B
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_6txShFh2kqJNyQ8zIiSXaxbK3dpMeRh5Z0PsEAh7qp8.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
19d8552b92ae03e066893a9d818a5336bd0d107812dff3c05daef636d8750d38
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
846702
cf-polished
origSize=763
x-cache
HIT
last-modified
Thu, 30 Dec 2021 18:15:57 GMT
x-cache-hits
12
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-99d5f14a-72bc-11ec-9c36-17d9743aa17f
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
6d80b4067c41900a-FRA
expires
Tue, 25 Jan 2022 08:58:10 GMT
forms2.min.js
app-sj10.marketo.com/js/forms2/js/
205 KB
68 KB
Script
General
Full URL
https://app-sj10.marketo.com/js/forms2/js/forms2.min.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.16.94.80 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
2689a0237a95cfd8135f8da3ac79c430e903f3c542f8b862f68141c84c348c43
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
last-modified
Wed, 12 Jan 2022 18:47:30 GMT
server
cloudflare
age
4343
etag
"1e40b8f-33210-5d567007b9480"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
public, max-age=14400
cf-ray
6d80b4079d679249-FRA
expires
Fri, 04 Feb 2022 07:09:58 GMT
js_7D5NINMm97AVjKhvsRV_XgPiqQeouLiSNcG1CZ8eWQM.js
www.fiercepharma.com/sites/fiercepharma/files/js/
5 KB
2 KB
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_7D5NINMm97AVjKhvsRV_XgPiqQeouLiSNcG1CZ8eWQM.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
8f00fec474ffe65144177c5c92038cc7ce0695fc9975ebf2130d3bc393a3e645
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
846471
cf-polished
origSize=4669
x-cache
HIT
last-modified
Thu, 30 Dec 2021 18:15:58 GMT
x-cache-hits
1
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-f4329574-6f1c-11ec-ae90-033872d0c646
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
6d80b4067c3c900a-FRA
expires
Thu, 03 Feb 2022 21:43:55 GMT
qFdH35WCmI96Ajtm81GlU9s.woff2
fonts.gstatic.com/s/overpass/v10/
38 KB
38 KB
Font
General
Full URL
https://fonts.gstatic.com/s/overpass/v10/qFdH35WCmI96Ajtm81GlU9s.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css2?family=Overpass:ital,wght@0,400;0,700;0,900;1,400&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:831::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
995dfb0c839090c9461662fca31b3d886f80dd9e881db8ea224374866eade55f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 05:25:53 GMT
x-content-type-options
nosniff
age
78245
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
38496
x-xss-protection
0
last-modified
Thu, 03 Feb 2022 00:25:12 GMT
server
sffe
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="apps-themes"
expires
Fri, 03 Feb 2023 05:25:53 GMT
cs
questex.blueconic.net/DG/DEFAULT/
0
0
Script
General
Full URL
https://questex.blueconic.net/DG/DEFAULT/cs?&callback=bc_json958
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.72.7.92 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-72-7-92.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

qFdU35WCmI96Ajtm81GgSdXCNs-VMF0vNLADeqqIncM.woff2
fonts.gstatic.com/s/overpass/v10/
16 KB
16 KB
Font
General
Full URL
https://fonts.gstatic.com/s/overpass/v10/qFdU35WCmI96Ajtm81GgSdXCNs-VMF0vNLADeqqIncM.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css2?family=Overpass:ital,wght@0,400;0,700;0,900;1,400&display=swap
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:831::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
94e5daea972ac93120f8535bff5a2bd57f1dc36dd36e5dbfe70639b75f1f8e33
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 06:28:40 GMT
x-content-type-options
nosniff
age
74478
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
16324
x-xss-protection
0
last-modified
Thu, 03 Feb 2022 00:25:41 GMT
server
sffe
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="apps-themes"
expires
Fri, 03 Feb 2023 06:28:40 GMT
fontello.woff2
www.fiercepharma.com/themes/custom/tektite/assets/fonts/
6 KB
7 KB
Font
General
Full URL
https://www.fiercepharma.com/themes/custom/tektite/assets/fonts/fontello.woff2
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
1daf67a5a85e55210b5e212a8be8392f1f93c01ce54effd63eab78f0b80dfb44
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.fiercepharma.com/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
846620
x-cache
HIT
x-cache-hits
231
x-ah-environment
prod
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length
6644
x-request-id
v-6f862608-28e3-11ec-a436-bbed65516c8b
x-robots-tag
noindex, nofollow
last-modified
Tue, 31 Aug 2021 05:57:18 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
cache-control
max-age=1209600
accept-ranges
bytes
cf-ray
6d80b4068c51900a-FRA
expires
Fri, 21 Jan 2022 22:02:28 GMT
asyncPixelSync
pixel.sitescout.com/dmp/ Frame E3FF
Redirect Chain
  • https://pixel-a.basis.net/dmp/asyncPixelSync
  • https://pixel.sitescout.com/dmp/asyncPixelSync
0
0
Document
General
Full URL
https://pixel.sitescout.com/dmp/asyncPixelSync
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
66.155.71.150 Portsmouth, United Kingdom, ASN13768 (COGECO-PEER1, CA),
Reverse DNS
Software
AC1.1 /
Resource Hash

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis

Response headers

cache-control
max-age=0,no-cache,no-store
pragma
no-cache
expires
Tue, 11 Oct 1977 12:34:56 GMT
p3p
CP="NON DEVa PSAa PSDa OUR NOR NAV",policyref="/w3c/p3p.xml"
date
Fri, 04 Feb 2022 03:09:57 GMT
server
AC1.1

Redirect headers

content-length
0
location
https://pixel.sitescout.com/dmp/asyncPixelSync
7f1874304d399254
pixel.sitescout.com/iap/
Redirect Chain
  • https://pixel-a.basis.net/iap/7f1874304d399254
  • https://pixel.sitescout.com/iap/7f1874304d399254
0
191 B
Image
General
Full URL
https://pixel.sitescout.com/iap/7f1874304d399254
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Server
66.155.71.150 Portsmouth, United Kingdom, ASN13768 (COGECO-PEER1, CA),
Reverse DNS
Software
AC1.1 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Feb 2022 03:09:58 GMT
cache-control
max-age=0,no-cache,no-store
server
AC1.1
p3p
CP="NON DEVa PSAa PSDa OUR NOR NAV",policyref="/w3c/p3p.xml"
expires
Tue, 11 Oct 1977 12:34:56 GMT

Redirect headers

location
https://pixel.sitescout.com/iap/7f1874304d399254
content-length
0
init.do
sample.dragonforms.com/ Frame A406
Redirect Chain
  • https://sample.dragonforms.com/FiercePharma_short
  • https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short
279 B
620 B
Document
General
Full URL
https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
82bf27f408e3d524f53a94492b845458ebb576e5873d57a452815f859953dff2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

X-Content-Type-Options
nosniff
X-XSS-Protection
1; mode=block
Access-Control-Allow-Origin
*
Content-Type
text/html;charset=ISO-8859-1
Date
Fri, 04 Feb 2022 03:09:58 GMT
Server
Apache
Vary
Accept-Encoding
Content-Encoding
gzip
Transfer-Encoding
chunked

Redirect headers

Location
init.do?omedasite=FiercePharma_short
Content-Length
0
Date
Fri, 04 Feb 2022 03:09:58 GMT
Server
Apache
p.js
d1z2jf7jlzjs58.cloudfront.net/
930 B
1 KB
Script
General
Full URL
https://d1z2jf7jlzjs58.cloudfront.net/p.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/sites/fiercepharma/files/js/js_K8WjWylJMuC9X7UPhFnx2PKpGfKXSmt2neJ09X-RgCQ.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
18.66.242.197 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-242-197.dus51.r.cloudfront.net
Software
nginx /
Resource Hash
62f586be8571b23584eb4a60a45a3157ff7c8388b1b1e3b4e8890e243b3e47de

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Thu, 03 Feb 2022 07:06:37 GMT
Via
1.1 6b2d62d60926d8d51fdcbcc94fce643a.cloudfront.net (CloudFront)
Age
72201
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
930
Pragma
public
Last-Modified
Wed, 06 May 2020 20:19:48 GMT
Server
nginx
ETag
"5eb31be4-3a2"
Content-Type
application/javascript
Cache-Control
max-age=86400, public
X-Amz-Cf-Pop
DUS51-P1
Accept-Ranges
bytes
X-Amz-Cf-Id
sO6pzZxhavAyiyacWYucJxeXR11yRq0aPMWSq7QjoKFyQx0rCXIwvg==
Expires
Fri, 04 Feb 2022 07:06:37 GMT
sm.23.html
static.addtoany.com/menu/ Frame 425F
741 B
820 B
Document
General
Full URL
https://static.addtoany.com/menu/sm.23.html
Requested by
Host: static.addtoany.com
URL: https://static.addtoany.com/menu/page.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700:10::6816:47c5 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4ca130786a2d2531241f8b8c7aaad6a4e27271f51b417b9c23f51bfb0c65c080
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
content-type
text/html; charset=utf-8
p3p
CP="ALL DSP COR CURa ADMa DEVa TAIa PSAa PSDa OUR IND UNI COM NAV INT"
last-modified
Wed, 22 Sep 2021 23:42:51 GMT
etag
W/"2e5-5cc9e128a4c38"
cache-control
max-age=315360000, immutable
vary
Accept-Encoding
via
e2s
cf-cache-status
HIT
age
1904446
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-content-type-options
nosniff
server
cloudflare
cf-ray
6d80b4074e2d3743-MXP
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
truncated
/
34 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
1e85ec81b9800b4c443d39caca0d0926089a3ac201120db1ceb45b93789480b8

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Content-Type
image/gif
pubads_impl_2022013101.js
securepubads.g.doubleclick.net/gpt/
356 KB
120 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022013101.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.186.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s08-in-f2.1e100.net
Software
sffe /
Resource Hash
80e9b90d32a294251cbec3aa3402fbd9c560100a23484d7947fd61e1faf5740e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 01:01:22 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
7716
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
122566
x-xss-protection
0
last-modified
Mon, 31 Jan 2022 09:40:52 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
public, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Sat, 04 Feb 2023 01:01:22 GMT
ppub_config
securepubads.g.doubleclick.net/pagead/
39 B
79 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/pagead/ppub_config?ippd=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.186.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s08-in-f2.1e100.net
Software
cafe /
Resource Hash
2ad9341e45c5e7676ed8925d391b5a96802a29c898d1e4909c4537c0f5a6a2ce
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/json; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
55
x-xss-protection
0
expires
Fri, 04 Feb 2022 03:09:58 GMT
hbw_master_302826_6936.js
player.hbmp.mediafuse.com/prebidlink/456651/
94 KB
29 KB
Script
General
Full URL
https://player.hbmp.mediafuse.com/prebidlink/456651/hbw_master_302826_6936.js
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/wrapper_hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.4 Philadelphia, United States, ASN7018 (ATT-INTERNET4, US),
Reverse DNS
Software
nginx /
Resource Hash
8fb5ace72c144d5fbfaf085db1d2fde5cfb3df870a9b1b5c1041b303c94647bf

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
last-modified
Thu, 03 Feb 2022 20:31:33 GMT
server
nginx
etag
W/"61fc3ba5-1783c"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Fri, 04 Feb 2022 04:09:58 GMT
icons.30.svg.js
static.addtoany.com/menu/svg/
77 KB
33 KB
Script
General
Full URL
https://static.addtoany.com/menu/svg/icons.30.svg.js
Requested by
Host: static.addtoany.com
URL: https://static.addtoany.com/menu/page.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700:10::6816:47c5 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
7e6f3eacf6af919ace45f10e39eda3e72143e0f57aad29590a6d37d5ddd0292f
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
via
e1s
x-content-type-options
nosniff
cf-cache-status
HIT
age
7415769
p3p
CP="ALL DSP COR CURa ADMa DEVa TAIa PSAa PSDa OUR IND UNI COM NAV INT"
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
last-modified
Wed, 10 Nov 2021 01:49:04 GMT
server
cloudflare
etag
W/"132a9-5d0656e4a26b3"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
application/javascript; charset=utf-8
vary
Accept-Encoding
cache-control
max-age=315360000, immutable
cf-ray
6d80b4074e2e3743-MXP
cf-bgj
minify
analytics.js
www.google-analytics.com/
49 KB
20 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80e::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
a1925038db769477ab74b4df34350c35688a795bb718727b0f4292a4a78a6210
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Tue, 02 Nov 2021 17:39:06 GMT
server
Golfe2
age
5704
date
Fri, 04 Feb 2022 01:34:54 GMT
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
20006
expires
Fri, 04 Feb 2022 03:34:54 GMT
4740.js
script.crazyegg.com/pages/scripts/0092/
5 KB
2 KB
Script
General
Full URL
https://script.crazyegg.com/pages/scripts/0092/4740.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:9408 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
daaf47e176780239d864e64b1729d088b9e9a005e19b1bd39fda65dee2e26a6f

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
cf-cache-status
HIT
age
35346
cf-polished
origSize=4899
cf-ray
6d80b407993583b4-MXP
ce-version
11.1.376
last-modified
Thu, 03 Feb 2022 17:20:52 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
access-control-allow-origin
*
access-control-expose-headers
CE-Version
cache-control
public, max-age=300, s-maxage=1209600
timing-allow-origin
*
cf-bgj
minify
munchkin.js
munchkin.marketo.net/
1 KB
1 KB
Script
General
Full URL
https://munchkin.marketo.net/munchkin.js
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
104.111.234.67 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-234-67.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
4bf3aca933aa233702f890083af601fb16149ec8a17f8c1b90d30450562bde08

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Fri, 04 Feb 2022 03:09:58 GMT
Content-Encoding
gzip
Last-Modified
Fri, 29 Oct 2021 01:24:07 GMT
Server
AkamaiNetStorage
ETag
"461ce1cffaadfebf2e7659745618ba8e:1635470647.434977"
Vary
Accept-Encoding
P3P
policyref="http://www.marketo.com/w3c/p3p.xml", CP="NOI DSP COR NID CURi OUR NOR"
Connection
keep-alive
Accept-Ranges
bytes
Content-Type
application/x-javascript
Content-Length
753
dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
s.dpmsrv.com/
127 KB
39 KB
Script
General
Full URL
https://s.dpmsrv.com/dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
108.157.4.42 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
9d2da124cff01ac4a3756346555d1f2cf049de603f2fb44a5d9fcb973a85686d

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Thu, 03 Feb 2022 15:40:22 GMT
Content-Encoding
gzip
Last-Modified
Thu, 03 Feb 2022 15:40:11 GMT
Server
AmazonS3
Age
41377
ETag
"bef77cacda1dde40b3506b2bde1566de"
X-Cache
Hit from cloudfront
Content-Type
application/x-javascript
Via
1.1 e4aaaf9d55a242f83ddc793442b0ebe2.cloudfront.net (CloudFront)
Connection
keep-alive
X-Amz-Cf-Pop
DUS51-P2
Accept-Ranges
bytes
Content-Length
39698
X-Amz-Cf-Id
8NMyuXPTrYvMU8ospqCKL355tcXNGLpYbaYAlPpMI02qTo_2RWP2Ig==
WgRbL7NLS90BFPSb6pBa
ws.zoominfo.com/pixel/
1 KB
1 KB
Script
General
Full URL
https://ws.zoominfo.com/pixel/WgRbL7NLS90BFPSb6pBa
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:650c , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare / Express
Resource Hash
ba8a68a79c27e3e5c5e617a1d99422de0ef3185b8937269e18c584ed86a6cb60
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
server
cloudflare
x-powered-by
Express
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
6d80b407cd555a25-MXP
access-control-allow-headers
Content-Type,cf-ipcountry,service-version,x-appengine-user-ip,x-forwarded-for
via
1.1 google
olytics.min.js
olytics.omeda.com/olytics/js/v3/p/
271 KB
73 KB
Script
General
Full URL
https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
007272a5de64355d0f00f3e6fa5b9362570130782071b3c7269d05752aec6d73
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Thu, 03 Feb 2022 19:09:58 PST
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Last-Modified
Tue, 11 Jan 2022 17:41:06 GMT
Server
Apache
ETag
W/"277863-1641922866000"
X-Frame-Options
SAMEORIGIN
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=21600
Transfer-Encoding
chunked
Accept-Ranges
bytes
vary
accept-encoding
X-XSS-Protection
1; mode=block
Expires
Fri, 04 Feb 2022 09:09:59 GMT
olytics.css
olytics.omeda.com/olytics/css/v3/p/
28 KB
3 KB
Stylesheet
General
Full URL
https://olytics.omeda.com/olytics/css/v3/p/olytics.css
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
78057ff881c7ceb369c163fee7ab0d93ae4754f3a7503d5dbfd4a0b80e203a79
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Thu, 03 Feb 2022 19:09:58 PST
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Last-Modified
Fri, 27 Aug 2021 04:05:28 GMT
Server
Apache
ETag
W/"28820-1630037128000"
X-Frame-Options
SAMEORIGIN
Content-Type
text/css
Access-Control-Allow-Origin
*
Cache-Control
max-age=21600
Transfer-Encoding
chunked
Accept-Ranges
bytes
vary
accept-encoding
X-XSS-Protection
1; mode=block
Expires
Fri, 04 Feb 2022 09:09:59 GMT
957
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0

p.js
cdn.parsely.com/keys/fiercepharma.com/
47 KB
18 KB
Script
General
Full URL
https://cdn.parsely.com/keys/fiercepharma.com/p.js
Requested by
Host: d1z2jf7jlzjs58.cloudfront.net
URL: https://d1z2jf7jlzjs58.cloudfront.net/p.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.103.127 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-103-127.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
e1feaafecf95d6dfa9fd5dc4ade49fcb29c6a697c713e423940b83e00ae3ad35

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma
public
date
Thu, 03 Feb 2022 05:11:11 GMT
content-encoding
gzip
last-modified
Fri, 02 Jul 2021 02:33:20 GMT
server
nginx
age
79127
etag
W/"60de7af0-bd27"
x-cache
Hit from cloudfront
content-type
application/javascript
via
1.1 ba77f90aac0ddbc2c4c2c02062fac762.cloudfront.net (CloudFront)
cache-control
max-age=86400, public
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
lWtgv6azesfsl8uhaGcl0ZlKUPp8CebrJk29Ejc-cqmN11s5DKS1jg==
expires
Fri, 04 Feb 2022 05:11:11 GMT
collect
www.google-analytics.com/j/
2 B
22 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j96&a=60163373&t=pageview&_s=1&dl=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&dr=https%3A%2F%2Fgo.questexnetwork.com%2F&ul=en-us&de=UTF-8&dt=Gilead%20to%20fork%20over%20%241.25B%2C%20pay%203%25%20royalty%20on%20blockbuster%20Biktarvy%20in%20GSK%20patent%20settlement%20%7C%20FiercePharma&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=YGBACAABBAAAAC~&jid=1314271389&gjid=202269060&cid=314761443.1643944198&tid=UA-336524-28&_gid=132336096.1643944198&_r=1&gtm=2wg220KLQFWCZ&z=1430498497
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
de3246094525b21a870fc7d2a67490d0132535c6fa5993755c549f1a9d1bd8af
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Fri, 04 Feb 2022 03:09:58 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
ghb.hbmp.mediafuse.com/geo/
132 B
388 B
XHR
General
Full URL
https://ghb.hbmp.mediafuse.com/geo/
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456651/hbw_master_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.239.173.66 , United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
5f0c7dd8b670ace5203d3cfb1e27bd394b7d64f82d17e50e841174d346bbdb5d

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Fri, 04 Feb 2022 03:09:58 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Content-Length
132
Content-Type
application/json
tracking
ghb.hbmp.mediafuse.com/adunit/
43 B
425 B
XHR
General
Full URL
https://ghb.hbmp.mediafuse.com/adunit/tracking?event=11&type=0&client_id=302826&site_id=6936&full_page_url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&adid=7txh43.dz&features=32&utm_source=nurture-email&utm_medium=email&vpbv=N048&lifecycle_tte=1049
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456651/hbw_master_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.239.173.66 , United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Fri, 04 Feb 2022 03:09:58 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Content-Length
43
Content-Type
image/gif
4740.json
script.crazyegg.com/pages/data-scripts/0092/
18 KB
2 KB
XHR
General
Full URL
https://script.crazyegg.com/pages/data-scripts/0092/4740.json?t=1
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/scripts/0092/4740.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:9408 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4de431dac68d10398133598ead8a1b33e17b83433c72fe8bd56a5a0963fd696a

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
cf-cache-status
HIT
age
35499
ce-version
11.1.376
content-length
1877
timing-allow-origin
*
last-modified
Thu, 03 Feb 2022 17:18:19 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
*
access-control-expose-headers
CE-Version
cache-control
public, max-age=300, s-maxage=1209600
accept-ranges
bytes
cf-ray
6d80b4085c275a07-MXP
munchkin.js
munchkin.marketo.net/161/
11 KB
5 KB
Script
General
Full URL
https://munchkin.marketo.net/161/munchkin.js
Requested by
Host: munchkin.marketo.net
URL: https://munchkin.marketo.net/munchkin.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
104.111.234.67 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-234-67.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
c2aee78040b4ed46c2377e6825db12a9691a2eb584adf338e77312c8978d8537

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Fri, 04 Feb 2022 03:09:58 GMT
Content-Encoding
gzip
Last-Modified
Wed, 08 Sep 2021 00:38:21 GMT
Server
AkamaiNetStorage
ETag
"0e0eefac8daf874e8b1aa34aeb160c52:1631061501.737429"
Vary
Accept-Encoding
P3P
policyref="http://www.marketo.com/w3c/p3p.xml", CP="NOI DSP COR NID CURi OUR NOR"
Cache-Control
max-age=8640000
Connection
keep-alive
Accept-Ranges
bytes
Content-Type
application/x-javascript
Content-Length
4681
Expires
Sun, 15 May 2022 03:09:58 GMT
index.php
a.dpmsrv.com/dpmpxl/
Redirect Chain
  • https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&q%3DxImp%26v%3D1.x%26cl%3D913%26pixelIndex%3D0%26r%3D447159%26tzOffset%3D0%26url%3Dhttps%253A%252F%252Fwww.fiercepharma.com...
  • https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fa.dpmsrv.com%2Fdpmpxl%2Findex.php%3Fid%3D%24UID%26q%253DxImp%2526v%253D1.x%2526cl%253D913%2526pixelIndex%253D0%2526r%253D447159%2526tzOffset%25...
  • https://a.dpmsrv.com/dpmpxl/index.php?id=3035801625078687012&q=xImp&v=1.x&cl=913&pixelIndex=0&r=447159&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-...
249 B
997 B
Script
General
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?id=3035801625078687012&q=xImp&v=1.x&cl=913&pixelIndex=0&r=447159&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&_=1643944197658
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
HTTP/1.1
Server
52.6.171.241 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-6-171-241.compute-1.amazonaws.com
Software
/
Resource Hash
ad1b2301bd562e4a428ae8ad1f346b339f69a0f779b9d94953e406a017e6c1f7

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma
no-cache
content-encoding
gzip
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin
*
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Type
text/javascript
Access-Control-Allow-Headers
content-type, accept
Content-Length
220
Expires
0

Redirect headers

Pragma
no-cache
Date
Fri, 04 Feb 2022 03:09:58 GMT
X-Proxy-Origin
193.27.14.20; 193.27.14.20; 536.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid
57b2a3b6-749e-4c71-ac8c-28e2829c5b63
Server
nginx/1.17.9
Access-Control-Allow-Origin
*
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Location
https://a.dpmsrv.com/dpmpxl/index.php?id=3035801625078687012&q=xImp&v=1.x&cl=913&pixelIndex=0&r=447159&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&_=1643944197658
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
collect
stats.g.doubleclick.net/j/
1 B
443 B
XHR
General
Full URL
https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j96&tid=UA-336524-28&cid=314761443.1643944198&jid=1314271389&gjid=202269060&_gid=132336096.1643944198&_u=YGBACAAABAAAAC~&z=1595801658
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:400c:c1b::9d Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
6b86b273ff34fce19d6b804eff5a3f5747ada4eaa22f1d49c01e52ddb7875b4b
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
date
Fri, 04 Feb 2022 03:09:58 GMT
content-type
text/plain
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
p1.parsely.com/plogger/
43 B
257 B
Image
General
Full URL
https://p1.parsely.com/plogger/?rand=1643944197688&plid=67642218&idsite=fiercepharma.com&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&urlref=https%3A%2F%2Fgo.questexnetwork.com%2F&screen=1600x1200%7C1600x1200%7C24&data=%7B%7D&sid=1&surl=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&sref=https%3A%2F%2Fgo.questexnetwork.com%2F&sts=1643944197685&slts=0&title=Gilead+to+fork+over+%241.25B%2C+pay+3%25+royalty+on+blockbuster+Biktarvy+in+GSK+patent+settlement+%7C+FiercePharma&date=Fri+Feb+04+2022+03%3A09%3A57+GMT%2B0000+(GMT)&action=pageview&pvid=27069023&u=pid%3D99242a0685fc932c91b15696b0e6866e
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.205.167.202 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-205-167-202.compute-1.amazonaws.com
Software
nginx /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Fri, 04 Feb 2022 03:09:58 GMT
Cache-Control
no-cache
Last-Modified
Friday, 04-Feb-2022 03:09:58 GMT
Server
nginx
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
visitWebPage
294-mqf-056.mktoresp.com/webevents/
2 B
311 B
Ping
General
Full URL
https://294-mqf-056.mktoresp.com/webevents/visitWebPage?_mchNc=1643944197694&_mchCn=&_mchId=294-MQF-056&_mchTk=_mch-fiercepharma.com-1643944197693-95979&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&_mchHo=www.fiercepharma.com&_mchPo=&_mchRu=%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement&_mchPc=https%3A&_mchVr=161&_mchEcid=&_mchHa=&_mchRe=https%3A%2F%2Fgo.questexnetwork.com%2F&_mchQp=utm_source%3Dnurture-email__-__utm_medium%3Demail__-__utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed__-__mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Requested by
Host: munchkin.marketo.net
URL: https://munchkin.marketo.net/161/munchkin.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
192.28.147.68 , United States, ASN15224 (OMNITURE, US),
Reverse DNS
Software
nginx /
Resource Hash
565339bc4d33d72817b583024112eb7f5cdf3e5eef0252d6ec1b9c9a94e12bb3

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Date
Fri, 04 Feb 2022 03:09:59 GMT
Content-Encoding
gzip
Server
nginx
Transfer-Encoding
chunked
Content-Type
text/plain; charset=UTF-8
Access-Control-Allow-Origin
*
Connection
keep-alive
X-Request-Id
a41434eb-0ed0-4958-9ca1-6c28de65f12b
11.1.376.js
script.crazyegg.com/pages/versioned/common-scripts/
71 KB
23 KB
Script
General
Full URL
https://script.crazyegg.com/pages/versioned/common-scripts/11.1.376.js
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/scripts/0092/4740.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:9408 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b401d1e804e0a5079603c8f74249ae0e2ec2c797703490f3a0c38079cd989027

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Wed, 01 Dec 2021 14:25:17 GMT
server
cloudflare
age
132559
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000, s-maxage=31536000
accept-ranges
bytes
cf-ray
6d80b4089a7383b4-MXP
content-length
23366
config.json
player.adtelligent.com/exchange_rates/279934/
8 KB
4 KB
XHR
General
Full URL
https://player.adtelligent.com/exchange_rates/279934/config.json?cb=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.3 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
444caa8ddf13eaba9faccc771ed11ca4a0ed77e016667caf9af840edad2356d0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
last-modified
Fri, 04 Feb 2022 00:03:05 GMT
server
nginx
etag
W/"61fc6d39-21f8"
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
expires
Fri, 04 Feb 2022 04:09:58 GMT
cache-control
max-age=3600
x-proxy-cache
HIT
tag.aspx
ml314.com/
27 KB
12 KB
Script
General
Full URL
https://ml314.com/tag.aspx?412022
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.229.143.145 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-229-143-145.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
e0eb74c400dded823098e4cdb9f71e9b360a3f33cad9b346879205851e70f887

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Fri, 04 Feb 2022 03:09:57 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
public, max-age=86400
Connection
keep-alive
Content-Length
11617
lead
www.fiercepharma.com/api/v1/marketo/
118 B
610 B
Fetch
General
Full URL
https://www.fiercepharma.com/api/v1/marketo/lead?mkto=id%3A294-MQF-056%26token%3A_mch-fiercepharma.com-1643944197693-95979&blueconicProfileId=null
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
7636741993ec5e8a1a82e6f2dbe4b6711fad6a8862403cd7e7e9c72c9f03ea9e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
MISS
x-cache
MISS
content-type
application/json
x-drupal-dynamic-cache
UNCACHEABLE
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-ef671266-8567-11ec-bcbf-7f2931de9d06
x-ua-compatible
IE=edge
last-modified
Fri, 04 Feb 2022 03:09:58 GMT
server
cloudflare
x-frame-options
SAMEORIGIN
etag
W/"1643944198"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Cookie,Accept-Encoding
content-language
en
x-generator
Drupal 8 (https://www.drupal.org)
cache-control
max-age=16588800, public
cf-ray
6d80b408fe9c900a-FRA
x-drupal-cache
MISS
expires
Sun, 19 Nov 1978 05:00:00 GMT
4740.json
script.crazyegg.com/pages/sampling-data-scripts/0092/
1 KB
483 B
XHR
General
Full URL
https://script.crazyegg.com/pages/sampling-data-scripts/0092/4740.json?t=456651
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/versioned/common-scripts/11.1.376.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:9408 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
327f4ccd4ebbe3848e299c7c883bde1540880e04876e8fac04454455a2c0e985

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
cf-cache-status
HIT
age
4041
ce-version
11.1.376
content-length
390
timing-allow-origin
*
last-modified
Fri, 04 Feb 2022 02:02:37 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
*
access-control-expose-headers
CE-Version
cache-control
public, max-age=300, s-maxage=1209600
accept-ranges
bytes
cf-ray
6d80b4090d525a07-MXP
healthcheck
pagestates-tracking.crazyegg.com/
19 B
421 B
XHR
General
Full URL
https://pagestates-tracking.crazyegg.com/healthcheck
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/versioned/common-scripts/11.1.376.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.98.81 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-98-81.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
830e67bda2532cd5880ee86e3b33e69721082f8458bb0df0cd4edbb1577fd375

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 21 Dec 2021 13:52:43 GMT
via
1.1 5ad96647558bd4911f05189f8afefd98.cloudfront.net (CloudFront)
last-modified
Tue, 05 Oct 2021 13:53:30 GMT
server
AmazonS3
age
3849436
etag
"d06f04fccf68d0b228a5923187ce1afd"
access-control-max-age
31536000
access-control-allow-methods
GET, HEAD
content-type
binary/octet-stream
access-control-allow-origin
*
x-cache
Hit from cloudfront
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
content-length
19
x-amz-cf-id
nAYaFZKqia0SIXWJWc-kKIbXEpFrFQCmIct-E5nrS2x0ETVAWnBYCA==
healthcheck
assets-tracking.crazyegg.com/
19 B
420 B
XHR
General
Full URL
https://assets-tracking.crazyegg.com/healthcheck
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/versioned/common-scripts/11.1.376.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.98.127 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-98-127.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
830e67bda2532cd5880ee86e3b33e69721082f8458bb0df0cd4edbb1577fd375

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 21 Dec 2021 13:24:28 GMT
via
1.1 9eb0e845437929074828e0cf53f179ae.cloudfront.net (CloudFront)
last-modified
Tue, 05 Oct 2021 13:53:30 GMT
server
AmazonS3
age
3851131
etag
"d06f04fccf68d0b228a5923187ce1afd"
access-control-max-age
31536000
access-control-allow-methods
GET, HEAD
content-type
binary/octet-stream
access-control-allow-origin
*
x-cache
Hit from cloudfront
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
content-length
19
x-amz-cf-id
wGeZIsKwHFEC7AHanvzUvhrQj0VT6kVzzqbYgqhoXq_3-MawIoGF6Q==
ece49d59-f8c9-48da-b2ee-fdb7e70ef2e9
https://www.fiercepharma.com/
53 B
0
Other
General
Full URL
blob:https://www.fiercepharma.com/ece49d59-f8c9-48da-b2ee-fdb7e70ef2e9
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
BLOB
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
8ff09cd0ee012fe06ed1b67dc914858cde819f21bb479f629994d9e49f3c0049

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Content-Length
53
Content-Type
text/javascript
prebid
prebid.deepintent.com/ Frame
0
0
Preflight
General
Full URL
https://prebid.deepintent.com/prebid
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
169.197.150.7 , United States, ASN398989 (DEEPINTENT, US),
Reverse DNS
g.deepintent.com
Software
c /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

access-control-allow-origin
https://www.fiercepharma.com
vary
Origin,Access-Control-Request-Method,Access-Control-Request-Headers
access-control-max-age
3600
access-control-allow-credentials
true
access-control-allow-methods
POST, GET, OPTIONS, DELETE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN
allow
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
content-length
0
date
Fri, 04 Feb 2022 03:09:58 GMT
server
c
auction
prebid.adnxs.com/pbs/v1/openrtb2/
88 B
481 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 Southall, United Kingdom, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
d1306870bdb1390bdd65f4db110c6837f6f9fd8f992950c5e257665720440bac

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Fri, 04 Feb 2022 03:09:58 GMT
Server
nginx/1.19.0
X-Prebid
pbs-go/0.194.0
Vary
Origin
Content-Type
text/plain; charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
88
Expires
0
ortb
bid.contextweb.com/header/
0
572 B
XHR
General
Full URL
https://bid.contextweb.com/header/ortb?src=prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
198.148.27.134 New York, United States, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
server
envoy
cwdl
22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148
access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
Access-Control-Allow-Origin
access-control-allow-credentials
true
x-envoy-upstream-service-time
5
cw-server
bid-deployment-66f4d6749f-grv44
fastlane.json
fastlane.rubiconproject.com/a/api/
261 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=55&alt_size_ids=57&eid_pubcid.org=fb0de1e4-d1ed-4074-92c2-685109b12cae%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=b8dbddc1-82c7-4deb-a04b-2a10b89f4ec0&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.6071036797676364
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
db3545353caa32293ffcf85a26db449e18218461b60e2c4b79b11848a71ba3ac

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Fri, 04 Feb 2022 03:09:58 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
261
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
261 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=15&alt_size_ids=10&eid_pubcid.org=fb0de1e4-d1ed-4074-92c2-685109b12cae%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=9b2d1538-99b1-4296-8ff0-5cae05ba7ac2&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.3789729816518328
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
99c8739d115931bc37e08d79c091eea8539732bab695db5a6a86ee01f368857a

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Fri, 04 Feb 2022 03:09:58 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
261
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
261 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=15&alt_size_ids=10&eid_pubcid.org=fb0de1e4-d1ed-4074-92c2-685109b12cae%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=5648ac3b-fd7b-45bf-8bda-f1b5da41e3f9&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.23303756200652015
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
a98943da227910eb53f498309343ea3e2db4095c0a77113b97072f8dd3e45882

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Fri, 04 Feb 2022 03:09:58 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
261
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
261 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=15&alt_size_ids=10&eid_pubcid.org=fb0de1e4-d1ed-4074-92c2-685109b12cae%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=c73784af-30c6-4a63-93dd-dc60b8a6f868&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.45531060459887174
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
27f75b453c62474791c078a502b49d97261de10f89b584f2a2632f432321639a

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Fri, 04 Feb 2022 03:09:59 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
261
Expires
Wed, 17 Sep 1975 21:32:10 GMT
c
prebid.a-mo.net/a/
0
352 B
XHR
General
Full URL
https://prebid.a-mo.net/a/c
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
147.75.61.140 Ashburn, United States, ASN54825 (PACKET, US),
Reverse DNS
Software
envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Fri, 04 Feb 2022 03:09:58 GMT
cache-control
max-age=0, private, must-revalidate
access-control-allow-credentials
true
server
envoy
x-envoy-upstream-service-time
219
vary
origin, Accept-Encoding
cygnus
htlb.casalemedia.com/
37 B
334 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=356568&v=7.2&ac=j&sd=1&r=%7B%22id%22%3A%2268c248e7aa09085%22%2C%22site%22%3A%7B%22ref%22%3A%22https%3A%2F%2Fgo.questexnetwork.com%2F%22%2C%22page%22%3A%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%2C%22ixdiag%22%3A%7B%22msd%22%3A4%2C%22msi%22%3A4%2C%22mfu%22%3A0%2C%22bu%22%3A4%2C%22iu%22%3A0%2C%22nu%22%3A0%2C%22ou%22%3A0%2C%22allu%22%3A4%2C%22ren%22%3Afalse%2C%22version%22%3A%226.7.0-pre%22%2C%22userIds%22%3A%5B%22pubcid%22%5D%7D%7D%2C%22imp%22%3A%5B%7B%22id%22%3A%22693132c2fed3c6e%22%2C%22banner%22%3A%7B%22topframe%22%3A1%2C%22format%22%3A%5B%7B%22w%22%3A970%2C%22h%22%3A250%2C%22ext%22%3A%7B%22siteID%22%3A%22356568%22%2C%22sid%22%3A%22970x250%22%7D%7D%5D%7D%7D%2C%7B%22id%22%3A%2271a15d864ee0ba%22%2C%22banner%22%3A%7B%22topframe%22%3A1%2C%22format%22%3A%5B%7B%22w%22%3A300%2C%22h%22%3A250%2C%22ext%22%3A%7B%22siteID%22%3A%22356568%22%2C%22sid%22%3A%22300x250%22%7D%7D%5D%7D%7D%2C%7B%22id%22%3A%227313e15ce41b4b8%22%2C%22banner%22%3A%7B%22topframe%22%3A1%2C%22format%22%3A%5B%7B%22w%22%3A300%2C%22h%22%3A250%2C%22ext%22%3A%7B%22siteID%22%3A%22356568%22%2C%22sid%22%3A%22300x250%22%7D%7D%5D%7D%7D%2C%7B%22id%22%3A%227540e6ca94ff0d5%22%2C%22banner%22%3A%7B%22topframe%22%3A1%2C%22format%22%3A%5B%7B%22w%22%3A300%2C%22h%22%3A250%2C%22ext%22%3A%7B%22siteID%22%3A%22356568%22%2C%22sid%22%3A%22300x250%22%7D%7D%5D%7D%7D%5D%2C%22at%22%3A1%2C%22user%22%3A%7B%22eids%22%3A%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22fb0de1e4-d1ed-4074-92c2-685109b12cae%22%7D%5D%7D%5D%7D%7D
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.111.28 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-21-111-28.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
f0c6b05bd3081ff497321a9faba68d0e8a4a4d8b99d91f4e5dd214d4fd96aba7

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Fri, 04 Feb 2022 03:09:58 GMT
x-ak-initial-geo
CC:[DE], RC:[HE], CN:[EU], CIP:[193.27.14.20], XFF:[]
server
Apache
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
x-cs-client-geo
12
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
37
x-ak-client-geo
12
expires
Fri, 04 Feb 2022 03:09:58 GMT
adreq
ads.servenobid.com/
596 B
638 B
XHR
General
Full URL
https://ads.servenobid.com/adreq?cb=3706
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.202.163.212 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-202-163-212.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
32cc35a950be9b832c08cab0f0024921b2bf1ef13bee16aad1e749ddfe28fb5b

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
amp-access-control-allow-source-origin
*
vary
accept-encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
AMP-Access-Control-Allow-Source-Origin
cache-control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
access-control-allow-credentials
true
prebid.1.2.aspx
inv-nets.admixer.net/
42 B
510 B
XHR
General
Full URL
https://inv-nets.admixer.net/prebid.1.2.aspx
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
146.0.227.110 , Ascension Island, ASN20773 (GODADDY, DE),
Reverse DNS
Software
nginx /
Resource Hash
c979ffd70003be58ccc574778b78d9303e8b5b3494a6cdeb01449d65a5a815e6
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Date
Fri, 04 Feb 2022 03:09:58 GMT
Server
nginx
P3p
CP="NID DSP ALL COR"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/javascript; charset=utf-8
Keep-Alive
timeout=25
Content-Length
42
X-Xss-Protection
0
/
ghb.adtelligent.com/v2/auction/
1 KB
594 B
XHR
General
Full URL
https://ghb.adtelligent.com/v2/auction/
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
209.58.175.20 , Singapore, ASN59253 (LEASEWEB-APAC-SIN-11 Leaseweb Asia Pacific pte. ltd., SG),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
304ee67ba714ba2383b0963fba1e097ea72568cd242f18444c3ace9603f967aa

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Date
Fri, 04 Feb 2022 03:09:58 GMT
Content-Encoding
gzip
Server
VertaMedia 1.0
Content-Type
application/json; charset=UTF-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
Content-Length
299
translator
hbopenbid.pubmatic.com/
0
120 B
XHR
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.237.133.116 Philadelphia, United States, ASN3257 (GTT-BACKBONE GTT, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Fri, 04 Feb 2022 03:09:59 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cdb
bidder.criteo.com/
18 B
317 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=34&wv=6.7.0-pre&cb=27633623986
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.2.131 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.am5.vip.prod.criteo.com
Software
Finatra /
Resource Hash
ad6aa18e132c373e6a0be7543103d4e5dfde8680587cea250550686591419910
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
server
Finatra
vary
Origin
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=31536000; preload;
timing-allow-origin
*
content-length
44
fastlane.json
fastlane.rubiconproject.com/a/api/
260 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=12398&site_id=48990&zone_id=1998744&size_id=55&alt_size_ids=57&rp_schain=1.0,1!luponmedia.com,1994122,1,,,&eid_pubcid.org=fb0de1e4-d1ed-4074-92c2-685109b12cae%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=b8dbddc1-82c7-4deb-a04b-2a10b89f4ec0&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.8797801666670284
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
63bca70a2894506ff88e5a84529f1ed4e4b5b0ec7ac5d6346042f6007376ab9f

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Fri, 04 Feb 2022 03:09:58 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
260
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
260 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=12398&site_id=48990&zone_id=1998744&size_id=15&alt_size_ids=10&rp_schain=1.0,1!luponmedia.com,1994122,1,,,&eid_pubcid.org=fb0de1e4-d1ed-4074-92c2-685109b12cae%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=9b2d1538-99b1-4296-8ff0-5cae05ba7ac2&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.9175235393454122
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
4f428f5f9ea0d7659702d2e0854bad158cd324e4fc164054f7b441c0c0fbdb2f

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Fri, 04 Feb 2022 03:09:58 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
260
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
260 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=12398&site_id=48990&zone_id=1998744&size_id=15&alt_size_ids=10&rp_schain=1.0,1!luponmedia.com,1994122,1,,,&eid_pubcid.org=fb0de1e4-d1ed-4074-92c2-685109b12cae%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=5648ac3b-fd7b-45bf-8bda-f1b5da41e3f9&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.17683901201008378
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
2b07b4c885027e5efc54f522ca46ca6741fa052eaaabe949422a6900fdf9d28f

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Fri, 04 Feb 2022 03:09:59 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
260
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
4 KB
3 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=12398&site_id=48990&zone_id=1998744&size_id=15&alt_size_ids=10&rp_schain=1.0,1!luponmedia.com,1994122,1,,,&eid_pubcid.org=fb0de1e4-d1ed-4074-92c2-685109b12cae%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=c73784af-30c6-4a63-93dd-dc60b8a6f868&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.8543352024031861
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
6643c9613b6d377daea94f430265876f261f2d11e4492c49b83682bb40f94eeb

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Fri, 04 Feb 2022 03:09:59 GMT
Content-Encoding
gzip
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
1775
Expires
Wed, 17 Sep 1975 21:32:10 GMT
/
colossusssp.com/
2 B
247 B
XHR
General
Full URL
https://colossusssp.com/?c=o&m=multi
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_CBC
Server
8.2.111.126 , United States, ASN46636 (NATCOWEB, US),
Reverse DNS
Software
nginx /
Resource Hash
4f53cda18c2baa0c0354bb5f9a3ecbe5ed12ab4d8e11ba873c2f11161202b945

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Fri, 04 Feb 2022 03:09:59 GMT
Access-Control-Allow-Credentials
true
Server
nginx
Connection
keep-alive
Content-Length
2
Content-Type
application/json
c
prebid.a-mo.net/a/
0
205 B
XHR
General
Full URL
https://prebid.a-mo.net/a/c
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
147.75.61.140 Ashburn, United States, ASN54825 (PACKET, US),
Reverse DNS
Software
envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Fri, 04 Feb 2022 03:09:58 GMT
cache-control
max-age=0, private, must-revalidate
access-control-allow-credentials
true
server
envoy
x-envoy-upstream-service-time
225
vary
origin, Accept-Encoding
adjson
ads.betweendigital.com/
2 B
916 B
XHR
General
Full URL
https://ads.betweendigital.com/adjson?t=prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
96.46.183.20 , United States, ASN7979 (SERVERS-COM, US),
Reverse DNS
Software
/
Resource Hash
4f53cda18c2baa0c0354bb5f9a3ecbe5ed12ab4d8e11ba873c2f11161202b945

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
content-encoding
gzip
vary
Accept-Encoding
content-type
application/json
prebid
prebid.media.net/rtb/
1 KB
869 B
XHR
General
Full URL
https://prebid.media.net/rtb/prebid?cid=8CUO2I9ST
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.148.139 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
139.148.107.34.bc.googleusercontent.com
Software
nginx /
Resource Hash
d32a3eea1c589ec442c54ff052bc0a6211c71e486011176863696a7fd23de893

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
via
1.1 google
prebid
ib.adnxs.com/ut/v3/
62 KB
14 KB
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.173.22 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),
Reverse DNS
536.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
2a3b9f921ce4402e8485e61063d71a26a7cd85b24b5e5af14c61e07c245086ed
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Date
Fri, 04 Feb 2022 03:09:58 GMT
Content-Encoding
gzip
Transfer-Encoding
chunked
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Connection
keep-alive
X-Proxy-Origin
193.27.14.20; 193.27.14.20; 536.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
X-XSS-Protection
0
Pragma
no-cache
AN-X-Request-Uuid
fba7062a-a486-4302-9097-ead8975715fe
Server
nginx/1.17.9
Vary
Accept-Encoding
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Expires
Sat, 15 Nov 2008 16:00:00 GMT
prebid
ads.yieldmo.com/exchange/
0
229 B
XHR
General
Full URL
https://ads.yieldmo.com/exchange/prebid?pbav=6.7.0-pre&p=%5B%7B%22placement_id%22%3A%22header-ad%22%2C%22callback_id%22%3A%221714406defe3968b%22%2C%22sizes%22%3A%5B%5B970%2C90%5D%2C%5B970%2C250%5D%2C%5B970%2C415%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%2C%7B%22placement_id%22%3A%22sidebar-ad%22%2C%22callback_id%22%3A%22172dbfe07319dc24%22%2C%22sizes%22%3A%5B%5B300%2C600%5D%2C%5B300%2C250%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%2C%7B%22placement_id%22%3A%22sidebar-ad2%22%2C%22callback_id%22%3A%22173f27802db0129b%22%2C%22sizes%22%3A%5B%5B300%2C600%5D%2C%5B300%2C250%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%2C%7B%22placement_id%22%3A%22sidebar-ad3%22%2C%22callback_id%22%3A%22174d1d3e1f0abe1c%22%2C%22sizes%22%3A%5B%5B300%2C600%5D%2C%5B300%2C250%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%2C%7B%22placement_id%22%3A%22wallpaper%22%2C%22callback_id%22%3A%221750080184657d51%22%2C%22sizes%22%3A%5B%5B1600%2C1000%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%5D&page_url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bust=1643944198019&dnt=false&description=GlaxoSmithKline%20and%20Gilead%20Sciences%20have%20been%20duking%20it%20out%20in%20the%20HIV%20arena%20for%20years%2C%20hoping%20to%20get%20an%20edge%20over%20one%20another%20with%20new%20launches%20and%20head-to-head%20drug%20trials.%20Now%2C%20in%20a%20Tuesday%20settlement%2C%20the%20companies%20are%20resolving%20a%20legal%20dispute%20over%20lucrative%20patents%20related%C2%A0to%20GSK%27s%20HIV%20drug%C2%A0dolutegravir.&userConsent=%7B%22gdprApplies%22%3A%22%22%2C%22cmp%22%3A%22%22%7D&us_privacy=&pr=https%3A%2F%2Fgo.questexnetwork.com%2F&scrd=1&title=Gilead%20to%20fork%20over%20%241.25B%2C%20pay%203%25%20royalty%20on%20blockbuster%20Biktarvy%20in%20GSK%20patent%20settlement%20%7C%20FiercePharma&w=1600&h=1200&pubcid=fb0de1e4-d1ed-4074-92c2-685109b12cae&schain=%7B%22ver%22%3A%221.0%22%2C%22complete%22%3A1%2C%22nodes%22%3A%5B%7B%22asi%22%3A%22mediafuse.com%22%2C%22sid%22%3A%22358%22%2C%22hp%22%3A1%7D%5D%7D&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22fb0de1e4-d1ed-4074-92c2-685109b12cae%22%2C%22atype%22%3A1%7D%5D%7D%5D
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.77.120.81 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-77-120-81.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
pragma
no-cache
date
Fri, 04 Feb 2022 03:09:58 GMT
access-control-allow-credentials
true
x-robots-tag
none,NOINDEX,NOFOLLOW
access-control-allow-methods
POST, GET, OPTIONS
access-control-request-headers
Cache-Control, Pragma
trinity.json
apex.go.sonobi.com/
184 B
884 B
XHR
General
Full URL
https://apex.go.sonobi.com/trinity.json?key_maker=%7B%22177fde8e3e356e47%22%3A%226af9de6bbe34255426d7%7C970x90%2C970x250%2C970x415%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%22%2C%22178aaf8d8b7a7988%22%3A%226af9de6bbe34255426d7%7C300x600%2C300x250%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%22%2C%221795353c80887b1f%22%3A%226af9de6bbe34255426d7%7C300x600%2C300x250%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%22%2C%22180d3ae1e540ae45%22%3A%226af9de6bbe34255426d7%7C300x600%2C300x250%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%22%2C%22181d114baa3d2596%22%3A%226af9de6bbe34255426d7%7C1600x1000%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%22%7D&ref=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&s=6a42dcde-16e2-4096-8a64-bb9f2ac7fc83&pv=89e3acad-4210-4452-a5d8-9bf091591e8c&vp=desktop&lib_name=prebid&lib_v=6.7.0-pre&us=0&ius=1&schain=%7B%22ver%22%3A%221.0%22%2C%22complete%22%3A1%2C%22nodes%22%3A%5B%7B%22asi%22%3A%22mediafuse.com%22%2C%22sid%22%3A%22358%22%2C%22hp%22%3A1%7D%5D%7D&userid=%7B%22pubcid%22%3A%22fb0de1e4-d1ed-4074-92c2-685109b12cae%22%7D&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22fb0de1e4-d1ed-4074-92c2-685109b12cae%22%2C%22atype%22%3A1%7D%5D%7D%5D&coppa=0
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
178.162.133.150 Rotterdam, Netherlands, ASN60781 (LEASEWEB-NL-AMS-01 Netherlands, NL),
Reverse DNS
ams-1-apex.go.sonobi.com
Software
sonobi-go /
Resource Hash
468a454357f4c045e388c4f5e62d851bc4381ab1d3ec7b1f1a710d369394fc09
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Fri, 04 Feb 2022 03:09:58 GMT
Content-Encoding
gzip
Server
sonobi-go
Vary
negotiate,Accept-Encoding
X-Go-Server
apex-ams-1-6-9
P3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, private
Access-Control-Allow-Credentials
true
Tcn
Choice
Content-Type
application/json
Content-Length
155
X-Xss-Protection
0
Expires
Sat, 26 Jul 1997 05:00:00 GMT
mvo
tag.1rx.io/rmp/212473/0/
0
176 B
XHR
General
Full URL
https://tag.1rx.io/rmp/212473/0/mvo?z=1r&hbv=6.7.0-pre,2.1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
213.19.147.43 , United Kingdom, ASN3356 (LEVEL3, US),
Reverse DNS
Software
Tengine /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
pragma
no-cache
date
Fri, 04 Feb 2022 03:09:58 GMT
cache-control
private, max-age=0, no-cache, no-store
access-control-allow-credentials
true
server
Tengine
prebid-request
onetag-sys.com/
15 B
367 B
XHR
General
Full URL
https://onetag-sys.com/prebid-request
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.89.9.252 London, United Kingdom, ASN16276 (OVH, FR),
Reverse DNS
ip252.ip-51-89-9.eu
Software
/
Resource Hash
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

strict-transport-security
max-age=15552000
content-encoding
gzip
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-transform, no-cache
access-control-allow-credentials
true
content-type
application/json
access-control-allow-headers
content-type, origin, referer, user-agent
content-length
41
arj
adtelligent-d.openx.net/w/1.0/
73 B
383 B
XHR
General
Full URL
https://adtelligent-d.openx.net/w/1.0/arj?ju=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&ch=UTF-8&res=1600x1200x24&ifr=false&tz=0&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=b8dbddc1-82c7-4deb-a04b-2a10b89f4ec0%2C9b2d1538-99b1-4296-8ff0-5cae05ba7ac2%2C5648ac3b-fd7b-45bf-8bda-f1b5da41e3f9%2Cc73784af-30c6-4a63-93dd-dc60b8a6f868%2C14e254c0-cc14-422a-b237-8e3716c890f3&nocache=1643944198026&pubcid=fb0de1e4-d1ed-4074-92c2-685109b12cae&schain=1.0%2C1!adtelligent.com%2C283366%2C1%2C%2C%2C&aus=970x90%2C970x250%2C970x415%7C300x600%2C300x250%7C300x600%2C300x250%7C300x600%2C300x250%7C1600x1000&divids=header-ad%2Csidebar-ad%2Csidebar-ad2%2Csidebar-ad3%2Cwallpaper&aucs=%2C%2C%2C%2C&auid=541177132%2C541177132%2C541177132%2C541177132%2C541177132
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/17.1.0 /
Resource Hash
08fca0953c73714df652acbd52f3a061da4ea8fe4e68aeaaab3c324659c2746a

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
server
OXGW/17.1.0
vary
Accept, Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.fiercepharma.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
79
via
1.1 google
expires
Mon, 26 Jul 1997 05:00:00 GMT
prebid
ib.adnxs.com/ut/v3/
62 KB
12 KB
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.173.22 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),
Reverse DNS
536.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
2975daa93b94bbb6100070f126446d6b4e7fda2874c69264aba20e091fa81c70
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Date
Fri, 04 Feb 2022 03:09:58 GMT
Content-Encoding
gzip
Transfer-Encoding
chunked
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Connection
keep-alive
X-Proxy-Origin
193.27.14.20; 193.27.14.20; 536.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
X-XSS-Protection
0
Pragma
no-cache
AN-X-Request-Uuid
50080b12-0288-4e3e-a444-20733c5ac02a
Server
nginx/1.17.9
Vary
Accept-Encoding
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Expires
Sat, 15 Nov 2008 16:00:00 GMT
translator
hbopenbid.pubmatic.com/
0
64 B
XHR
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.237.133.116 Philadelphia, United States, ASN3257 (GTT-BACKBONE GTT, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Fri, 04 Feb 2022 03:09:58 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
prebid
ib.adnxs.com/ut/v3/
618 B
1 KB
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.173.22 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),
Reverse DNS
536.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
57c7a34fba5e963bc9e01147602bfd151be7211f254787f9aae7fb1e5e07fc2b
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Date
Fri, 04 Feb 2022 03:09:59 GMT
Content-Encoding
gzip
Transfer-Encoding
chunked
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Connection
keep-alive
X-Proxy-Origin
193.27.14.20; 193.27.14.20; 536.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
X-XSS-Protection
0
Pragma
no-cache
AN-X-Request-Uuid
7c0d8e44-98d2-4968-a8dd-3cb448d7a6a6
Server
nginx/1.17.9
Vary
Accept-Encoding
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Expires
Sat, 15 Nov 2008 16:00:00 GMT
bid
ap.lijit.com/rtb/
25 B
526 B
XHR
General
Full URL
https://ap.lijit.com/rtb/bid?src=prebid_prebid_6.7.0-pre
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
216.52.2.30 , United States, ASN29791 (VOXEL-DOT-NET, US),
Reverse DNS
Software
/
Resource Hash
1b76cac67f991b8ab423f7280b6b4d662a8f345f6d0d1e476a967d86baff1b71

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Date
Fri, 04 Feb 2022 03:09:58 GMT
Vary
Accept-Encoding, User-Agent
Access-Control-Allow-Methods
GET, POST, DELETE, PUT
Content-Type
application/json
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
X-Sovrn-Pod
ad_ap6ams1
Access-Control-Allow-Headers
X-Requested-With, Content-Type
Content-Length
25
ROS
pbjs.e-planning.net/pbjs/1/2e43c/1/www.fiercepharma.com/
2 B
162 B
XHR
General
Full URL
https://pbjs.e-planning.net/pbjs/1/2e43c/1/www.fiercepharma.com/ROS?rnd=0.9769198529473293&e=970x250_0%3A970x250%2C970x90%2C970x415%2B300x250_0%3A300x250%2C300x600%2B300x250_1%3A300x250%2C300x600%2B300x250_2%3A300x250%2C300x600%2B1600x1000_0%3A1600x1000&ur=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&pbv=6.7.0-pre&ncb=1&vs=FFFFF&crs=UTF-8&fr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&e_pubcid=fb0de1e4-d1ed-4074-92c2-685109b12cae
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
5.178.65.246 Amsterdam, Netherlands, ASN50673 (SERVERIUS-AS, NL),
Reverse DNS
ads.us.e-planning.net
Software
openresty /
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Fri, 04 Feb 2022 03:09:58 GMT
access-control-allow-credentials
true
server
openresty
content-type
text/plain
content-length
2
x-sid
AMS-603
bids
prebid-us.creativecdn.com/bidder/prebid/
0
182 B
XHR
General
Full URL
https://prebid-us.creativecdn.com/bidder/prebid/bids
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.10.30 , Poland, ASN203690 (RTB-HOUSE-ASH, PL),
Reverse DNS
ip-185-184-10-30.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Fri, 04 Feb 2022 03:09:59 GMT
access-control-allow-credentials
true
access-control-max-age
3600
vary
Origin
access-control-allow-methods
POST
prebid
prebid.deepintent.com/
0
235 B
XHR
General
Full URL
https://prebid.deepintent.com/prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
169.197.150.7 , United States, ASN398989 (DEEPINTENT, US),
Reverse DNS
g.deepintent.com
Software
c /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
application/json

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
server
c
vary
Origin
access-control-allow-methods
POST, GET, OPTIONS, DELETE
access-control-allow-origin
https://www.fiercepharma.com
access-control-max-age
3600
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44ae0500ac&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
107745fceb3cd1be490a97291bf258a485215fd595732299c7a997f01aada7b0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
296 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44ad1a00b1&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
f5d56a97efb9d13cc5cc10307452e891760a29f1f9368911f41890036f9f02d9

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44a8a300aa&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
10f2722f90eb5b1ec563aba9b1a939c04d2021069cfd568d53469d42831f673f

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44aa6300b0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
5cd71cae8f442d4910833309cf9ceeab78ba739bd7c57792c671da83f8a854af

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9690f1017575bc3e53bd15f72c001b&pos=8a96940d017575bc4351bd44a97500c0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
0775e3399cf8426215bc3725ea6f4b9961c360d29b44d5f81028952a53d5e43f

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44a8a300aa&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
809eadbf45f9f74200304470e87598fac7405c8ec3e94486560d9fc2cf6067b8

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44aa6300b0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
39523d68beabf6c0cb5e8c860648c3126f48a395e0a9eab247e83de95cac4111

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
117 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9690f1017575bc3e53bd15f72c001b&pos=8a96940d017575bc4351bd44a97500c0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
187713b5132250d90e4dccf00d1f9556786996f26ddb2cb3228f128f7e5ba72d

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Fri, 04 Feb 2022 03:09:59 GMT
server
ATS/9.1.0.33
age
1
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44a8a300aa&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
ca7e0b1ec81205937086f39df8c3fb7250d6887d2242e24b269c4c50c83dcd35

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44aa6300b0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
31a335b097dfcf0ac13e36450e67a1717a2ff26ee19c33a0801955d2a309662c

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9690f1017575bc3e53bd15f72c001b&pos=8a96940d017575bc4351bd44a97500c0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
85156b872e00bed017e0234f87df362eb46c47ce16ef359d40b10b6a8d05ae8a

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
integrator.js
adservice.google.de/adsid/
107 B
792 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022013101.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:811::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3="googleads.g.doubleclick.net:443"; ma=2592000,h3=":443"; ma=2592000,h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
107 B
549 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022013101.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:802::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/
10 KB
5 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=318755892570846&correlator=1152266297769857&output=ldjh&impl=fifs&eid=31063378%2C31064657%2C31063223%2C31062931&vrg=2022013101&ptt=17&sc=1&sfv=1-0-38&ecs=20220204&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cpharma&enc_prev_ius=%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3&prev_iu_szs=1x1%2C1x1%2C1x1%2C1x1&ists=15&prev_scp=pos%3D4%26hb_rfBid%3D0%7Cpos%3D7%26hb_rfBid%3D0%7Cpos%3D9%26hb_rfBid%3D0%7Cpos%3D8%26hb_rfBid%3D0&eri=1&cust_params=section%3DPharma%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D519456%26fm-tester%3Dundefined%26topic%3Dpatent%2520litigation%252C%2520HIV%26keyword%3DGlaxoSmithKline%252C%2520Gilead%2520Sciences%252C%2520Biktarvy%252C%2520ViiV%2520Healthcare%252C%2520dolutegravir%26tag%3DGlaxoSmithKline%252C%2520Gilead%2520Sciences%252C%2520Biktarvy%252C%2520ViiV%2520Healthcare%252C%2520dolutegravir%252Cpatent%2520litigation%252C%2520HIV%252CPharma%26path%3D%252Fpharma%252Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%26browserLargerThan1460%3D1&cookie_enabled=1&bc=31&abxe=1&dt=1643944198064&lmt=1643944197&dlt=1643944197269&idt=366&frm=20&biw=1600&bih=1200&oid=2&adxs=200%2C-12245933%2C800%2C262&adys=24%2C-12245933%2C2321%2C999&adks=204464188%2C1585981893%2C937470483%2C1373237453&ucis=1%7C2%7C3%7C4&ifi=1&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&dmc=8&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&ref=https%3A%2F%2Fgo.questexnetwork.com%2F&vis=1&scr_x=0&scr_y=0&psz=1200x0%7C1200x0%7C1600x0%7C710x0&msz=1200x0%7C0x0%7C1600x0%7C710x0&ga_vid=314761443.1643944198&ga_sid=1643944198&ga_hid=60163373&ga_fc=true&fws=0%2C128%2C0%2C0&ohw=0%2C0%2C0%2C0&btvi=0%7C-1%7C1%7C0&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXV0.&nvt=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022013101.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.186.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s08-in-f2.1e100.net
Software
cafe /
Resource Hash
8c7a08febed3295a26bc473297738f26fc2eebe89c9cc0eeaac91d15d655a3fc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2,-2,-2,-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4618
x-xss-protection
0
google-lineitem-id
4686405525,5883744871,-2,-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138234349545,138379004766,-2,-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
1ded3c4c8da534897706a63a9c80e842.safeframe.googlesyndication.com/safeframe/1-0-38/html/ Frame EBA4
6 KB
4 KB
Document
General
Full URL
https://1ded3c4c8da534897706a63a9c80e842.safeframe.googlesyndication.com/safeframe/1-0-38/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022013101.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:802::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a73730123a43c3040d889aaee11ec35094277ce5f778076b262c23a293870adb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
timing-allow-origin
*
content-length
3108
date
Fri, 04 Feb 2022 03:09:58 GMT
expires
Sat, 04 Feb 2023 03:09:58 GMT
cache-control
public, immutable, max-age=31536000
last-modified
Tue, 02 Mar 2021 20:17:03 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
clock
tracking.crazyegg.com/
26 B
133 B
XHR
General
Full URL
https://tracking.crazyegg.com/clock?t=1643944198082
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/versioned/common-scripts/11.1.376.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.255.166.68 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-255-166-68.eu-west-1.compute.amazonaws.com
Software
awselb/2.0 /
Resource Hash
3c5ac99850e78257c5c1db47883774fe38f6bfac6c89ea92deb6ab3cea7f5490

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

access-control-allow-origin
*
date
Fri, 04 Feb 2022 03:09:58 GMT
cache-control
no-store
server
awselb/2.0
content-length
26
content-type
text/plain
/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221643944197395%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis%5C%22%5D%2C%5C%22referrerhost%5C%22%3A%5B%5C%22go.questexnetwork.com%5C%22%5D%2C%5C%22current_utm_source%5C%22%3A%5B%5C%22nurture-email%5C%22%5D%2C%5C%22current_utm_medium%5C%22%3A%5B%5C%22email%5C%22%5D%2C%5C%22current_utm_campaign%5C%22%3A%5B%5C%22jan2022-fp-nurture-email4-what-you-missed%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%2C%5C%22referrerhost%5C%22%2C%5C%22current_utm_source%5C%22%2C%5C%22current_utm_medium%5C%22%2C%5C%22current_utm_campaign%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944197397%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22referrerhosts%5C%22%3A%5B%5C%22go.questexnetwork.com%5C%22%5D%2C%5C%22utm_source%5C%22%3A%5B%5C%22nurture-email%5C%22%5D%2C%5C%22utm_medium%5C%22%3A%5B%5C%22email%5C%22%5D%2C%5C%22utm_campaign%5C%22%3A%5B%5C%22jan2022-fp-nurture-email4-what-you-missed%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%2C%5C%22referrerhosts%5C%22%2C%5C%22utm_source%5C%22%2C%5C%22utm_medium%5C%22%2C%5C%22utm_campaign%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944197398%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22https%3A%2F%2Fgo.questexnetwork.com%2F%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221643944197399%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A58%2B00%3A00&callback=bc_json959
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.98.80 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-98-80.fra50.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

csyncs
ghb.hbmp.mediafuse.com/
441 B
578 B
XHR
General
Full URL
https://ghb.hbmp.mediafuse.com/csyncs?aid1=535746&aid2=535749&aid3=undefined
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456651/hbw_master_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.239.173.66 , United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
8511f98206804fb8c0075966c6b5d03399d359e87c22aa0a4285ed906fdeffe0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Fri, 04 Feb 2022 03:09:58 GMT
Content-Encoding
gzip
Server
VertaMedia 1.0
Content-Type
application/json; charset=UTF-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
Content-Length
283
7c3.js
sync.medidexs.com/ps/10/
54 KB
20 KB
Script
General
Full URL
https://sync.medidexs.com/ps/10/7c3.js
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456651/hbw_master_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.3 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
f5255993f0f87ee7c4652d2ebc41beeb8b8e54ff07440bc06075921f4360e4ca

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
content-encoding
gzip
last-modified
Wed, 02 Feb 2022 21:50:56 GMT
server
nginx
etag
W/"61fafcc0-d80d"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Fri, 04 Feb 2022 04:09:58 GMT
170
a.ad.gt/api/v1/u/matches/
3 KB
4 KB
Script
General
Full URL
https://a.ad.gt/api/v1/u/matches/170
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456651/hbw_master_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.165.207.228 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-35-165-207-228.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
09fdb36cb248ed866b4e531af23cb2811a019da0403fe257b6ec3b752a50f06c

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:59 GMT
server
nginx/1.18.0
content-length
3198
content-type
application/javascript
init-1016mnvd6jvjr44ajs9g.js
api.fouanalytics.com/api/
488 B
938 B
Script
General
Full URL
https://api.fouanalytics.com/api/init-1016mnvd6jvjr44ajs9g.js
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456651/hbw_master_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3033::6815:3a2a , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
1358934f104fd2ec6d852ab3458c2481f1d24cd05ca656f67c6820a46558cc62

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:59 GMT
content-encoding
br
cf-cache-status
DYNAMIC
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=jWaLsBEBjlPfJS2yRWRbXlZuk4FI3Z0TaBaeoLuktx6N14zBSXuFXt4DqqMFK2%2BQv2Y1MnoIAZD3zLAFlV7z567J0t2heKQIbzsMXQHX8Wj1RkM%2BHyGtSj0attgnjh9XSKOuZaSfIPvSBqgwKqNKJgCoTg%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/javascript
cache-control
no-cache, no-store, must-revalidate
cf-ray
6d80b40b2c303743-MXP
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
expires
0
utsync.ashx
ml314.com/
62 B
572 B
Script
General
Full URL
https://ml314.com/utsync.ashx?pub=&adv=&et=0&eid=66459&ct=js&pi=&fp=GA1.2.314761443.1643944198&clid=&if=0&ps=&cl=&mlt=&data=&&cp=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&pv=1643944198098_lffqswbc0&bl=en-us&cb=2853739&return=&ht=&d=&dc=&si=1643944198098_lffqswbc0&cid=&s=1600x1200&rp=https%3A%2F%2Fgo.questexnetwork.com%2F
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?412022
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.229.143.145 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-229-143-145.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
5a1ba6ff6db12f791bbbfc4da3cb389e06f0cd53eede09ef3eb3ceb074089ef1

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 04 Feb 2022 03:09:58 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
p3P
CP="NON DSP COR ADMo PSAo DEVo BUS COM UNI NAV DEM STA"
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Type
application/javascript; charset=utf-8
Content-Length
147
Expires
0
ud.ashx
in.ml314.com/
20 B
482 B
Script
General
Full URL
https://in.ml314.com/ud.ashx?topiclimit=&cb=412022
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?412022
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.72.150.209 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-72-150-209.compute-1.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
d0e4a6372d6fb5ffe9505dbe9e94aee8f1b9b96ec8e5e20684cce8b4c5a88fa7

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Fri, 04 Feb 2022 03:09:59 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public
Connection
keep-alive
Content-Length
138
Expires
Sat, 05 Feb 2022 03:09:59 GMT
1px-matching-adtelligent.gif
t.trafmag.com/images/images/
Redirect Chain
  • https://sync.adtelligent.com/csync?&redir=https%3A%2F%2Ft.trafmag.com%2Fimages%2Fimages%2F1px-matching-adtelligent.gif%3Fid%3D%7Buid%7D
  • https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=82bfe3fa89b1c5fc
35 B
351 B
Image
General
Full URL
https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=82bfe3fa89b1c5fc
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
HTTP/1.1
Server
193.200.65.5 Amsterdam, Netherlands, ASN6681 (GIVEME-CLOUD, PL),
Reverse DNS
t.trafmag.com
Software
nginx /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Fri, 04 Feb 2022 03:09:59 GMT
Server
nginx
Connection
keep-alive
Content-Type
image/gif
Content-Length
35
P3P
CP="NON DSP COR CURa TIA"

Redirect headers

Location
https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=82bfe3fa89b1c5fc
Date
Fri, 04 Feb 2022 03:09:59 GMT
Server
VertaMedia 1.0
Etag
82bfe3fa89b1c5fc
Content-Length
0
match
dm.hybrid.ai/
0
238 B
Image
General
Full URL
https://dm.hybrid.ai/match?id=186&burl=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Da%26ep%3D324902%26extuid%3D%24%7BVID%7D
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
37.18.16.23 , Netherlands, ASN205675 (HYBRID-AS, RU),
Reverse DNS
Software
Hybrid Web Server /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Feb 2022 03:09:59 GMT
server
Hybrid Web Server
p3p
CP="NOI DSP COR CUR ADMa DEVo TAIo PSAo PSDo IVAo IVDo OUR IND COM NAV INT STA OTC"
access-control-allow-origin
*
cache-control
no-cache, no-store
x-mode
122
x-xss-protection
1; mode=block
expires
-1
universal-tag.js
ads.spotible.com/tag/ Frame 65ED
0
0

truncated
/ Frame 65ED
211 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
fad35c9dc1470b46d503e9be4ee8ec77efdc38b6a5dcf6e956178f51cc600e59

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Content-Type
image/png
allstream.js
creative.spotible.com/tag/ Frame D3DA
4 KB
2 KB
Script
General
Full URL
https://creative.spotible.com/tag/allstream.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022013101.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
54.144.118.149 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-144-118-149.compute-1.amazonaws.com
Software
/
Resource Hash
13b3e0ebce53b1bad544de9ab941325c97244335a255d701f964667fdcec7e12

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
cache-control
public, max-age=3600
content-encoding
gzip
etag
"13d60a009d7a4ed35e01731ee02c2db7"
vary
accept-encoding
content-type
application/javascript
index.php
a.dpmsrv.com/dpmpxl/
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm&ap_id=3035801625078687012&pixelIndex=0&_=1643944197659
  • https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=3035801625078687012&pixelIndex=0&_=1643944197659&google_gid=CAESEDTbqaQQ_3PSkMAwV2q2IQ0&google_cver=1
0
597 B
Script
General
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=3035801625078687012&pixelIndex=0&_=1643944197659&google_gid=CAESEDTbqaQQ_3PSkMAwV2q2IQ0&google_cver=1
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
HTTP/1.1
Server
52.6.171.241 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-6-171-241.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma
no-cache
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin
*
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Type
text/javascript
Access-Control-Allow-Headers
content-type, accept
Content-Length
0
Expires
0

Redirect headers

pragma
no-cache
date
Fri, 04 Feb 2022 03:09:58 GMT
server
HTTP server (unknown)
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=3035801625078687012&pixelIndex=0&_=1643944197659&google_gid=CAESEDTbqaQQ_3PSkMAwV2q2IQ0&google_cver=1
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
text/html; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
368
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
423396.gif
idsync.rlcdn.com/
0
66 B
Image
General
Full URL
https://idsync.rlcdn.com/423396.gif?partner_uid=3035801625078687012
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.174.68 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
68.174.244.35.bc.googleusercontent.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:59 GMT
via
1.1 google
alt-svc
clear
content-length
0
spinner.gif
cdn.omeda.com/hosted/images/dragon/generic/ Frame A406
9 KB
9 KB
Image
General
Full URL
https://cdn.omeda.com/hosted/images/dragon/generic/spinner.gif
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
205.162.42.5 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
cdn.omeda.com
Software
Apache /
Resource Hash
056dd44aece96c67e45ba421d734f125e1497bbdb3b70194b7aadb8a68d10085
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Fri, 04 Feb 2022 04:09:59 CET
X-Content-Type-Options
nosniff
Last-Modified
Mon, 10 Oct 2016 22:45:12 CEST
Server
Apache
ETag
W/"8851-1476132312178"
X-Frame-Options
SAMEORIGIN
Content-Type
image/gif
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding
chunked
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
pp.js
api-52-43-59-220.b2c.com/s/
13 KB
5 KB
Script
General
Full URL
https://api-52-43-59-220.b2c.com/s/pp.js
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::681a:623 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4f999f96da9bb7bd681b62c42ef5e5e2c9d80896b8aafa4a030279c0d05ea674

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:59 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Mon, 03 Jan 2022 15:12:15 GMT
server
cloudflare
age
5450
etag
W/"61d3124f-3346"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=8urXx3azTxOoaOGSzZxWlnsuq4wW6vRfbPCMQuCXXR3yZXkJO%2FXssgNjR5qYV8l7M3Za7e1BX7RfV0o0L0w6JztMQP%2Fophj2oIV6B2C7eNS561dzWTMcJPH1s0bGsLWjwxV5filDkjfFwADYOfQ12JQcAMf2Iw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/javascript
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
6d80b40ddc8a68f8-FRA
/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221643944197395%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis%5C%22%5D%2C%5C%22referrerhost%5C%22%3A%5B%5C%22go.questexnetwork.com%5C%22%5D%2C%5C%22current_utm_source%5C%22%3A%5B%5C%22nurture-email%5C%22%5D%2C%5C%22current_utm_medium%5C%22%3A%5B%5C%22email%5C%22%5D%2C%5C%22current_utm_campaign%5C%22%3A%5B%5C%22jan2022-fp-nurture-email4-what-you-missed%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%2C%5C%22referrerhost%5C%22%2C%5C%22current_utm_source%5C%22%2C%5C%22current_utm_medium%5C%22%2C%5C%22current_utm_campaign%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944197397%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22referrerhosts%5C%22%3A%5B%5C%22go.questexnetwork.com%5C%22%5D%2C%5C%22utm_source%5C%22%3A%5B%5C%22nurture-email%5C%22%5D%2C%5C%22utm_medium%5C%22%3A%5B%5C%22email%5C%22%5D%2C%5C%22utm_campaign%5C%22%3A%5B%5C%22jan2022-fp-nurture-email4-what-you-missed%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%2C%5C%22referrerhosts%5C%22%2C%5C%22utm_source%5C%22%2C%5C%22utm_medium%5C%22%2C%5C%22utm_campaign%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944197398%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22https%3A%2F%2Fgo.questexnetwork.com%2F%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221643944197399%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A58%2B00%3A00&callback=bc_json960
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.98.80 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-98-80.fra50.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

ad.gif
api-52-43-59-220.b2c.com/s/
43 B
383 B
Image
General
Full URL
https://api-52-43-59-220.b2c.com/s/ad.gif
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::681a:623 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
dcecab1355b5c2b9ecef281322bf265ac5840b4688748586e9632b473a5fe56b

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:59 GMT
cf-cache-status
HIT
last-modified
Mon, 03 Jan 2022 15:12:15 GMT
server
cloudflare
age
5441
etag
"61d3124f-2b"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=sz0X2BrW1oiMyxsKJC973LHND5m6P%2Fx1wR1%2FXk%2F4w3XsPYcmTaEbbKUwkfxyocQVFbFRjY8%2BC18PSxa3ORE3HdTZHz6fyLIx7wWW7gLPTNb6cK7H7aNPYdsrVM%2BcyFHFO51AC8g18mGlUuFJ1qsLQ2e9FWzTsw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/plain; charset=utf-8
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
accept-ranges
bytes
cf-ray
6d80b40e3d1e68f8-FRA
content-length
43
storage-delegate.html
creative.spotible.com/tag/ Frame 5027
581 B
498 B
Document
General
Full URL
https://creative.spotible.com/tag/storage-delegate.html
Requested by
Host: creative.spotible.com
URL: https://creative.spotible.com/tag/allstream.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
54.144.118.149 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-144-118-149.compute-1.amazonaws.com
Software
/
Resource Hash
3560bdf6b103e68c5e0aa13507ad74e7e2ced19d36257d4f7685e121fa4fa30d

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

etag
"60fdf8d946db5045a34df20232ae250b"
cache-control
public, max-age=3600
vary
accept-encoding
content-encoding
gzip
content-type
text/html
date
Fri, 04 Feb 2022 03:09:58 GMT
delivery.js
creative.spotible.com/creative/GZee/
76 KB
25 KB
Script
General
Full URL
https://creative.spotible.com/creative/GZee/delivery.js?referrer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement
Requested by
Host: creative.spotible.com
URL: https://creative.spotible.com/tag/allstream.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
54.144.118.149 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-144-118-149.compute-1.amazonaws.com
Software
/
Resource Hash
59e82d3bcbb8ec98b76a5e13016c03c23942df44948f90e7a67f8f6f450a2fdd

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:58 GMT
cache-control
no-cache
content-encoding
gzip
etag
"4d89ea314e5b8f78c8610276d28e6911"
vary
accept-encoding
content-type
application/javascript;charset=utf-8
haloid
aufp.io/api/v1/
6 KB
3 KB
Script
General
Full URL
https://aufp.io/api/v1/haloid
Requested by
Host: a.ad.gt
URL: https://a.ad.gt/api/v1/u/matches/170
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
44.228.48.137 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-44-228-48-137.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
85e50082d7ce113bfa87dbade18dbf747d1bacfcffdbd628296dcffa98a08f94

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:59 GMT
content-encoding
gzip
last-modified
Wed, 02 Feb 2022 00:28:16 GMT
server
nginx/1.18.0
etag
W/"1643761696.0-6132-2958560116"
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/javascript
access-control-allow-origin
*, *
access-control-expose-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
cache-control
public, max-age=43200
origin-trial
A/KTxPuSXtwcggydvUxw5B4dXspsb2iweedc7KDi2xv9M89MtnOpULTs7DQJVHBxGDV5wj5a3LW9S4ev3WfQkwIAAAB+eyJvcmlnaW4iOiJodHRwczovL2hhbG9mbG9jLmNvbTo0NDMiLCJmZWF0dXJlIjoiSW50ZXJlc3RDb2hvcnRBUEkiLCJleHBpcnkiOjE2MjYyMjA3OTksImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
expires
Fri, 04 Feb 2022 15:09:59 GMT
170
p.ad.gt/api/v1/p/
26 KB
8 KB
Script
General
Full URL
https://p.ad.gt/api/v1/p/170
Requested by
Host: a.ad.gt
URL: https://a.ad.gt/api/v1/u/matches/170
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.41.22.107 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-41-22-107.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
e6974b62b821dafba979149e0d3dd2d2942c2f49be62d2d2c581c1e2899a9027

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:59 GMT
content-encoding
gzip
last-modified
Wed, 02 Feb 2022 00:25:44 GMT
server
nginx/1.18.0
etag
W/"1643761544.0-26279-2710964840"
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/javascript
access-control-allow-origin
*
access-control-expose-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
cache-control
public, max-age=43200
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
expires
Fri, 04 Feb 2022 15:09:59 GMT
match
ids.ad.gt/api/v1/
Redirect Chain
  • https://secure.adnxs.com/getuid?https://ids.ad.gt/api/v1/match?id=70a36042-ea6e-46be-a9ff-2e7c1131d901&adnxs_id=$UID
  • https://ids.ad.gt/api/v1/match?id=70a36042-ea6e-46be-a9ff-2e7c1131d901&adnxs_id=3035801625078687012
43 B
565 B
Image
General
Full URL
https://ids.ad.gt/api/v1/match?id=70a36042-ea6e-46be-a9ff-2e7c1131d901&adnxs_id=3035801625078687012
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:59 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Fri, 04 Feb 2022 15:09:59 GMT

Redirect headers

Pragma
no-cache
Date
Fri, 04 Feb 2022 03:09:59 GMT
X-Proxy-Origin
193.27.14.20; 193.27.14.20; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid
c590c3c4-1dd6-4367-8c25-161c05700783
Server
nginx/1.17.9
Access-Control-Allow-Origin
*
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Location
https://ids.ad.gt/api/v1/match?id=70a36042-ea6e-46be-a9ff-2e7c1131d901&adnxs_id=3035801625078687012
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
t_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=70a36042-ea6e-46be-a9ff-2e7c1131d901
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=70a36042-ea6e-46be-a9ff-2e7c1131d901
  • https://ids.ad.gt/api/v1/t_match?tdid=806389c4-2d34-4560-9cd8-f621883bd145&id=70a36042-ea6e-46be-a9ff-2e7c1131d901
43 B
571 B
Image
General
Full URL
https://ids.ad.gt/api/v1/t_match?tdid=806389c4-2d34-4560-9cd8-f621883bd145&id=70a36042-ea6e-46be-a9ff-2e7c1131d901
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:59 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Fri, 04 Feb 2022 15:09:59 GMT

Redirect headers

pragma
no-cache
date
Fri, 04 Feb 2022 03:09:59 GMT
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
location
https://ids.ad.gt/api/v1/t_match?tdid=806389c4-2d34-4560-9cd8-f621883bd145&id=70a36042-ea6e-46be-a9ff-2e7c1131d901
cache-control
private,no-cache, must-revalidate
content-type
text/html
content-length
259
pbm_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3D70a36042-ea6e-46be-a9ff-2e7c1131d901
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?ird=1&rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3D70a36042-ea6e-46be-a9ff-2e7c1131d901
  • https://ids.ad.gt/api/v1/pbm_match?pbm=B700EDD9-77F1-4FB8-A9D9-2197767F6769&id=70a36042-ea6e-46be-a9ff-2e7c1131d901
43 B
571 B
Image
General
Full URL
https://ids.ad.gt/api/v1/pbm_match?pbm=B700EDD9-77F1-4FB8-A9D9-2197767F6769&id=70a36042-ea6e-46be-a9ff-2e7c1131d901
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:10:00 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Fri, 04 Feb 2022 15:10:00 GMT

Redirect headers

location
https://ids.ad.gt/api/v1/pbm_match?pbm=B700EDD9-77F1-4FB8-A9D9-2197767F6769&id=70a36042-ea6e-46be-a9ff-2e7c1131d901
date
Fri, 04 Feb 2022 03:09:59 GMT
cache-control
no-store, no-cache, private
server
nginx
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
g_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_cm&google_sc&google_ula=450542624&id=70a36042-ea6e-46be-a9ff-2e7c1131d901
  • https://ids.ad.gt/api/v1/g_match?id=70a36042-ea6e-46be-a9ff-2e7c1131d901&google_gid=CAESEJOrZg-xVfFp-wAb9ZVWuSE&google_cver=1&google_ula=450542624,0
43 B
572 B
Image
General
Full URL
https://ids.ad.gt/api/v1/g_match?id=70a36042-ea6e-46be-a9ff-2e7c1131d901&google_gid=CAESEJOrZg-xVfFp-wAb9ZVWuSE&google_cver=1&google_ula=450542624,0
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:59 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Fri, 04 Feb 2022 15:09:59 GMT

Redirect headers

pragma
no-cache
date
Fri, 04 Feb 2022 03:09:59 GMT
server
HTTP server (unknown)
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://ids.ad.gt/api/v1/g_match?id=70a36042-ea6e-46be-a9ff-2e7c1131d901&google_gid=CAESEJOrZg-xVfFp-wAb9ZVWuSE&google_cver=1&google_ula=450542624,0
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
text/html; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
357
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel
cm.g.doubleclick.net/
Redirect Chain
  • https://ids.ad.gt/api/v1/g_hosted?id=70a36042-ea6e-46be-a9ff-2e7c1131d901
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=NzBhMzYwNDItZWE2ZS00NmJlLWE5ZmYtMmU3YzExMzFkOTAx
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=NzBhMzYwNDItZWE2ZS00NmJlLWE5ZmYtMmU3YzExMzFkOTAx
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H3
Server
142.250.185.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s49-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Feb 2022 03:10:00 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=NzBhMzYwNDItZWE2ZS00NmJlLWE5ZmYtMmU3YzExMzFkOTAx
date
Fri, 04 Feb 2022 03:09:59 GMT
server
nginx/1.18.0
content-length
473
content-type
text/html; charset=utf-8
us
sync.go.sonobi.com/
0
474 B
Image
General
Full URL
https://sync.go.sonobi.com/us?https://ids.ad.gt/api/v1/son_match?id=70a36042-ea6e-46be-a9ff-2e7c1131d901&uid=[UID]
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
178.162.133.149 Rotterdam, Netherlands, ASN60781 (LEASEWEB-NL-AMS-01 Netherlands, NL),
Reverse DNS
ams-1-sync.go.sonobi.com
Software
sonobi-go /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 04 Feb 2022 03:09:59 GMT
Server
sonobi-go
Vary
negotiate,Accept-Encoding
X-Go-Server
xcp-ams-1-7-9
P3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Cache-Control
no-cache, no-store, private
Tcn
Choice
Content-Type
text/plain; charset=utf8
Content-Length
0
X-Xss-Protection
0
Expires
Sat, 26 Jul 1997 05:00:00 GMT
ppnt_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://bh.contextweb.com/bh/rtset?pid=562316&ev=1&rurl=https://ids.ad.gt/api/v1/ppnt_match?uid=%%VGUID%%&id=70a36042-ea6e-46be-a9ff-2e7c1131d901
  • https://ids.ad.gt/api/v1/ppnt_match?uid=3R3n4DSJqHMl&ev=1&pid=562316&id=70a36042-ea6e-46be-a9ff-2e7c1131d901
43 B
465 B
Image
General
Full URL
https://ids.ad.gt/api/v1/ppnt_match?uid=3R3n4DSJqHMl&ev=1&pid=562316&id=70a36042-ea6e-46be-a9ff-2e7c1131d901
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:10:00 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Fri, 04 Feb 2022 15:09:59 GMT

Redirect headers

strict-transport-security
max-age=15768000
server
Jetty(9.4.14.v20181114)
p3p
policyref="/bh/w3c/p3p.xml", CP="NOI DSP COR NID CURa DEVa PSAa OUR BUS COM NAV INT"
content-language
de-DE
location
https://ids.ad.gt/api/v1/ppnt_match?uid=3R3n4DSJqHMl&ev=1&pid=562316&id=70a36042-ea6e-46be-a9ff-2e7c1131d901
cache-control
private, max-age=0, no-cache, no-store
cw-server
bh-deployment-56659f45bd-nhs7f
expires
-1
token
token.rubiconproject.com/
Redirect Chain
  • https://ids.ad.gt/api/v1/rub?id=70a36042-ea6e-46be-a9ff-2e7c1131d901
  • https://token.rubiconproject.com/token?pid=50242&puid=70a36042-ea6e-46be-a9ff-2e7c1131d901&gdpr=0
0
214 B
Image
General
Full URL
https://token.rubiconproject.com/token?pid=50242&puid=70a36042-ea6e-46be-a9ff-2e7c1131d901&gdpr=0
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
HTTP/1.1
Server
69.173.144.138 Frankfurt am Main, Germany, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma
no-cache
Expires
0
Cache-Control
no-cache,no-store,must-revalidate
X-RPHost
78e3bdce5107450057bade54d54a0a7e
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"

Redirect headers

location
https://token.rubiconproject.com/token?pid=50242&puid=70a36042-ea6e-46be-a9ff-2e7c1131d901&gdpr=0
date
Fri, 04 Feb 2022 03:09:59 GMT
server
nginx/1.18.0
content-length
417
content-type
text/html; charset=utf-8
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/
0
0
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:801::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Feb 2022 03:09:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
etag
1529218356270468902
vary
Accept-Encoding, Origin
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
private, max-age=3600
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
text/javascript; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
expires
Fri, 04 Feb 2022 03:09:59 GMT
olytics
oqs.omeda.com/oqs/rest/
15 B
307 B
XHR
General
Full URL
https://oqs.omeda.com/oqs/rest/olytics
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.165 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
ee2bd946a7a0e25dd3f7606bf975cfaa824c7eb902568f5e711f361be35196ee
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
application/json

Response headers

Date
Fri, 04 Feb 2022 03:10:00 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
olytics
oqs.omeda.com/oqs/rest/ Frame
0
0
Preflight
General
Full URL
https://oqs.omeda.com/oqs/rest/olytics
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.165 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

X-Frame-Options
SAMEORIGIN
X-Content-Type-Options
nosniff
X-XSS-Protection
1; mode=block
Access-Control-Max-Age
600
Access-Control-Allow-Origin
*
Access-Control-Allow-Headers
Access-Control-Request-Headers, Content-Type, Origin, Accept, Accept-Encoding, Accept-Language, HOST, User-Agent, Access-Control-Request-Method, Access-Control-Max-Age
Content-Type
text/plain
Content-Length
0
Date
Fri, 04 Feb 2022 03:09:59 GMT
Server
Apache
4
v4-api-52-43-59-220.b2c.com/api/
Redirect Chain
  • https://api-52-43-59-220.b2c.com/api/x?TybpjEJ74q5QaqtF$dXJsJDAkaHR0cHM6Ly93d3cuZmllcmNlcGhhcm1hLmNvbS9waGFybWEvZ2lsZWFkLXRvLWZvcmstb3Zlci0xLTI1LWJpbGxpb24tcGF5LTMtcm95YWx0eS1ibG9ja2J1c3Rlci1iaWt0Y...
  • https://v4-api-52-43-59-220.b2c.com:444/api/4?TybpjEJ74q5QaqtF
0
141 B
XHR
General
Full URL
https://v4-api-52-43-59-220.b2c.com:444/api/4?TybpjEJ74q5QaqtF
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
HTTP/1.1
Server
52.43.59.220 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-59-220.us-west-2.compute.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Access-Control-Allow-Origin
*
Connection
keep-alive
Transfer-Encoding
chunked
Access-Control-Allow-Methods
*

Redirect headers

date
Fri, 04 Feb 2022 03:09:59 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
location
https://v4-api-52-43-59-220.b2c.com:444/api/4?TybpjEJ74q5QaqtF
access-control-allow-methods
*
content-type
text/html
access-control-allow-origin
*
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=nfiLbaMm9EPa29Uh8Ug%2B82c5d9mN0FxThUSuOPQN3xZqreMaIqR55PI%2Bzvc5dmw%2FR5mXGlgpMFsHSFwYuAl6cCB9xvDMyn7wU8u85PC3OjV7hDNnopbpg4agLkjO8Uw9MpFxCAjn0MarlwazFzsxb6gQHVXINQ%3D%3D"}],"group":"cf-nel","max_age":604800}
cf-ray
6d80b4102a073761-MXP
gpt.js
www.googletagservices.com/tag/js/
0
0
Fetch
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1121 / 773 of 1000 / last-modified: 1643929548"
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Fri, 04 Feb 2022 03:09:59 GMT
integrator.js
adservice.google.de/adsid/
107 B
122 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022013101.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Feb 2022 03:09:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3="googleads.g.doubleclick.net:443"; ma=2592000,h3=":443"; ma=2592000,h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
107 B
122 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022013101.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Feb 2022 03:09:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/
184 KB
56 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=318755892570846&correlator=3959422245273251&output=ldjh&impl=fifs&eid=31063378%2C31064657%2C31063223%2C31062931&vrg=2022013101&ptt=17&sc=1&sfv=1-0-38&ecs=20220204&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cpharma&enc_prev_ius=%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3&prev_iu_szs=970x90%7C970x250%7C970x415%2C300x600%7C300x250%2C300x600%7C300x250%2C300x600%7C300x250%2C1600x1000&prev_scp=pos%3D0%26hb_rfBid%3D0%26excl_cat%3DPREPOST%7Cpos%3D1%26hb_rfBid%3D0%26excl_cat%3DPREPOST%7Cpos%3D2%26hb_rfBid%3D0%26excl_cat%3DPREPOST%7Cpos%3D3%26hb_rfBid%3D0%26hb_div_id%3Dsidebar-ad3%26is_vmhbmp%3Dtrue%26hb_override_id%3D2218060%26hb_buyer_id%3D13732%26hb_r_id%3D16417afd2355cf05%26hb_site_id%3D6936%26hb_format%3Dbanner%26hb_size%3D300x250%26hb_pb%3D1.58%26hb_adid%3D2875018aa54ba28f%26hb_bidder%3Dappnexus%26excl_cat%3DPREPOST%7Cpos%3D5%26hb_rfBid%3D0%26excl_cat%3DPREPOST&eri=1&cust_params=section%3DPharma%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D519456%26fm-tester%3Dundefined%26topic%3Dpatent%2520litigation%252C%2520HIV%26keyword%3DGlaxoSmithKline%252C%2520Gilead%2520Sciences%252C%2520Biktarvy%252C%2520ViiV%2520Healthcare%252C%2520dolutegravir%26tag%3DGlaxoSmithKline%252C%2520Gilead%2520Sciences%252C%2520Biktarvy%252C%2520ViiV%2520Healthcare%252C%2520dolutegravir%252Cpatent%2520litigation%252C%2520HIV%252CPharma%26path%3D%252Fpharma%252Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%26browserLargerThan1460%3D1%26hbmp_loc%3Dhttps%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement&cookie=ID%3D6016d9e119222885-22b37be534cd0046%3AT%3D1643944198%3AS%3DALNI_MaqUU6pU85oQipWiKfoiMr7umnbGQ&bc=31&abxe=1&dt=1643944198978&lmt=1643944197&dlt=1643944197269&idt=366&frm=20&biw=1600&bih=1200&oid=2&adxs=200%2C1100%2C1100%2C1100%2C-12245933&adys=34%2C242%2C704%2C854%2C-12245933&adks=564636127%2C3263208563%2C2184391133%2C2184391132%2C3786707769&ucis=5%7C6%7C7%7C8%7C9&ifi=5&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&dmc=8&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&ref=https%3A%2F%2Fgo.questexnetwork.com%2F&vis=1&scr_x=0&scr_y=0&psz=1200x0%7C300x0%7C300x0%7C300x0%7C1200x0&msz=1200x0%7C300x0%7C300x0%7C300x0%7C1600x0&psts=AGkb-H-5tHN37tFs_Wuqsm534Dggn95GSH2qbfWredUDue5E0xR_sboBi6FBKywIedht6J8pd4LZl6PpO5h3roCjNuc1EQA%2CAGkb-H_clkEBRragGWF2FNSnjoGVdldaHSk3P29F-DnSkbOYSIYxy2r7JSMs5z0IhQ5ihom0lRs6U_H5boHAkwtxJx9UM6c%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=314761443.1643944198&ga_sid=1643944198&ga_hid=60163373&ga_fc=true&fws=4%2C4%2C4%2C4%2C132&ohw=1600%2C1600%2C1600%2C1600%2C1600&btvi=0%7C0%7C0%7C0%7C-1&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXV0.&nvt=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022013101.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.186.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s08-in-f2.1e100.net
Software
cafe /
Resource Hash
f9ce3ff5f913e8afbf8be0a54995c3ef7b0198d8cd933a826eafda4f04aa7160
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:59 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2,-2,-2,-2,-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
57700
x-xss-protection
0
google-lineitem-id
5773092226,5773092226,5773092226,5773092226,-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138379479778,138379479784,138379479787,138379479781,-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
Airfinity_FiercePharma_Brackground%20image.gif
cdn.spotible.com/creative/GZee/hashed/948ceb8186134ba09c892726da12f303/
234 KB
235 KB
Image
General
Full URL
https://cdn.spotible.com/creative/GZee/hashed/948ceb8186134ba09c892726da12f303/Airfinity_FiercePharma_Brackground%20image.gif
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.122.61 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-122-61.fra60.r.cloudfront.net
Software
/
Resource Hash
5b1ecd3ea7df7c575af66c025ae80c56c580ddb81b294ae0d8d41c54251b6061

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Mon, 31 Jan 2022 05:18:11 GMT
via
1.1 1662abbf731d8832e73c83b2467e7f38.cloudfront.net (CloudFront)
age
337907
etag
"948ceb8186134ba09c892726da12f303"
x-cache
Hit from cloudfront
content-type
image/gif
cache-control
public, max-age=604800
x-amz-cf-pop
FRA60-P2
accept-ranges
bytes
content-length
239966
x-amz-cf-id
DsLlTRaJSGXsJeLZOB1hBhob-jdx2ntIEDAHjot-qAcIXcRVfS5LRw==
Airfiinty_FiercePharma_Foreground_72dpi.png
cdn.spotible.com/creative/GZee/hashed/d204ecda279e472fec445eabf618fb3e/
30 KB
30 KB
Image
General
Full URL
https://cdn.spotible.com/creative/GZee/hashed/d204ecda279e472fec445eabf618fb3e/Airfiinty_FiercePharma_Foreground_72dpi.png
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.122.61 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-122-61.fra60.r.cloudfront.net
Software
/
Resource Hash
95a2b7ec86e3a80636259dfbce926725176bd5a9fd7e90c6b0094646944a33ce

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Mon, 31 Jan 2022 05:18:11 GMT
via
1.1 1662abbf731d8832e73c83b2467e7f38.cloudfront.net (CloudFront)
age
337907
etag
"d204ecda279e472fec445eabf618fb3e"
x-cache
Hit from cloudfront
content-type
image/png
cache-control
public, max-age=604800
x-amz-cf-pop
FRA60-P2
accept-ranges
bytes
content-length
30346
x-amz-cf-id
M9_PWNMM8gMMwKSJdRkLlyb6hVWm2v-37n4ovEpMbF38lmh2eqYcSw==
view
googleads4.g.doubleclick.net/pcs/ Frame 5B08
0
0
Fetch
General
Full URL
https://googleads4.g.doubleclick.net/pcs/view?xai=AKAOjssZmLIaiyOrHggyA2VaDhCDRfO8Me9KUzazslZq72JMJ4Q5xabBd3bFXt3y31MYQDD3bRugnuafNSixgEi3zQAohpDEoWPX5Lj14-MnwWvyj3xRjSSv5-LK3vR0CpAhC6UvwHn9NgNyFQ-93vQlZpb4gKe8XBflUJynUGOPWBQEur76WJL7DsoDj3KNizGVQTLJTgac-j6_6dNlR-ioVU5bNJtRQvcxs1-kYYLlwz04P1yStkGlGZdqmCRISRTey-TaLM8h00EYgIbetxBwyFqBOpfEJ0RUk4fLUMqs1lOETVNUduGZdCCofvWqCPwTefWeAptuwaoi-B5AmZTtfJOVy2WolxybQ86f6poZ8U94-2fTX6_zUvIQvrdtpk-7RJwtumdYeIxriHb7imEWpuN-5pPn371MaUJLzTqFMxLu&sig=Cg0ArKJSzIfoXrtHfFWTEAE&uach_m=[UACH]&fbs_aeid=[gw_fbsaeid]&urlfix=1&adurl=
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.186.66 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s05-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Feb 2022 03:09:59 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
express_html_inpage_rendering_lib_200_275.js
s0.2mdn.net/879366/ Frame 5B08
106 KB
38 KB
Script
General
Full URL
https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_275.js
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:802::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a23e44d9d02a2a9641a9bd3b47693656054c00b71890aed2fa7fc90151750f73
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 16:38:19 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
37900
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
37892
x-xss-protection
0
last-modified
Mon, 27 Sep 2021 18:44:52 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Fri, 04 Feb 2022 16:38:19 GMT
UFYwWwmt.js
tpc.googlesyndication.com/sodar/ Frame 5B08
41 KB
15 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/UFYwWwmt.js
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:801::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5056305b09ad6474ea540f796c79be51d6b8e96043cb3d7bc4ef774e56765f4f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 16:37:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
37967
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15207
x-xss-protection
0
last-modified
Tue, 03 Mar 2020 20:15:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 03 Feb 2023 16:37:12 GMT
rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame 5B08
123 KB
37 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022013101.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:812::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
d3a6fb9e39c82eed501889521b19cc4fc13d1104f83128928775b520c86f8abc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
38146
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1643806174374025"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Fri, 04 Feb 2022 03:09:59 GMT
view
googleads4.g.doubleclick.net/pcs/ Frame 235C
0
0
Fetch
General
Full URL
https://googleads4.g.doubleclick.net/pcs/view?xai=AKAOjsvOy3MMD77MU510HagrDKsVKaw6_0P1nZFadeg_wUyplUjC_1SmklPgpLUd2SBcj-L3ZwcnwHxizF9aQPuzeETQwbFq86V5bKFjrtvVXp4vE8h1bzLoEtKwZmGxiKtqSqaqjCN7fHR0dh-8LOdb4UwXf1zSt6NkWul4TtOHJLs_xEXmQH6t1VPrmjDvAYpS0kGWYtsHemsleC15sbe8QhGDySmJlmhP22cmOLH6jrD9s0R-oa4Yhd1N2C_-Foldrfs-9WupSlf_ehEoifVZqFHrS9LTHO1DRwBtsHU-2rf2YL4MuL7GFhOxB7vauLyTtS7_jcx5Jp2ecsbxA1A9t6EzvgzbhG5cGm3RDI1dxW4Ot4vUWfwTiMWdbm-q1Ujx11EclRc_ngD74tOf2DaBmEBGNzMHtas1Q5bgfSPqEgLL&sig=Cg0ArKJSzLsUpTOe8svTEAE&uach_m=[UACH]&fbs_aeid=[gw_fbsaeid]&urlfix=1&adurl=
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.186.66 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s05-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Feb 2022 03:09:59 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
express_html_inpage_rendering_lib_200_275.js
s0.2mdn.net/879366/ Frame 235C
106 KB
37 KB
Script
General
Full URL
https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_275.js
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a23e44d9d02a2a9641a9bd3b47693656054c00b71890aed2fa7fc90151750f73
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 16:38:19 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
37900
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
37892
x-xss-protection
0
last-modified
Mon, 27 Sep 2021 18:44:52 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Fri, 04 Feb 2022 16:38:19 GMT
UFYwWwmt.js
tpc.googlesyndication.com/sodar/ Frame 235C
41 KB
15 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/UFYwWwmt.js
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:801::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5056305b09ad6474ea540f796c79be51d6b8e96043cb3d7bc4ef774e56765f4f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 16:37:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
37967
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15207
x-xss-protection
0
last-modified
Tue, 03 Mar 2020 20:15:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 03 Feb 2023 16:37:12 GMT
rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame 235C
123 KB
37 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022013101.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:812::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
d3a6fb9e39c82eed501889521b19cc4fc13d1104f83128928775b520c86f8abc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
38146
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1643806174374025"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Fri, 04 Feb 2022 03:09:59 GMT
view
googleads4.g.doubleclick.net/pcs/ Frame 798C
0
0
Fetch
General
Full URL
https://googleads4.g.doubleclick.net/pcs/view?xai=AKAOjssQ3qIM3MTLgpAnPyqH9glkPIlBOQ2xJ7EyUbTwTknltySdR0Xpos5n90G8SzkMv8c5RB0lQPW9beNylrjiv-lzbwUc3qST0WZx6Kl22vTQa6XxMw1TxvtA6ynuKwP6Uf_gl4wNs53A_8YbyTzoagHlc2wRxpI8wC8FX_j5pHljq1bXmrnSOA-nvWsMSM8Zc0BiUzITwvlRjsDzhyoUjy-9Q5oUYD6uCYkY_jt1fPn7_sf5OSrwPmWokYvhetP18sisi3zIsOtbm6LR37xECfMJ7uYqUNLun-3HpKqk4ja-AD-egvffCRkPd0_Ap5GmKIqsD87AqSNKXs_74EXW_JynC9t9jGHKmuTlCAiblTS5JcJFLaNKfcU3LmQxsqrmGpeoBv-GpsIEZ7RY_hR2yr7dPFq68lJQIaavzaOeZSoq&sig=Cg0ArKJSzDQRQV8rGlx4EAE&uach_m=[UACH]&fbs_aeid=[gw_fbsaeid]&urlfix=1&adurl=
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.186.66 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s05-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Feb 2022 03:09:59 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
express_html_inpage_rendering_lib_200_275.js
s0.2mdn.net/879366/ Frame 798C
106 KB
37 KB
Script
General
Full URL
https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_275.js
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a23e44d9d02a2a9641a9bd3b47693656054c00b71890aed2fa7fc90151750f73
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 16:38:19 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
37900
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
37892
x-xss-protection
0
last-modified
Mon, 27 Sep 2021 18:44:52 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Fri, 04 Feb 2022 16:38:19 GMT
UFYwWwmt.js
tpc.googlesyndication.com/sodar/ Frame 798C
41 KB
15 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/UFYwWwmt.js
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:801::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5056305b09ad6474ea540f796c79be51d6b8e96043cb3d7bc4ef774e56765f4f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 16:37:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
37967
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15207
x-xss-protection
0
last-modified
Tue, 03 Mar 2020 20:15:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 03 Feb 2023 16:37:12 GMT
rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame 798C
123 KB
37 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022013101.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:812::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
d3a6fb9e39c82eed501889521b19cc4fc13d1104f83128928775b520c86f8abc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
38146
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1643806174374025"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Fri, 04 Feb 2022 03:09:59 GMT
view
googleads4.g.doubleclick.net/pcs/ Frame C3C9
0
0
Fetch
General
Full URL
https://googleads4.g.doubleclick.net/pcs/view?xai=AKAOjst4EPjzZMM8zO3zip9ZvNE9tzlg6obvhASvdTWIUHKGwVgwJT2EW4SieKSm29fYCzY4F5J4pZDhyKNY-Frh6p2_TYu89OwvfhN8zf9vF8R2sQHuIa3SXeIQK9Gt7M7EJ8orM8DGW-LqLIpK7ND5WIZ-D6NMy8JRh22k-VJ7hltv17O8nSPIQtZxmmcq2twROEpp9EXUiqVL21MZtIY6FUwV2B79wQ8kZsHSCuQmxfkBCVyRWiVwH6TWWH9XiuiRHf69K8H4-95GXPIByaiOSmFzLShQfmUFdVmqJW6ANAy3jnQEziTLoMWeXNd_lDahZcb8Yy9Hh97yf6XZDq-EHd6clumpqqGOOE4yASLR5iGDrTJHmuUxwtcC6UcIBIwWQV_Lf3eAtDYBWVzfsYK9uTa3cT3EPESg-IasqhKqNY_e&sig=Cg0ArKJSzEjhADzYpffcEAE&uach_m=[UACH]&fbs_aeid=[gw_fbsaeid]&urlfix=1&adurl=
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.186.66 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s05-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Feb 2022 03:09:59 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
express_html_inpage_rendering_lib_200_275.js
s0.2mdn.net/879366/ Frame C3C9
106 KB
37 KB
Script
General
Full URL
https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_275.js
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a23e44d9d02a2a9641a9bd3b47693656054c00b71890aed2fa7fc90151750f73
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 16:38:19 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
37900
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
37892
x-xss-protection
0
last-modified
Mon, 27 Sep 2021 18:44:52 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Fri, 04 Feb 2022 16:38:19 GMT
UFYwWwmt.js
tpc.googlesyndication.com/sodar/ Frame C3C9
41 KB
15 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/UFYwWwmt.js
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/Mjk0LU1RRi0wNTYAAAGCYGthXPR48D--R8txbl8ejfB-FvDkxGpfZOZmw0D3oYsGwbSdyOiIcuxzYoYph8f4SJhAMsU=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:801::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5056305b09ad6474ea540f796c79be51d6b8e96043cb3d7bc4ef774e56765f4f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 16:37:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
37967
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15207
x-xss-protection
0
last-modified
Tue, 03 Mar 2020 20:15:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 03 Feb 2023 16:37:12 GMT
rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame C3C9
123 KB
37 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022013101.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:812::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
d3a6fb9e39c82eed501889521b19cc4fc13d1104f83128928775b520c86f8abc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:09:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
38146
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1643806174374025"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Fri, 04 Feb 2022 03:09:59 GMT
957
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0

truncated
/ Frame 5B08
217 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
653ffadbcef0e23845eaab5ab9ce8a5439502f51f08b7f7848072a7c6c3bba4d

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Content-Type
image/png
957
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0

truncated
/ Frame 235C
217 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
9d7c143af3da02f87cc3cac8b8eef316f550de7d021f5d24dd6fdc01315b7209

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Content-Type
image/png
loading.do
sample.dragonforms.com/ Frame A406
21 KB
6 KB
Document
General
Full URL
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
859512c9c1255cfcd980fd323b13f26fb10e00a42bf076c1318af39eff61356c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short

Response headers

X-Content-Type-Options
nosniff
X-XSS-Protection
1; mode=block
Access-Control-Allow-Origin
*
Content-Type
text/html;charset=ISO-8859-1
Date
Fri, 04 Feb 2022 03:09:59 GMT
Server
Apache
Vary
Accept-Encoding
Content-Encoding
gzip
Transfer-Encoding
chunked
957
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0

truncated
/ Frame 798C
218 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
e84d66950da258da6d1da29eb31d73fbb65780cb923adeaad831cbbb06a2d2fe

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Content-Type
image/png
957
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0

truncated
/ Frame C3C9
212 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
6a468ac2efb29ab55b510aa57423f9db2ae632ca8fcf1541463dba9e193e71ff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Content-Type
image/png
index.html
s0.2mdn.net/10583188/1640880412777/ Frame 37E3
69 KB
27 KB
Document
General
Full URL
https://s0.2mdn.net/10583188/1640880412777/index.html
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_275.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
c1f0f4aac0c33c055a3af7ebc23010be97cec4e74888c88e619da62fb555bd12
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
access-control-allow-origin
*
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-length
27319
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
date
Thu, 03 Feb 2022 08:35:51 GMT
expires
Fri, 04 Feb 2022 08:35:51 GMT
cache-control
public, max-age=86400
age
66849
last-modified
Thu, 30 Dec 2021 16:06:52 GMT
content-type
text/html
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
index.html
s0.2mdn.net/10583188/1640879416687/ Frame 16C4
70 KB
27 KB
Document
General
Full URL
https://s0.2mdn.net/10583188/1640879416687/index.html
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_275.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5098a0c240e499d63380d7b0c1b5776d6a139f80a270d77fe7347d861294ff74
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
access-control-allow-origin
*
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-length
27500
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
date
Thu, 03 Feb 2022 08:42:11 GMT
expires
Fri, 04 Feb 2022 08:42:11 GMT
cache-control
public, max-age=86400
age
66469
last-modified
Thu, 30 Dec 2021 15:50:16 GMT
content-type
text/html
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
Enqz_20U.html
tpc.googlesyndication.com/sodar/ Frame 6EED
22 KB
8 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/UFYwWwmt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:801::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
127ab3ff6d14112ae6aa40b68d9d3144748eda08efbc60a48a5be0555cf8622b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
timing-allow-origin
*
content-length
8395
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
date
Thu, 03 Feb 2022 16:37:12 GMT
expires
Fri, 03 Feb 2023 16:37:12 GMT
cache-control
public, max-age=31536000
last-modified
Tue, 03 Mar 2020 20:15:00 GMT
content-type
text/html
age
37968
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
Enqz_20U.html
tpc.googlesyndication.com/sodar/ Frame 888F
22 KB
8 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/UFYwWwmt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:801::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
127ab3ff6d14112ae6aa40b68d9d3144748eda08efbc60a48a5be0555cf8622b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
timing-allow-origin
*
content-length
8395
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
date
Thu, 03 Feb 2022 16:37:12 GMT
expires
Fri, 03 Feb 2023 16:37:12 GMT
cache-control
public, max-age=31536000
last-modified
Tue, 03 Mar 2020 20:15:00 GMT
content-type
text/html
age
37968
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
Enqz_20U.html
tpc.googlesyndication.com/sodar/ Frame 7FC6
22 KB
8 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/UFYwWwmt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:801::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
127ab3ff6d14112ae6aa40b68d9d3144748eda08efbc60a48a5be0555cf8622b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
timing-allow-origin
*
content-length
8395
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
date
Thu, 03 Feb 2022 16:37:12 GMT
expires
Fri, 03 Feb 2023 16:37:12 GMT
cache-control
public, max-age=31536000
last-modified
Tue, 03 Mar 2020 20:15:00 GMT
content-type
text/html
age
37968
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
Enqz_20U.html
tpc.googlesyndication.com/sodar/ Frame EB7C
22 KB
8 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/UFYwWwmt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:801::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
127ab3ff6d14112ae6aa40b68d9d3144748eda08efbc60a48a5be0555cf8622b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
timing-allow-origin
*
content-length
8395
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
date
Thu, 03 Feb 2022 16:37:12 GMT
expires
Fri, 03 Feb 2023 16:37:12 GMT
cache-control
public, max-age=31536000
last-modified
Tue, 03 Mar 2020 20:15:00 GMT
content-type
text/html
age
37968
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
index.html
s0.2mdn.net/10583188/1640879416687/ Frame 11AD
70 KB
27 KB
Document
General
Full URL
https://s0.2mdn.net/10583188/1640879416687/index.html
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_275.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5098a0c240e499d63380d7b0c1b5776d6a139f80a270d77fe7347d861294ff74
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
access-control-allow-origin
*
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-length
27500
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
date
Thu, 03 Feb 2022 08:42:11 GMT
expires
Fri, 04 Feb 2022 08:42:11 GMT
cache-control
public, max-age=86400
age
66469
last-modified
Thu, 30 Dec 2021 15:50:16 GMT
content-type
text/html
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
index.html
s0.2mdn.net/10583188/1640879416687/ Frame DF24
70 KB
27 KB
Document
General
Full URL
https://s0.2mdn.net/10583188/1640879416687/index.html
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_275.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5098a0c240e499d63380d7b0c1b5776d6a139f80a270d77fe7347d861294ff74
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
access-control-allow-origin
*
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-length
27500
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
date
Thu, 03 Feb 2022 08:42:11 GMT
expires
Fri, 04 Feb 2022 08:42:11 GMT
cache-control
public, max-age=86400
age
66469
last-modified
Thu, 30 Dec 2021 15:50:16 GMT
content-type
text/html
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
getpixels
pixels.ad.gt/api/v1/
0
344 B
Script
General
Full URL
https://pixels.ad.gt/api/v1/getpixels?tagger_id=e0fc5aa47bed062e265fc29d169e5770&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&code=%27none%27
Requested by
Host: p.ad.gt
URL: https://p.ad.gt/api/v1/p/170
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.83.23.20 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-35-83-23-20.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

access-control-allow-origin
*
date
Fri, 04 Feb 2022 03:10:00 GMT
server
nginx/1.18.0
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
access-control-allow-methods
GET, POST, OPTIONS
access-control-expose-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
ecommerce.js
www.google-analytics.com/plugins/ua/
1 KB
763 B
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/ecommerce.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
8e1b84265e633c043720dd0921476c16bc9f75e393e855c9116ca7c3a847b5c7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:07:18 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
162
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
738
x-xss-protection
0
last-modified
Tue, 22 Oct 2019 18:15:00 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"static-on-bigtable","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/static-on-bigtable"}]}
content-type
text/javascript
cache-control
public, max-age=3600
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="static-on-bigtable"
expires
Fri, 04 Feb 2022 04:07:18 GMT
ec.js
www.google-analytics.com/plugins/ua/
3 KB
1 KB
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/ec.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
058ed961bfe422af7bfc65865f4c08531ec8ace995f8a1ec560a46581cb7712c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 02:55:28 GMT
content-encoding
br
x-content-type-options
nosniff
age
872
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1129
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 12:48:00 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"static-on-bigtable","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/static-on-bigtable"}]}
content-type
text/javascript
cache-control
public, max-age=3600
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="static-on-bigtable"
expires
Fri, 04 Feb 2022 03:55:28 GMT
cm
u.openx.net/w/1.0/
43 B
131 B
Image
General
Full URL
https://u.openx.net/w/1.0/cm?id=998eaf06-9905-4eae-9e26-9fac75960c53&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fopenx%3Fopenx_id%3D%7BOPENX_ID%7D%26id%3D0201tlxlfd07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8b5po0ntek210qskvk40trr7270wqxik90zq3u2c12pa5j31k0gxf118nmsj90fzd0bt1elzfjf1hl5r1i1kkc2jl%26auid%3D70a36042-ea6e-46be-a9ff-2e7c1131d901
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/17.1.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Feb 2022 03:10:00 GMT
content-encoding
gzip
server
OXGW/17.1.0
vary
Accept, Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
via
1.1 google
cache-control
private, max-age=0, no-cache
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
56
expires
Mon, 26 Jul 1997 05:00:00 GMT
halo_match
ids.ad.gt/api/v1/
43 B
650 B
Image
General
Full URL
https://ids.ad.gt/api/v1/halo_match?id=70a36042-ea6e-46be-a9ff-2e7c1131d901&halo_id=0201tlxlfd07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8b5po0ntek210qskvk40trr7270wqxik90zq3u2c12pa5j31k0gxf118nmsj90fzd0bt1elzfjf1hl5r1i1kkc2jl
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:10:00 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Fri, 04 Feb 2022 15:10:00 GMT
entity_313b.css
hostedcontent.dragonforms.com/hosted/images/dragon/generic/313/ Frame A406
19 KB
19 KB
Stylesheet
General
Full URL
https://hostedcontent.dragonforms.com/hosted/images/dragon/generic/313/entity_313b.css
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
205.162.42.5 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
cdn.omeda.com
Software
Apache /
Resource Hash
a33614a196d3854d7d068b3d73dca4806956c548d1ae3163bcd8e0b7664a2ed6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Fri, 04 Feb 2022 04:10:00 CET
X-Content-Type-Options
nosniff
Last-Modified
Fri, 22 Nov 2019 15:51:34 CET
Server
Apache
ETag
W/"19161-1574434294960"
X-Frame-Options
SAMEORIGIN
Content-Type
text/css
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding
chunked
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
jquery-2.2.4.min.js
code.jquery.com/ Frame A406
84 KB
29 KB
Script
General
Full URL
https://code.jquery.com/jquery-2.2.4.min.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4de0:ac18::1:a:2a , Netherlands, ASN20446 (HIGHWINDS3, US),
Reverse DNS
Software
nginx /
Resource Hash
05b85d96f41fff14d8f608dad03ab71e2c1017c2da0914d7c59291bad7a54f8e

Request headers

Referer
https://sample.dragonforms.com/
Origin
https://sample.dragonforms.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:10:00 GMT
content-encoding
gzip
last-modified
Fri, 20 Aug 2021 17:47:53 GMT
server
nginx
etag
W/"611feac9-14e4a"
vary
Accept-Encoding
x-hw
1643944200.dop220.fr8.t,1643944200.cds253.fr8.hn,1643944200.cds130.fr8.c
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=315360000, public
accept-ranges
bytes
content-length
29811
conditional.js
sample.dragonforms.com/js/ Frame A406
31 KB
32 KB
Script
General
Full URL
https://sample.dragonforms.com/js/conditional.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
d7993cf613408050b47ca5417eac7f90986d57213211a6b27f7579894e306389
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Fri, 04 Feb 2022 03:10:00 GMT
X-Content-Type-Options
nosniff
Last-Modified
Fri, 03 Sep 2021 16:11:38 GMT
Server
Apache
ETag
W/"31881-1630685498000"
Transfer-Encoding
chunked
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
dragonCampaign.js
sample.dragonforms.com/js/ Frame A406
13 KB
13 KB
Script
General
Full URL
https://sample.dragonforms.com/js/dragonCampaign.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
0dbc0190864fe5c6e0bd63e7b5233f94265ee535dc3c3e2031f27a251bbb2f60
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Fri, 04 Feb 2022 03:10:00 GMT
X-Content-Type-Options
nosniff
Last-Modified
Mon, 30 Aug 2021 17:56:04 GMT
Server
Apache
ETag
W/"13235-1630346164000"
Transfer-Encoding
chunked
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
generic.css
sample.dragonforms.com/style/ Frame A406
2 KB
1 KB
Stylesheet
General
Full URL
https://sample.dragonforms.com/style/generic.css
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
a75268aabd3efca2333dda30048a44d566fca0fa0c70f87249784d6c4dbaaa50
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Fri, 04 Feb 2022 03:10:00 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Last-Modified
Thu, 10 Jun 2021 15:35:48 GMT
Server
Apache
ETag
W/"2478-1623339348000"
Vary
Accept-Encoding
Content-Type
text/css;charset=UTF-8
Access-Control-Allow-Origin
*
Transfer-Encoding
chunked
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
962.css
hostedcontent.dragonforms.com/hosted/images/dragon/12247/ Frame A406
3 KB
3 KB
Stylesheet
General
Full URL
https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/962.css
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
205.162.42.5 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
cdn.omeda.com
Software
Apache /
Resource Hash
9b7e5dca586aec7050576b4dad559ab2688067149e60467be5ca505970455229
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Fri, 04 Feb 2022 04:10:00 CET
X-Content-Type-Options
nosniff
Last-Modified
Mon, 04 Oct 2021 19:31:31 CEST
Server
Apache
ETag
W/"2856-1633368691606"
X-Frame-Options
SAMEORIGIN
Content-Type
text/css
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding
chunked
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
363.js
hostedcontent.dragonforms.com/hosted/images/dragon/12247/ Frame A406
5 KB
6 KB
Script
General
Full URL
https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/363.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
205.162.42.5 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
cdn.omeda.com
Software
Apache /
Resource Hash
3f680ec1d9f173ca064c4fc16850d78e3b0bd291f4e0908f203245011861567d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Fri, 04 Feb 2022 04:10:00 CET
X-Content-Type-Options
nosniff
Last-Modified
Fri, 28 May 2021 14:35:55 GMT
Server
Apache
ETag
W/"5462-1622212555614"
X-Frame-Options
SAMEORIGIN
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding
chunked
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
olyticsLinkAssistance.js
sample.dragonforms.com/js/ Frame A406
4 KB
4 KB
Script
General
Full URL
https://sample.dragonforms.com/js/olyticsLinkAssistance.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
f88e771cd7aeeb1241c61b165090b9d197534d937e2bd53a62631a738439a2e6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Fri, 04 Feb 2022 03:10:00 GMT
X-Content-Type-Options
nosniff
Last-Modified
Fri, 16 Nov 2018 20:46:06 GMT
Server
Apache
ETag
W/"3961-1542401166000"
Transfer-Encoding
chunked
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
bg.jpg
s0.2mdn.net/10583188/1640879416687/ Frame 16C4
23 KB
23 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640879416687/bg.jpg
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640879416687/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
302f7648b1edc744ef010060096e2e0f105e32d5929a72dd68bcf14adbf49df1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640879416687/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 08:56:21 GMT
x-content-type-options
nosniff
age
65619
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
23776
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 15:50:16 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Fri, 04 Feb 2022 08:56:21 GMT
spriteSheet.png
s0.2mdn.net/10583188/1640879416687/ Frame 16C4
40 KB
40 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640879416687/spriteSheet.png
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640879416687/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
532337cded60f0e9913a958cdc4ca9c6707920088c269728907239600b6adfe6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640879416687/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 08:56:21 GMT
x-content-type-options
nosniff
age
65619
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
40808
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 15:50:16 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Fri, 04 Feb 2022 08:56:21 GMT
bg2.jpg
s0.2mdn.net/10583188/1640879416687/ Frame 16C4
20 KB
20 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640879416687/bg2.jpg
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640879416687/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a68f80768156c7ea00c4220898cb246b1faabb6b9b659e7ee3b74064a632f616
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640879416687/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 08:56:21 GMT
x-content-type-options
nosniff
age
65619
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
20428
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 15:50:16 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Fri, 04 Feb 2022 08:56:21 GMT
bg.jpg
s0.2mdn.net/10583188/1640880412777/ Frame 37E3
12 KB
12 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640880412777/bg.jpg
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640880412777/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
be071b2790c3e9de54bfe05374e726fd48d67c230382872b8b633a32d94a5711
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640880412777/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 08:35:52 GMT
x-content-type-options
nosniff
age
66848
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
12094
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 16:06:52 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Fri, 04 Feb 2022 08:35:52 GMT
spriteSheet.png
s0.2mdn.net/10583188/1640880412777/ Frame 37E3
15 KB
15 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640880412777/spriteSheet.png
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640880412777/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
7eb1827ca80ee431a782fd091c19ab41b794885cab1edd6bb3267432c118c44b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640880412777/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 08:35:51 GMT
x-content-type-options
nosniff
age
66849
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15146
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 16:06:52 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Fri, 04 Feb 2022 08:35:51 GMT
spriteSheet.png
s0.2mdn.net/10583188/1640879416687/ Frame 11AD
40 KB
40 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640879416687/spriteSheet.png
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640879416687/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
532337cded60f0e9913a958cdc4ca9c6707920088c269728907239600b6adfe6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640879416687/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 08:56:21 GMT
x-content-type-options
nosniff
age
65619
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
40808
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 15:50:16 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Fri, 04 Feb 2022 08:56:21 GMT
bg.jpg
s0.2mdn.net/10583188/1640879416687/ Frame 11AD
23 KB
23 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640879416687/bg.jpg
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640879416687/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
302f7648b1edc744ef010060096e2e0f105e32d5929a72dd68bcf14adbf49df1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640879416687/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 08:56:21 GMT
x-content-type-options
nosniff
age
65619
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
23776
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 15:50:16 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Fri, 04 Feb 2022 08:56:21 GMT
bg2.jpg
s0.2mdn.net/10583188/1640879416687/ Frame 11AD
20 KB
20 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640879416687/bg2.jpg
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640879416687/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a68f80768156c7ea00c4220898cb246b1faabb6b9b659e7ee3b74064a632f616
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640879416687/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 08:56:21 GMT
x-content-type-options
nosniff
age
65619
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
20428
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 15:50:16 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Fri, 04 Feb 2022 08:56:21 GMT
spriteSheet.png
s0.2mdn.net/10583188/1640879416687/ Frame DF24
40 KB
40 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640879416687/spriteSheet.png
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640879416687/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
532337cded60f0e9913a958cdc4ca9c6707920088c269728907239600b6adfe6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640879416687/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 08:56:21 GMT
x-content-type-options
nosniff
age
65619
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
40808
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 15:50:16 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Fri, 04 Feb 2022 08:56:21 GMT
bg.jpg
s0.2mdn.net/10583188/1640879416687/ Frame DF24
23 KB
23 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640879416687/bg.jpg
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640879416687/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
302f7648b1edc744ef010060096e2e0f105e32d5929a72dd68bcf14adbf49df1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640879416687/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 08:56:21 GMT
x-content-type-options
nosniff
age
65619
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
23776
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 15:50:16 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Fri, 04 Feb 2022 08:56:21 GMT
bg2.jpg
s0.2mdn.net/10583188/1640879416687/ Frame DF24
20 KB
20 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640879416687/bg2.jpg
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640879416687/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:802::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a68f80768156c7ea00c4220898cb246b1faabb6b9b659e7ee3b74064a632f616
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640879416687/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 08:56:21 GMT
x-content-type-options
nosniff
age
65619
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
20428
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 15:50:16 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Fri, 04 Feb 2022 08:56:21 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 235C
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstMTv997PPbY8hHQr-cC5k_7CBLL8fE0nZNnMBUC2c8cG-mYgam3J9ktiCvTKf36jjUYWlNIBzpTu4tJAzdLmWvqUZX5K2BSSXCRRBTaZnLi9_N_vgDYUwz-gIoyXGQX9nvEC-7TjdO1MapfL4PA17JC62qEGkTi03qKphg0sRk78rvUT1nUbpIzumunS08HY4Ng5t4wyU9HtBL-0LfB17yfR_Djfs1nSB_T9l17zHRNNvzoztjUweTs7LZXGsMxpIk66rAE6uRiUrHpVWZmzKdC26zGmB1bf22fIh62eQLI85R9Ffs36om4BqUiMAC6dPZ6BiKsCa5IHqDC40xl5ECgtxY-UQLzyag&sig=Cg0ArKJSzEYRZegv7VgJEAE&uach_m=[UACH]&urlfix=1&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXV0%3D&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.186.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s08-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Feb 2022 03:10:00 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
expires
Fri, 04 Feb 2022 03:10:00 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 5B08
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsucl6RrPvr5_iVH0TTGAsIeGGnz56bmFyxYejV3sX9ISgZPFxSyZmJMxwSNVHlRWz178F8piWyVBXW2DYvUjz8OXg-d-Eob-Fl2s_VfW2ZcNtbgj5BrSfkO6Exm6YaWxMcX9MdsYYFZZcmWKklYu6e_8Lw7Ro262FtfGzsSfc0isDZyTdRP_YSlqeUXrz8iZWVIJ51xR5mzC7obhGAfceH-6zGYzS4sCkWhOryNo3fzQ2AAAwmt1emGTOpKihi38HlBoaagkGob_8scv-a38ezxJxm2MbeHgNOEIX3fYxwhPkDykMneiC62HimxD8CqGLT3l1sEn7xEtkvyaaYBCdqmeRgZNWMJCRHJ&sig=Cg0ArKJSzJySB7sLTJhTEAE&uach_m=[UACH]&urlfix=1&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXV0%3D&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.186.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s08-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Feb 2022 03:10:00 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
expires
Fri, 04 Feb 2022 03:10:00 GMT
-RQXuketuW9jWIYsaM5S-Ql31PXoBsmd6vdkFHZtDQI.js
pagead2.googlesyndication.com/bg/ Frame EB7C
35 KB
13 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/-RQXuketuW9jWIYsaM5S-Ql31PXoBsmd6vdkFHZtDQI.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:801::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f91417ba47adb96f6358862c68ce52f90977d4f5e806c99deaf76414766d0d02
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Wed, 02 Feb 2022 17:36:34 GMT
content-encoding
br
x-content-type-options
nosniff
age
120806
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13701
x-xss-protection
0
last-modified
Thu, 27 Jan 2022 13:28:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 02 Feb 2023 17:36:34 GMT
-RQXuketuW9jWIYsaM5S-Ql31PXoBsmd6vdkFHZtDQI.js
pagead2.googlesyndication.com/bg/ Frame 888F
35 KB
13 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/-RQXuketuW9jWIYsaM5S-Ql31PXoBsmd6vdkFHZtDQI.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:801::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f91417ba47adb96f6358862c68ce52f90977d4f5e806c99deaf76414766d0d02
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Wed, 02 Feb 2022 17:36:34 GMT
content-encoding
br
x-content-type-options
nosniff
age
120806
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13701
x-xss-protection
0
last-modified
Thu, 27 Jan 2022 13:28:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 02 Feb 2023 17:36:34 GMT
-RQXuketuW9jWIYsaM5S-Ql31PXoBsmd6vdkFHZtDQI.js
pagead2.googlesyndication.com/bg/ Frame 7FC6
35 KB
13 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/-RQXuketuW9jWIYsaM5S-Ql31PXoBsmd6vdkFHZtDQI.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:801::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f91417ba47adb96f6358862c68ce52f90977d4f5e806c99deaf76414766d0d02
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Wed, 02 Feb 2022 17:36:34 GMT
content-encoding
br
x-content-type-options
nosniff
age
120806
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13701
x-xss-protection
0
last-modified
Thu, 27 Jan 2022 13:28:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 02 Feb 2023 17:36:34 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame C3C9
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstkNAvQaZwIBbEUy616s_ECdelBVMeqf22782mlE6PCger1RDGmSWy_qqRlmyqLJDJj4CozO-2475Y-_CDwev62IiFFqNspqhXR9RDvX2O2wK_5ph77w7SDCGN9aVKS07CXhsyk70kOMt3XYzgx0h_-1jMntCoLOLucTLpayEtwi9o7TC9WNVHu5W1vxFPV2-0zbhiHsGXf-CiXk9KFOpUYY-qkFOZ1QF1MdLufhwht4JDjcXrIDfMsREUrC4o0GZorai8qmgutU4WqwIllvYenWAjaw_A4OUsz8o3BeHqJbyd4N68rWatDGDXrchE_I8Z-454QOrOLbywRTFiN4FS-n3rMYuPVDFeU&sig=Cg0ArKJSzL1-nIhdgSYDEAE&uach_m=[UACH]&urlfix=1&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXV0%3D&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.186.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s08-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Feb 2022 03:10:00 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
expires
Fri, 04 Feb 2022 03:10:00 GMT
-RQXuketuW9jWIYsaM5S-Ql31PXoBsmd6vdkFHZtDQI.js
pagead2.googlesyndication.com/bg/ Frame 6EED
35 KB
13 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/-RQXuketuW9jWIYsaM5S-Ql31PXoBsmd6vdkFHZtDQI.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:801::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f91417ba47adb96f6358862c68ce52f90977d4f5e806c99deaf76414766d0d02
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Wed, 02 Feb 2022 17:36:34 GMT
content-encoding
br
x-content-type-options
nosniff
age
120806
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13701
x-xss-protection
0
last-modified
Thu, 27 Jan 2022 13:28:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 02 Feb 2023 17:36:34 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 798C
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssc5UrePlO28BWzBLafBPbSBPZfSnWeM1DXuyfVWVz8N4l9Mj9sHsx_5dkD9S3QPDYQFBLcKZkCf7bvcZgkwFWN2aCGUF8Lg6AjoV9DbCgUcMqrGYfdsFT27NTSg7HDxe3NrEYNpCtkHtfGVCnHcuR8Mf3oCmyDnzc1EPpWKZT11lqrYuzrybOTs2GIKghMfuUNiAz0WJ8PYq2w2cwhCxyB407K1R0kMFeIdJzDkZ2Mggv7PMC5lvYHSJ0Qur6TUQycp6cEVB-FBZOqScTypDzl-65vqfBY-vI3UX04Hn-JpXam8FCVaN30EyQnQR9D3S67v7D97Nd0vgvFFHyOMlwP-idJah2LfZDX&sig=Cg0ArKJSzNUv1YwygRZsEAE&uach_m=[UACH]&urlfix=1&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXV0%3D&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.186.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s08-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Feb 2022 03:10:00 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
expires
Fri, 04 Feb 2022 03:10:00 GMT
/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221643944199199%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199204%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221643944199199%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_all_%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_all_%5C%22%3A%5B%5C%222898354882%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199205%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&callback=bc_json961
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.98.80 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-98-80.fra50.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221643944199219%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199227%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221643944199219%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199228%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&callback=bc_json962
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.98.80 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-98-80.fra50.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221643944199255%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199264%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221643944199255%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199265%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&callback=bc_json963
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.98.80 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-98-80.fra50.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221643944199273%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199284%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221643944199273%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199285%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&callback=bc_json964
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.98.80 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-98-80.fra50.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

p
olytics.omeda.com/olytics/segments/ Frame
0
0
Preflight
General
Full URL
https://olytics.omeda.com/olytics/segments/p
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Access-Control-Allow-Origin
*
vary
Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age
1800
Access-Control-Allow-Methods
HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers
access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length
0
Date
Thu, 03 Feb 2022 19:10:01 PST
Server
Apache
/
olytics.omeda.com/olytics/segments/form/check/ Frame
0
0
Preflight
General
Full URL
https://olytics.omeda.com/olytics/segments/form/check/
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Access-Control-Allow-Origin
*
vary
Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age
1800
Access-Control-Allow-Methods
HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers
access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length
0
Date
Thu, 03 Feb 2022 19:10:01 PST
Server
Apache
p
olytics.omeda.com/olytics/segments/
4 KB
4 KB
XHR
General
Full URL
https://olytics.omeda.com/olytics/segments/p
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
40068bfeb1cd8a14e1c3230d793c081916a00bc1b6f7ca97f698373d906b3551
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
application/json

Response headers

Date
Thu, 03 Feb 2022 19:10:01 PST
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
/
olytics.omeda.com/olytics/segments/form/check/
20 B
313 B
XHR
General
Full URL
https://olytics.omeda.com/olytics/segments/form/check/
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
a8e427db11a8744bebbcdfd050f7b9d0a84b5a1754d086f1787c40db21955264
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
application/json

Response headers

Date
Thu, 03 Feb 2022 19:10:01 PST
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
cswitch
olytics.omeda.com/olytics/segments/ Frame
0
0
Preflight
General
Full URL
https://olytics.omeda.com/olytics/segments/cswitch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Access-Control-Allow-Origin
*
vary
Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age
1800
Access-Control-Allow-Methods
HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers
access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length
0
Date
Thu, 03 Feb 2022 19:10:01 PST
Server
Apache
cswitch
olytics.omeda.com/olytics/segments/
88 B
381 B
XHR
General
Full URL
https://olytics.omeda.com/olytics/segments/cswitch
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
6a035d9c29943e99874c663ecd6c2db2930b5001f488f710bd314165cdbee906
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
application/json

Response headers

Date
Thu, 03 Feb 2022 19:10:01 PST
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
publishertag.prebid.117.js
static.criteo.net/js/ld/
87 KB
28 KB
Script
General
Full URL
https://static.criteo.net/js/ld/publishertag.prebid.117.js
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:2638::3 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
nginx /
Resource Hash
90c9017a8a6447588520f38cd94ba14cdb9839c92626aa06bb8a4a1052c2ab7e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:10:00 GMT
content-encoding
gzip
last-modified
Wed, 29 Dec 2021 12:30:46 GMT
server
nginx
etag
W/"61cc54f6-15c19"
strict-transport-security
max-age=31536000; preload;
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=86400, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Sat, 05 Feb 2022 03:10:00 GMT
/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221643944199199%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199204%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221643944199199%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_all_%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_all_%5C%22%3A%5B%5C%222898354882%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199205%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A10%3A00%2B00%3A00&callback=bc_json965
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.98.80 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-98-80.fra50.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

report
creative.spotible.com/creative/GZee/
43 B
113 B
Image
General
Full URL
https://creative.spotible.com/creative/GZee/report?,1643944198,684001;UNIQUE_USER_GLOBAL!0,1,0;UNIQUE_USER_DAILY!0,1,0;UNIQUE_USER_HOURLY!0,1,0;IMPRESSION!0,1,0!18,1,0!55,1,0!69,1,0!113,1,0!120,1,0;IN_VIEW!0,1,1!18,1,1!55,1,1!69,1,1!113,1,1!120,1,1;IN_VIEW_TIME!0,1,0!18,1,0!55,1,0!69,1,0!113,1,0!120,1,0&referrer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
54.144.118.149 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-144-118-149.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:10:00 GMT
cache-control
no-store
content-length
43
content-type
image/gif
view
securepubads.g.doubleclick.net/pcs/
0
23 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjss_YYbiP9SXR0FaSg7Pkz6GS2x5ASduQBDtsSDX7K4vE_ZF-8GIcXRQz4hIVdPAXq5hfpFbmlZWmzpYlzq9DfAjslVtp2rqg3pe-JuJq0G5IAdp_Fi7YUqHbKT79QsMcQ36_pQ315mtFvCXop2QHLpu8WEd3okKOFg28mjQOAXNjKBTpjng1wAFY3hQAMxabiezAl16rOPyc38BARy4fL0XgM-H7mq-Vt-CfqHcA-5es4ONi6bs6scGcbUJikLQorhtu067TBl0f_uV9f6NiR8ZDq5K3jmynZDffMNcfFKAXIzseDuVa1nT2ulAOIhJ-plcZK9u231yzKrqJi6cESx-hvE5DGqDKdP-ciGnWnIa326wa_x4ua77wIYxRykCKQvLpGDcL67P&sai=AMfl-YQBS3MTeTVdizTOZO0_Jyg4ru3aFSbUSKlAaf_Hl9jjy1EPjzD2CCPDxWHcF_XVf58xmD12H-dc5fLyJ2AuI1J2q2XyY_gmdB8FbkujTwIMOPJrJKSrvm4XfHNAIeU&sig=Cg0ArKJSzIJcu4S5ijqyEAE&uach_m=[UACH]&urlfix=1&adurl=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.186.162 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s08-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 04 Feb 2022 03:10:00 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221643944199219%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199227%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221643944199219%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199228%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A10%3A00%2B00%3A00&callback=bc_json966
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.98.80 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-98-80.fra50.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221643944199255%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199264%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221643944199255%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199265%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A10%3A00%2B00%3A00&callback=bc_json967
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.98.80 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-98-80.fra50.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221643944199273%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199284%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221643944199273%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199285%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A10%3A00%2B00%3A00&callback=bc_json968
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
143.204.98.80 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-98-80.fra50.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

gen_204
pagead2.googlesyndication.com/pagead/ Frame EB7C
0
20 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=sodar&v=30&t=2&bgai=B4WHUB5n8Yb23Lrmu7_UPnvCD8AEAAAAAOAHgBAI&bg=!iomlic3NAAYZkRhwGZE7ACkAdvg8Wto2B97JvEjAX-___Xvs8PZJRxxrfItvD2Oe-0wdgg_XrSldtgIAAAG8UgAAAARoAQeZAs0f3Ey1UQIa2tTKYeRJYYkRxoa1v8DStntx52Qjy7mYwQGj_4AhYKhBKmikA8JKTCL3VS-y0ZrfiZlAivYfpclFGR8RiU69vM0-uapqTxjYCDKeJ3wzZAzQ5jbpPJOig7NDcmEDZF92L5xe7mxDZUgI6okh2QpJhfIS1SXNImbdzeKDFvIp3G2sxbGCPW28Ni7ER9GXmJgqkI16gXcOod6M6_kUZb_pP1kel3z87Zr-yKiW5A1V47XUSRfpU4ajKcqj1feKyDvci7gSDV9hT4gsitkkEJcZNnxEprWpT0xyzyQ-GRdMN4Ofif6W3hvYqcIW4AfFd5Y57nbCTAAq9CH65_ho6Et2unz5LRY1ORmXbGEe0sjFLANirdCIIpYZYED4WlaWvcYUe1-r_s_WpSRO6t0HLgAdCRWuAznM-mPP1cTqHUsOi0XyKoi9ReksQYdhDVZDHQd34E4ratAXRxpanMWhdqMyRSHoP0q4johJNIKhL0SRcXhWfvsBBog7A4DbHe718gxTjH2rMp29K0uhaOi3syoSEJ6ArORZmT1vXfIf4wBRfW-t5Trg597GBDUj2maKbEHpucsYB-kqIqa92yJP4_MNSJTclhMHJlFG1PNLr6VqlgjqF6n6kgkCDINOs1MMA1NQdECgHZisg52K6a1qWjm99rjIVINeMDkJ0RAjQ_xXZmMMWZNtv_yGvn0swv0Nh7w-fYqcDDG_umbPV7zBvV1nwQvEftxanErPaHh6fISvGSf4TFE-Zd3kRmcWxnKU-nzEF9kkGAKpHQAgYoyNl3qVoZ7ut2-fYjjlKmbI0SX6909Ytg3YOGriVIeh5-HhGtlqjmkIO9edCyqK4SlwUqTRicuH7lo-E8UtldFZnHnhBq-gRxp5Q4SEjh8cDzAU7ow5M0Uqh2DiP5hAuuoIYoHKATW5xoPsEqkKY40566uqB3rAuBsDWZE
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:801::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Feb 2022 03:10:00 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
gen_204
pagead2.googlesyndication.com/pagead/ Frame 888F
0
20 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=sodar&v=30&t=2&bgai=BG28ZB5n8Ybu3Lrmu7_UPnvCD8AEAAAAAOAHgBAI&bg=!vb6lvvrNAAYZkRhwGZE7ACkAdvg8WtUw9UckPyaSVyqWokDe8R6deQgC6x5x0ukDgAzOJ6zCgJiXcAIAAAH8UgAAAARoAQeZAts6D6Jy6F50jlrrQNsR3eZ1eAGUhxJPrRP5PC2W0mxaw0bI8WPAYgaouQ1N-3uutTaQGLvync-GK4jI3q30c9UV_sZgaCG8a88O5ISJQwYS-gTXDrNN73tQDCd3Z-OJpI-PmAPHpedaI397VMTWuk0v-Q736AAd0wrNcUT68xbl6kKGKsbtQ3FnxHKFxnu8S3CxxhYC8wqUthpiZ-ynJIY5n8Tm6Wc44UWPU-kgzE01Uf3oXcQZMOiBcykYWWfI34WlyCiwrqToKYeyUkncUXV6TSbJGu13WXCALM8rtX7rRa8z-yBsAmI6UbvdTYau9EmpzYYI4Y6EHhb80BzaOckZstV-JDEHXej1JoMjQLZ17LyATKGbPu0FkFyy0pI4sJ4ELuLmaKhejX8AvBzZO3Lwz0bAVJ3ckW9_wwSDGa6M0vr-wlvee-YqDme4BnY2-kaOrYafBXhFEd7Af9IAjPh6Gl-UI6-YkrxyMraphpiqkXd45gCCQEpzQSC0daKC_T7ARNoVi6-lgzGhPH5gb5Au-_AzLvN-uT92CUI1zwW-de4yQaK6W0pImSUcBM33vIPBo5aEGb7TZh6BkbAE-Q88JP6EcSGY769N6DInWmAgnVq_f9_4yitXifbyxFfLoifYU193T3UFa8N9ps1dt43qo5C-iHGs43B5ecXuawOylGEer8R0jWQr4x345uucqPIvFGcqxhinyq_k2JAJ4-aeAyE0tB7cBk-LlfvRIWFcWXNbZyaeFAdwx1NfrOQ2LNmH3vDqtIpojGdkPKc37VrrkqashxIgDx0tobFj2yenOtCuFy0zIYmLq1xYxQcPQhxNy4LTS6GxdvednVwnXCgECI3YQrUjr-eM-tcmeXZkX3wmydkuuyXxcCCebUQrF54sUGdVixrPTn4SFoBeGGh21pUNs5Gkd7mczjC9bWIx0NJuP8KFfC__MHwD36NqN0pCYoUoXYyavgl-0Q
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:801::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Feb 2022 03:10:00 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
multitracking
ghb.hbmp.mediafuse.com/adunit/
0
211 B
XHR
General
Full URL
https://ghb.hbmp.mediafuse.com/adunit/multitracking
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456651/hbw_master_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.239.173.66 , United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Fri, 04 Feb 2022 03:10:00 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
gen_204
pagead2.googlesyndication.com/pagead/ Frame 7FC6
0
20 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=sodar&v=30&t=2&bgai=BdaWmB5n8Yby3Lrmu7_UPnvCD8AEAAAAAOAHgBAI&bg=!Pj2lPXnNAAYZkRhwGZE7ACkAdvg8WrNxPfb8N949834k2OhF4TXRndGZlzdQtA3SC2s3nTibYLQpbAIAAAHsUgAAAAJoAQcKADOxZzKYPSYLK6hRZkNy6pRbMuNgneICqfcN4HnlHEwMn2nxBpofjZpjH1avbBSz--vR4XWZAs_trJLAa1ASxLul9PmW8mc3_VXQPeDIyENE41Te2Yw-OcPj1ylmNACne_CYmz-lWoNbGe2Koag4yRWo8TSv5cmmLmBxZNNRkGRJTriycIY8u8pmOhK0burPGSflWvR-O_thCSvtkU7jW7dz21e2S2JMr-BLBGV1hLC-d6v9fOKnI5ya16P1_CCNijXHG_mqZh8B0_6BzAq3Mzm4avpjptijn1tGmSpVpIZqtMNhUHMz2tTgOCM8k0HcPO0rO0WWnS_v6F5wkmXkCVbpxvzz7DPgwppS2PhZbzotwnwL54pgrd995m3SHvkDCFu8zgWITKjOk_2XvLdKkNMcV2ApNuPs5tkBbfIwZgInXIpSRLPPr3qlUeE92BOymFH31iJt7ydeB1jWHEPvlLrpHcy9tIO3IbTQ5WNGgTvZnsFH9WAxxs9hGG3sfYWlxqn2akzeDlXuHNDLbQwYB9x86iKe0EQp_E2K8t-WkInwOaEop9v_rhigTv6H11XlG35gpB6aTqKvW9I81Kll9OGZbMn75TSaONAsBeyGdROHvsua6kKGlOYyabxs4u3LaLQJo0ZiExZxTm1Vpca9mGjkGbRu3zs7VF2n68_rRJOMS0kwsN37QtS7ZCSQaKKbVIImsglmxsprpaNoknYCxKuUy1n55AnqcosbEcy-ra0PiSx1LZlmltJj2CPVxMnEhpTLHVkYo53riQbLrRuT2yWeKdT6FJi48OmQZIvlRDp1gq9lOJTsAhzw8fj_SsDGpbnYKucbmIfWGBTPg2rewQ6ToJygQwYYCjIuNGimrdZtgTVsiseWwfJpDMEoCzZz85OPJDxaRRttRXP54ELdYKPR9JN_uY-PFd-9ETL6YNbQCqv198eBc9LfLqEH4fSNmCQ3ZXzo-fwYMWyOlVNB46youTPDWG2Cdf7BxUTyu8nAFu4yRgT6mJYgJGqb4xV3PEEnr-C53g
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:801::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Feb 2022 03:10:00 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
gen_204
pagead2.googlesyndication.com/pagead/ Frame 6EED
0
20 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=sodar&v=30&t=2&bgai=BqFZ3B5n8Ybq3Lrmu7_UPnvCD8AEAAAAAOAHgBAI&bg=!YmGlYSXNAAYZkRhwGZE7ACkAdvg8Wjeh0IE3axpIHsKYg2fi9q8bWI2krDsYb9dTgdjLzJG_UnVJyQIAAAHiUgAAAANoAQeZAuZ-oZSmZAtDTBr5-rbFiqhyX3M_VBFQ-ZZiAqrUuBQEQ4NJ_tl_emjwtceBIf5DHzdVTbGD8_spc4EL0ktq9sc6A4KfFewvh6Ax4sI-6GTmx5R3k32S5vJSk-4792uc1-sezuFfGBkJFH-7wbvNXtUDf_SCaamLsIipb4XjI8j9c2hcZWM4ZM1Ru6q6nNHR5qLD9HWf3yddqww4lr7H8HRK3POVR129mtRvmF3yjJBz2iH_8vUA-o_d6EJwBH2uJwXz7Oh8meBBYh9mUZKptQxwa_oKxfVyUr2qTPuV7n5zPM0kN7mt3WvH9m3HNyfF6gweqzou7GadVo3-AKuMMsu8-UWuDhYsvqMea8T_jl-2Njv1N0ir-kILC1a6UWV_R7LznpIl9pFTDj2qmPlICuE49DreOHdPSQIYXIFpntVqS1IenUiBjaKlGt-LgKP6Jd-MZjHR_MmMiQkbouAobYrOlsBdA6N2p8ECAeQeW5tqlLG_o7A_BgwBMkciiMazRb4qGO8D3F4TVnzD_1ytG-dXL2_sfixbUh26WLy3B0vCnew95RyDISpOfqeZiqwALNDDo-c_cb8SAV5A9Ic84Ocy87A_V9sMNuO5Rn_JDb7DMV5xLrOBCBFbsv2pK5qepBmMSadnIcPl_i86H7-jCyuo2O4ghbweu_lQR4rgnIQNb25Jv4mj39QJ8ftgkXSot7aEfJldWi50gIYB6prvrBVhtyh2V7NLvZ_KBejRKCRW5-79ASm9X9yBbix5f1GGaWydFwv3BZ8_C8h2OJtQ0IuyDVgJv4tK41jT2EaC2tEmuWybzSiUjo8G1Fq_Gl9Xrn4TsIXG-nRJiBSCdta94APl_koSaMNptycMTI6u0VfUjm0J-pY32u8TEiM8ocgizJi8x9LuEdHMb0QTKl_mro9yG_3jyEII8QaNouccqYrSGimsEu48wTnov_Jwn8fcSilbQhHyyIktiEyJ1JbmMnyXIQpC_ECh
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:801::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Feb 2022 03:10:00 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
publishertag.prebid.js
static.criteo.net/js/ld/
89 KB
28 KB
XHR
General
Full URL
https://static.criteo.net/js/ld/publishertag.prebid.js
Requested by
Host: static.criteo.net
URL: https://static.criteo.net/js/ld/publishertag.prebid.117.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:2638::3 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
nginx /
Resource Hash
5f1a0eb046f22533fd96fde5da0c9f951cb8b69354839596657271c9af223be0
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:10:00 GMT
content-encoding
gzip
last-modified
Mon, 24 Jan 2022 04:27:55 GMT
server
nginx
etag
W/"61ee2acb-16429"
strict-transport-security
max-age=31536000; preload;
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=86400, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Sat, 05 Feb 2022 03:10:00 GMT
gtm.js
www.googletagmanager.com/ Frame A406
95 KB
37 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-MV5SCJ
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82f::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
b65d2591856c922a5b2037401f183b2e9440743c755b5093cc01a6111add259b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:10:01 GMT
content-encoding
br
server
Google Tag Manager
access-control-allow-headers
Cache-Control
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=31536000; includeSubDomains
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
37930
x-xss-protection
0
expires
Fri, 04 Feb 2022 03:10:01 GMT
index.php
a.dpmsrv.com/dpmpxl/
5 B
1 KB
Script
General
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?q=xSeg&v=1.x&ep%5Bids%5D=29315642%2C29315652%2C29028703%2C16013439%2C16671093&cl=913&pixelIndex=0&r=234490&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&id=3035801625078687012&_=1643944197660
Requested by
Host: s.dpmsrv.com
URL: https://s.dpmsrv.com/dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.6.171.241 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-6-171-241.compute-1.amazonaws.com
Software
/
Resource Hash
fbc45fe018830de401f0cf801177a57d0039bc72d922b8ff2c82af7af05dd32b

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma
no-cache
content-encoding
gzip
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin
*
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Type
text/javascript
Access-Control-Allow-Headers
content-type, accept
Content-Length
31
Expires
0
seg
ib.adnxs.com/
43 B
1019 B
Image
General
Full URL
https://ib.adnxs.com/seg?member=827&add=29315642,29315652,29028703,16013439,16671093
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.173.22 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),
Reverse DNS
536.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 04 Feb 2022 03:10:01 GMT
X-Proxy-Origin
193.27.14.20; 193.27.14.20; 536.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid
ad54d666-c961-4b14-aabc-dfc33c7ca08a
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
956.svg
hostedcontent.dragonforms.com/hosted/images/dragon/12247/ Frame A406
2 KB
2 KB
Image
General
Full URL
https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/956.svg
Requested by
Host: hostedcontent.dragonforms.com
URL: https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/962.css
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
205.162.42.5 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
cdn.omeda.com
Software
Apache /
Resource Hash
576f1c20a3f2469e8fc92810450d9d4f25642aa38c0777307cc47ce8c59c6cef
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/962.css
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Fri, 04 Feb 2022 04:10:01 CET
X-Content-Type-Options
nosniff
Last-Modified
Mon, 04 Oct 2021 19:02:01 CEST
Server
Apache
ETag
W/"1609-1633366921443"
X-Frame-Options
SAMEORIGIN
Content-Type
image/svg+xml
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding
chunked
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
olytics.min.js
olytics.omeda.com/olytics/js/v3/p/ Frame A406
271 KB
73 KB
Script
General
Full URL
https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
c3a7557477adc5716e0f3fce8153c92bfc1aea35b03cdbcbedf56e341a80bcba
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Thu, 03 Feb 2022 19:10:01 PST
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Last-Modified
Tue, 11 Jan 2022 17:41:06 GMT
Server
Apache
ETag
W/"277863-1641922866000"
X-Frame-Options
SAMEORIGIN
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=21600
Transfer-Encoding
chunked
Accept-Ranges
bytes
vary
accept-encoding
X-XSS-Protection
1; mode=block
Expires
Fri, 04 Feb 2022 09:10:01 GMT
evaluateConditionalContent.do;jsessionid=CDB301AD3FC26F41C58CF7448923886D
sample.dragonforms.com/ Frame A406
277 B
467 B
XHR
General
Full URL
https://sample.dragonforms.com/evaluateConditionalContent.do;jsessionid=CDB301AD3FC26F41C58CF7448923886D?demo100824=short&demo100825=&demo100826=&opt100835=1&dragon_pagenumber=1&jsessionid=CDB301AD3FC26F41C58CF7448923886D&timestemp=1643944200410
Requested by
Host: code.jquery.com
URL: https://code.jquery.com/jquery-2.2.4.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
453fe30c44224213638b7785bb2672ae599c47363b7964b24a5efdfa4c30c1fb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept
application/json, text/javascript, */*; q=0.01
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
X-Requested-With
XMLHttpRequest
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Fri, 04 Feb 2022 03:10:01 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Server
Apache
Vary
Accept-Encoding
Content-Type
text/x-json;charset=UTF-8
Access-Control-Allow-Origin
*
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
evaluateConditionalContent.do;jsessionid=CDB301AD3FC26F41C58CF7448923886D
sample.dragonforms.com/ Frame A406
277 B
467 B
XHR
General
Full URL
https://sample.dragonforms.com/evaluateConditionalContent.do;jsessionid=CDB301AD3FC26F41C58CF7448923886D?demo100824=short&demo100825=&demo100826=&opt100835=1&dragon_pagenumber=1&jsessionid=CDB301AD3FC26F41C58CF7448923886D&timestemp=1643944200429
Requested by
Host: code.jquery.com
URL: https://code.jquery.com/jquery-2.2.4.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
453fe30c44224213638b7785bb2672ae599c47363b7964b24a5efdfa4c30c1fb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept
application/json, text/javascript, */*; q=0.01
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
X-Requested-With
XMLHttpRequest
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Fri, 04 Feb 2022 03:10:01 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Server
Apache
Vary
Accept-Encoding
Content-Type
text/x-json;charset=UTF-8
Access-Control-Allow-Origin
*
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
analytics.js
www.google-analytics.com/ Frame A406
49 KB
20 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-MV5SCJ
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80e::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
a1925038db769477ab74b4df34350c35688a795bb718727b0f4292a4a78a6210
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Tue, 02 Nov 2021 17:39:06 GMT
server
Golfe2
age
5707
date
Fri, 04 Feb 2022 01:34:54 GMT
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
20006
expires
Fri, 04 Feb 2022 03:34:54 GMT
activeview
pagead2.googlesyndication.com/pcs/ Frame 5B08
42 B
64 B
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsssRLTWmdebe5be2iVKlAyf6Nzjekn6DgkGa6b6lUnHvb3rtyKEwjDgG4ySemn8fk8sJCyD6r3vmoDWSLdH8BebChT3iolCNz8yn4A0Y56N3rYbf4pmMVkywcGOmR3x7dV8FYNJI_5icMHA3zyM5Ke77NslYf9jEuSd3xTbcSZsMacf8B6svANV&sig=Cg0ArKJSzD_NZsK5ZeshEAE&id=lidar2&mcvt=1019&p=988,315,1078,1285&mtos=1019,1019,1019,1019,1019&tos=1019,0,0,0,0&v=20220202&bin=7&avms=nio&bs=1600,1200&mc=1&app=0&itpl=19&adk=564636127&rs=4&la=0&cr=0&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXV0%3D&vs=4&r=v&rst=1643944199096&rpt=446&isd=0&lsd=0&met=ie&wmsd=0
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:801::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Feb 2022 03:10:01 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
evaluateConditionalContent.do;jsessionid=CDB301AD3FC26F41C58CF7448923886D
sample.dragonforms.com/ Frame A406
277 B
467 B
XHR
General
Full URL
https://sample.dragonforms.com/evaluateConditionalContent.do;jsessionid=CDB301AD3FC26F41C58CF7448923886D?demo100824=short&demo100825=&demo100826=&opt100835=1&dragon_pagenumber=1&jsessionid=CDB301AD3FC26F41C58CF7448923886D&timestemp=1643944200671
Requested by
Host: code.jquery.com
URL: https://code.jquery.com/jquery-2.2.4.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
453fe30c44224213638b7785bb2672ae599c47363b7964b24a5efdfa4c30c1fb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept
application/json, text/javascript, */*; q=0.01
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
X-Requested-With
XMLHttpRequest
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Fri, 04 Feb 2022 03:10:01 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Server
Apache
Vary
Accept-Encoding
Content-Type
text/x-json;charset=UTF-8
Access-Control-Allow-Origin
*
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/ Frame A406
0
0
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:801::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:10:01 GMT
content-encoding
gzip
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
52588
x-xss-protection
0
server
cafe
etag
11221154054108962446
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=3600
timing-allow-origin
*
expires
Fri, 04 Feb 2022 03:10:01 GMT
gpt.js
www.googletagservices.com/tag/js/ Frame A406
0
0
Fetch
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:812::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:10:01 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27234
x-xss-protection
0
server
sffe
etag
"1121 / 973 of 1000 / last-modified: 1643929548"
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Fri, 04 Feb 2022 03:10:01 GMT
p
olytics.omeda.com/olytics/segments/ Frame A406
0
197 B
XHR
General
Full URL
https://olytics.omeda.com/olytics/segments/p
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://sample.dragonforms.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
application/json

Response headers

Access-Control-Allow-Origin
*
Date
Fri, 04 Feb 2022 03:10:02 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-XSS-Protection
1; mode=block
X-Frame-Options
SAMEORIGIN
cswitch
olytics.omeda.com/olytics/segments/ Frame A406
94 B
387 B
XHR
General
Full URL
https://olytics.omeda.com/olytics/segments/cswitch
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
3dfa79f74fa390a90f9d1806c6c64f3cf789b1be61749662de88aca1ab9139a3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://sample.dragonforms.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
application/json

Response headers

Date
Fri, 04 Feb 2022 03:10:02 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
p
olytics.omeda.com/olytics/segments/ Frame
0
0
Preflight
General
Full URL
https://olytics.omeda.com/olytics/segments/p
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://sample.dragonforms.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Access-Control-Allow-Origin
*
vary
Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age
1800
Access-Control-Allow-Methods
HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers
access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length
0
Date
Fri, 04 Feb 2022 03:10:02 GMT
X-Cnection
close
Server
Apache
cswitch
olytics.omeda.com/olytics/segments/ Frame
0
0
Preflight
General
Full URL
https://olytics.omeda.com/olytics/segments/cswitch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://sample.dragonforms.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Access-Control-Allow-Origin
*
vary
Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age
1800
Access-Control-Allow-Methods
HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers
access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length
0
Date
Fri, 04 Feb 2022 03:10:02 GMT
Server
Apache
json
gum.criteo.com/sid/ Frame
0
0
Preflight
General
Full URL
https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Fwww.fiercepharma.com%2F&domain=www.fiercepharma.com&cw=1&pbt=1&lsw=1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:2638:1::13 -, , ASN (),
Reverse DNS
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept
*/*
Access-Control-Request-Method
GET
Access-Control-Request-Headers
content-type
Origin
https://www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

cache-control
no-cache, no-store, must-revalidate
pragma
no-cache
content-type
application/json; charset=utf-8
expires
0
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-headers
content-type
access-control-allow-credentials
true
access-control-allow-methods
GET
server-processing-duration-in-ticks
1542
date
Fri, 04 Feb 2022 03:10:02 GMT
strict-transport-security
max-age=31536000; preload;
content-encoding
gzip
vary
Accept-Encoding
sid
mug.criteo.com/
Redirect Chain
  • https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Fwww.fiercepharma.com%2F&domain=www.fiercepharma.com&cw=1&pbt=1&lsw=1
  • https://mug.criteo.com/sid?cpp=OmTaFHxnVGIwc3FlMWpkc2RyMFphd3ZqaVdudlVoYjBPeFZXa0lIVG9oa0ZKTEVSK0RtL3IwR2dHRzJWOGcrM0ZlSkpMQjZrQUVTVm04cnViTlU2MCs3RHJPa2NzcTladkc0OUwzMG9MeTYyOXdiM2hLTHZKOXJYb2J2MD...
353 B
617 B
XHR
General
Full URL
https://mug.criteo.com/sid?cpp=OmTaFHxnVGIwc3FlMWpkc2RyMFphd3ZqaVdudlVoYjBPeFZXa0lIVG9oa0ZKTEVSK0RtL3IwR2dHRzJWOGcrM0ZlSkpMQjZrQUVTVm04cnViTlU2MCs3RHJPa2NzcTladkc0OUwzMG9MeTYyOXdiM2hLTHZKOXJYb2J2MDljM0ptT2xvUDJya0RoQ3ZvRVlkbE9VcnNxQXQwMEYwMmtTSytPRkgvRTJXeXc4NVRxbWo3eTlUODdXei9vSlhjVVE0UXdiQnF2UWR2c0ZVTGxQSDh1ZDBsSGp6empXcFoyNkxQSCtSNERBZDhIUUNub1h3ZWV6eFVmN3dGUVBPd05Cbk5OeFo0fA&cppv=2
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Server
178.250.0.157 -, , ASN (),
Reverse DNS
Software
/
Resource Hash
631dd5834a1e67a8bc235e5a9974dc1e60cf5ae044ba170d56353bad1f25057d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 04 Feb 2022 03:10:02 GMT
content-encoding
gzip
vary
Accept-Encoding
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
access-control-allow-origin
null
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
server-processing-duration-in-ticks
2629
strict-transport-security
max-age=31536000; preload;
expires
0

Redirect headers

pragma
no-cache
date
Fri, 04 Feb 2022 03:10:02 GMT
location
https://mug.criteo.com/sid?cpp=OmTaFHxnVGIwc3FlMWpkc2RyMFphd3ZqaVdudlVoYjBPeFZXa0lIVG9oa0ZKTEVSK0RtL3IwR2dHRzJWOGcrM0ZlSkpMQjZrQUVTVm04cnViTlU2MCs3RHJPa2NzcTladkc0OUwzMG9MeTYyOXdiM2hLTHZKOXJYb2J2MDljM0ptT2xvUDJya0RoQ3ZvRVlkbE9VcnNxQXQwMEYwMmtTSytPRkgvRTJXeXc4NVRxbWo3eTlUODdXei9vSlhjVVE0UXdiQnF2UWR2c0ZVTGxQSDh1ZDBsSGp6empXcFoyNkxQSCtSNERBZDhIUUNub1h3ZWV6eFVmN3dGUVBPd05Cbk5OeFo0fA&cppv=2
strict-transport-security
max-age=31536000; preload;
access-control-allow-methods
GET
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
server-processing-duration-in-ticks
1647
content-length
509
expires
0
692.json
id5-sync.com/g/v2/
213 B
538 B
XHR
General
Full URL
https://id5-sync.com/g/v2/692.json
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456651/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
51.89.20.86 -, , ASN (),
Reverse DNS
Software
/
Resource Hash
497398d688ee6dfa030317de489cc2e0a69ad7e1b1f53b084c775caee69eda4e
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Fri, 04 Feb 2022 03:10:02 GMT
Access-Control-Allow-Credentials
true
Vary
Origin
Transfer-Encoding
chunked
Strict-Transport-Security
max-age=63072000; includeSubDomains; preload
Content-Type
application/json;charset=UTF-8
sid
mug.criteo.com/ Frame
0
0
Preflight
General
Full URL
https://mug.criteo.com/sid?cpp=OmTaFHxnVGIwc3FlMWpkc2RyMFphd3ZqaVdudlVoYjBPeFZXa0lIVG9oa0ZKTEVSK0RtL3IwR2dHRzJWOGcrM0ZlSkpMQjZrQUVTVm04cnViTlU2MCs3RHJPa2NzcTladkc0OUwzMG9MeTYyOXdiM2hLTHZKOXJYb2J2MDljM0ptT2xvUDJya0RoQ3ZvRVlkbE9VcnNxQXQwMEYwMmtTSytPRkgvRTJXeXc4NVRxbWo3eTlUODdXei9vSlhjVVE0UXdiQnF2UWR2c0ZVTGxQSDh1ZDBsSGp6empXcFoyNkxQSCtSNERBZDhIUUNub1h3ZWV6eFVmN3dGUVBPd05Cbk5OeFo0fA&cppv=2
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.157 -, , ASN (),
Reverse DNS
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept
*/*
Access-Control-Request-Method
GET
Access-Control-Request-Headers
content-type
Origin
null
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

cache-control
no-cache, no-store, must-revalidate
pragma
no-cache
content-type
application/json; charset=utf-8
expires
0
access-control-allow-origin
null
access-control-allow-headers
content-type
access-control-allow-credentials
true
access-control-allow-methods
GET
server-processing-duration-in-ticks
2704
date
Fri, 04 Feb 2022 03:10:02 GMT
strict-transport-security
max-age=31536000; preload;
content-encoding
gzip
vary
Accept-Encoding
report
creative.spotible.com/creative/GZee/
43 B
98 B
Image
General
Full URL
https://creative.spotible.com/creative/GZee/report?,1643944198,684003;IN_VIEW_TIME!0,3,0!18,3,0!55,3,0!69,3,0!113,3,0!120,3,0&referrer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
54.144.118.149 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-144-118-149.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Fri, 04 Feb 2022 03:10:03 GMT
cache-control
no-store
content-length
43
content-type
image/gif

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
c405.fiercepharma.com
URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/957?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A57%2B00%3A00&ts=1643944197583
Domain
ads.spotible.com
URL
https://ads.spotible.com/tag/universal-tag.js
Domain
c405.fiercepharma.com
URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/957?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&ts=1643944199199
Domain
c405.fiercepharma.com
URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/957?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&ts=1643944199220
Domain
c405.fiercepharma.com
URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/957?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&ts=1643944199255
Domain
c405.fiercepharma.com
URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/957?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&ts=1643944199273

Verdicts & Comments Add Verdict or Comment

114 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 object| 3 object| 4 object| 5 object| 6 object| 7 object| 8 object| 9 object| 10 object| event object| NREUM object| newrelic function| __nr_require function| mobileCheck object| dataLayerValues object| dataLayer object| googletag object| vmpbjs object| vpb object| a2a_config object| Modernizr object| blueConicPreListeners function| BCClass object| blueConicClient function| bc_json958 string| ssaUrl undefined| $ function| jQuery object| drupalSettings object| Drupal object| picturefillCFG function| picturefill function| _toConsumableArray function| disablePurgingButton object| WebFont object| a2a function| a2a_show_dropdown function| a2a_miniLeaveDelay function| a2a_init number| a2apage_init object| ggeac object| google_js_reporting_queue object| google_tag_manager object| google_tag_data string| GoogleAnalyticsObject function| ga string| method string| bid string| oid object| olytics object| a string| qtxSection function| vmpbjsChunk object| _pbjsGlobals object| mnet string| nobidVersion object| nobid object| PARSELY object| gaplugins object| gaGlobal object| gaData undefined| google_measure_js_timing boolean| CE_USER_SCRIPT object| CE2 string| CE_USER_DATA_URL function| mktoMunchkinFunction object| Munchkin function| mktoMunchkin function| Dpxl object| dpmPixels object| jQuery111108635253355865988 function| _typeof object| MunchkinTracker string| CE_USER_COMMON_SCRIPT_URL string| CE_USER_THIRDPARTY_SCRIPT_URL object| MktoForms2 function| mktoFormSubmitCallback object| _ml function| readCookie function| profileIdExecute string| queryString boolean| disableBcMarketoIntegration object| CE2BH function| CE_URL_FINGERPRINT object| Criteo object| googleToken object| googleIMState function| processGoogleToken number| google_unique_id function| bc_json959 function| __$PP function| bc_json960 object| spotible object| auvars function| setImmediate function| clearImmediate function| normalize object| w7eDOMEvents function| docReady object| au object| autag function| bc_json961 function| bc_json962 function| bc_json963 function| bc_json964 function| bc_json965 function| bc_json966 function| bc_json967 function| bc_json968 object| criteo_pubtag object| criteo_pubtag_prebid_117 object| Criteo_prebid_117

69 Cookies

Domain/Path Name / Value
www.fiercepharma.com/pharma Name: hasLiveRampMatch
Value: true
go.questexnetwork.com/ Name: BIGipServersj_mailtracking_http
Value: !XD98MpVFBjbeM96PurFYsUVmfdh2KJ1e0dxgGQC5Z9nWKVYZKDggWdd9hc/VQewjIY2cnSYlGHlgpbA=
.go.questexnetwork.com/ Name: __cf_bm
Value: tn7Np_uxPBnSckk3dJ.SBxu90x0yzjAfn5pxGM3g.wI-1643944197-0-ASiUJIIS9/ZwAsRe0iNjWGNqOHk+X23O+5iYvmpBGrf666NgKQOUiGzxmb0WWUSoB/l6fszRqJ29FRorDjxdkHg=
www.fiercepharma.com/ Name: last_visit_bc
Value: 1643944197394
.fiercepharma.com/ Name: _ga
Value: GA1.2.314761443.1643944198
.fiercepharma.com/ Name: _gid
Value: GA1.2.132336096.1643944198
.fiercepharma.com/ Name: _gat_UA-336524-28
Value: 1
www.fiercepharma.com/ Name: dpm_url_count
Value: 1
.fiercepharma.com/ Name: _parsely_session
Value: {%22sid%22:1%2C%22surl%22:%22https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis%22%2C%22sref%22:%22https://go.questexnetwork.com/%22%2C%22sts%22:1643944197685%2C%22slts%22:0}
.adnxs.com/ Name: uuid2
Value: 3035801625078687012
.fiercepharma.com/ Name: _parsely_visitor
Value: {%22id%22:%22pid=99242a0685fc932c91b15696b0e6866e%22%2C%22session_count%22:1%2C%22last_session_ts%22:1643944197685}
.fiercepharma.com/ Name: _mkto_trk
Value: id:294-MQF-056&token:_mch-fiercepharma.com-1643944197693-95979
.app-sj10.marketo.com/ Name: __cf_bm
Value: yfdE0T43nvmke8AZ2yx1UyvSiZ1jLb70YhKZ5jiozhU-1643944198-0-Ae+lGAtJ+orO8g5GjUZ0A3foE5Xr89kNlsU8q8d50OfyqfLfQBVqFtIgZzVQ2I4cVoGZf6m4tyalJbqZ+ijUQGQ=
.ws.zoominfo.com/ Name: visitorId
Value: c58a197dcb22d0e5e98f3e2f3b37af4bfdab8d5a9a0190cced77c17781d9e5b0
.hbmp.mediafuse.com/ Name: vmuid
Value: 7c980bab5bb33876
www.fiercepharma.com/ Name: _pbjs_userid_consent_data
Value: 3524755945110770
.fiercepharma.com/ Name: _pubcid
Value: fb0de1e4-d1ed-4074-92c2-685109b12cae
.admixer.net/ Name: am-uid
Value: 544f1666cd8e4b90aa2a8d247c2cfa40
.lijit.com/ Name: ljtrtb
Value: eJyrrgUAAXUA%2BQ%3D%3D
.go.sonobi.com/ Name: __uih
Value: 1
.go.sonobi.com/ Name: HAPLB5A
Value: s569|YfyZC
.dpmsrv.com/ Name: dpm_pxl
Value: f4f8421b52ef3024b532f6c2780d563d636e0464
.dpmsrv.com/ Name: dpm_pxl_aid
Value: 3035801625078687012
.doubleclick.net/ Name: IDE
Value: AHWqTUkmCU61R3ZrObJNOgY84fyqzSYeRMr2vhD6tcC8g3Lwg8vO5uYSvjaqMXQZ6uw
sample.dragonforms.com/ Name: JSESSIONID
Value: CDB301AD3FC26F41C58CF7448923886D
.betweendigital.com/ Name: dc
Value: was1
.betweendigital.com/ Name: tuuid
Value: 514cb331-e0d2-5323-a86c-8dfcc99014fb
.betweendigital.com/ Name: ut
Value: YfyZBwABX5Aj0JfFtxrR05VZcVEdpWN0RiOxeQ==
.betweendigital.com/ Name: ss
Value: 1
.betweendigital.com/ Name: unm
Value: 1
.rubiconproject.com/ Name: khaos
Value: KZ7TXI4Z-8-HQN6
.rubiconproject.com/ Name: audit
Value: 1|naVuGyos1qruAaLdmS/WvHNEnEPvxbSem0AuhTX0VRyAc5uHgCNHviu6wkVESidf2Viil87TsQADU4L+VXaOPcBQn6AvuCLF61D5O5FC39QCLOF+SfmOaw==
.adnxs.com/ Name: icu
Value: ChgIk419EAoYASABKAEwh7LyjwY4AUABSAEQh7LyjwYYAA..
prebid.a-mo.net/ Name: __amc
Value: 1_1643944198_1643944198
.adtelligent.com/ Name: vmuid
Value: 82bfe3fa89b1c5fc
.ad.gt/ Name: au_id
Value: 70a36042-ea6e-46be-a9ff-2e7c1131d901
.ad.gt/ Name: au_idmatch
Value: {"apn": "2022-02-04", "ttd": "2022-02-04", "pub": "2022-02-04", "adx": "2022-02-04", "halo": "2022-02-04", "goo": "2022-02-04", "son": "2022-02-04", "ppnt": "2022-02-04", "rub": "2022-02-04"}
.fiercepharma.com/ Name: oly_enc_id
Value: null
.fiercepharma.com/ Name: oly_anon_id
Value: %22f01c24f5-b0d9-4b29-ace9-7fa7e2f5d04c%22
.adsrvr.org/ Name: TDID
Value: 806389c4-2d34-4560-9cd8-f621883bd145
.adsrvr.org/ Name: TDCPM
Value: CAEYBSABKAIyCwj8g6r10eWzOhAFOAE.
.fiercepharma.com/ Name: __gads
Value: ID=6016d9e119222885:T=1643944198:S=ALNI_MZrTYu-XKDcxwkngaAOZ6Uk-EiETg
bh.contextweb.com/ Name: INGRESSCOOKIE
Value: 9aa82e7edabc169c
.pubmatic.com/ Name: KTPCACOOKIE
Value: true
.ad.gt/ Name: last_seenrub
Value: 1643944199943
.ad.gt/ Name: rub
Value:
.ad.gt/ Name: last_seeng_hosted
Value: 1643944199943
.ad.gt/ Name: g_hosted
Value:
.ad.gt/ Name: last_seenadx
Value: 1643944199954
.ad.gt/ Name: google_gid
Value: CAESEJOrZg-xVfFp-wAb9ZVWuSE
.ad.gt/ Name: first_seenadx
Value: 1643944199954
.ad.gt/ Name: last_seenadnxs
Value: 1643944199957
.ad.gt/ Name: adnxs_id
Value: 3035801625078687012
.ad.gt/ Name: first_seenadnxs
Value: 1643944199957
.pubmatic.com/ Name: KADUSERCOOKIE
Value: B700EDD9-77F1-4FB8-A9D9-2197767F6769
.ad.gt/ Name: last_seentd
Value: 1643944199958
.ad.gt/ Name: tdid
Value: 806389c4-2d34-4560-9cd8-f621883bd145
.ad.gt/ Name: first_seentd
Value: 1643944199958
.ad.gt/ Name: last_seenpulsepoint
Value: 1643944200001
.ad.gt/ Name: uid
Value: 3R3n4DSJqHMl
.ad.gt/ Name: last_seenhaloid
Value: 1643944200289
.ad.gt/ Name: halo_id
Value: 0201tlxlfd07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8b5po0ntek210qskvk40trr7270wqxik90zq3u2c12pa5j31k0gxf118nmsj90fzd0bt1elzfjf1hl5r1i1kkc2jl
.ad.gt/ Name: first_seenhaloid
Value: 1643944200290
.ad.gt/ Name: last_seenpbm
Value: 1643944200291
.ad.gt/ Name: pbm
Value: B700EDD9-77F1-4FB8-A9D9-2197767F6769
.ad.gt/ Name: first_seenpbm
Value: 1643944200291
www.fiercepharma.com/ Name: dpm_time_site
Value: 2.051
c405.fiercepharma.com/ Name: AWSALB
Value: HJSEfbwmvlt7y2DaxGd+lENzIDTRfOdkfptQTLdadT+akMf/TDshBgyZ/v8MktexpssrxqCEZktHEKiVoPdFv+zBv60gwe49tfL6Z0UdRKvzDPNDt7KuZMm6Fxy/
c405.fiercepharma.com/ Name: AWSALBCORS
Value: HJSEfbwmvlt7y2DaxGd+lENzIDTRfOdkfptQTLdadT+akMf/TDshBgyZ/v8MktexpssrxqCEZktHEKiVoPdFv+zBv60gwe49tfL6Z0UdRKvzDPNDt7KuZMm6Fxy/

23 Console Messages

Source Level URL
Text
network error URL: https://questex.blueconic.net/DG/DEFAULT/cs?&callback=bc_json958
Message:
Failed to load resource: the server responded with a status of 404 ()
javascript error URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Message:
Access to XMLHttpRequest at 'https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/957?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A57%2B00%3A00&ts=1643944197583' from origin 'https://www.fiercepharma.com' has been blocked by CORS policy: No 'Access-Control-Allow-Origin' header is present on the requested resource.
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/957?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A57%2B00%3A00&ts=1643944197583
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Message:
Failed to load resource: the server responded with a status of 400 (Bad Request)
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221643944197395%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis%5C%22%5D%2C%5C%22referrerhost%5C%22%3A%5B%5C%22go.questexnetwork.com%5C%22%5D%2C%5C%22current_utm_source%5C%22%3A%5B%5C%22nurture-email%5C%22%5D%2C%5C%22current_utm_medium%5C%22%3A%5B%5C%22email%5C%22%5D%2C%5C%22current_utm_campaign%5C%22%3A%5B%5C%22jan2022-fp-nurture-email4-what-you-missed%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%2C%5C%22referrerhost%5C%22%2C%5C%22current_utm_source%5C%22%2C%5C%22current_utm_medium%5C%22%2C%5C%22current_utm_campaign%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944197397%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22referrerhosts%5C%22%3A%5B%5C%22go.questexnetwork.com%5C%22%5D%2C%5C%22utm_source%5C%22%3A%5B%5C%22nurture-email%5C%22%5D%2C%5C%22utm_medium%5C%22%3A%5B%5C%22email%5C%22%5D%2C%5C%22utm_campaign%5C%22%3A%5B%5C%22jan2022-fp-nurture-email4-what-you-missed%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%2C%5C%22referrerhosts%5C%22%2C%5C%22utm_source%5C%22%2C%5C%22utm_medium%5C%22%2C%5C%22utm_campaign%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944197398%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22https%3A%2F%2Fgo.questexnetwork.com%2F%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221643944197399%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A58%2B00%3A00&callback=bc_json959
Message:
Failed to load resource: the server responded with a status of 404 ()
network error URL: https://idsync.rlcdn.com/423396.gif?partner_uid=3035801625078687012
Message:
Failed to load resource: the server responded with a status of 451 ()
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221643944197395%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis%5C%22%5D%2C%5C%22referrerhost%5C%22%3A%5B%5C%22go.questexnetwork.com%5C%22%5D%2C%5C%22current_utm_source%5C%22%3A%5B%5C%22nurture-email%5C%22%5D%2C%5C%22current_utm_medium%5C%22%3A%5B%5C%22email%5C%22%5D%2C%5C%22current_utm_campaign%5C%22%3A%5B%5C%22jan2022-fp-nurture-email4-what-you-missed%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%2C%5C%22referrerhost%5C%22%2C%5C%22current_utm_source%5C%22%2C%5C%22current_utm_medium%5C%22%2C%5C%22current_utm_campaign%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944197397%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22referrerhosts%5C%22%3A%5B%5C%22go.questexnetwork.com%5C%22%5D%2C%5C%22utm_source%5C%22%3A%5B%5C%22nurture-email%5C%22%5D%2C%5C%22utm_medium%5C%22%3A%5B%5C%22email%5C%22%5D%2C%5C%22utm_campaign%5C%22%3A%5B%5C%22jan2022-fp-nurture-email4-what-you-missed%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%2C%5C%22referrerhosts%5C%22%2C%5C%22utm_source%5C%22%2C%5C%22utm_medium%5C%22%2C%5C%22utm_campaign%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944197398%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22https%3A%2F%2Fgo.questexnetwork.com%2F%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221643944197399%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A58%2B00%3A00&callback=bc_json960
Message:
Failed to load resource: the server responded with a status of 404 ()
javascript error URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Message:
Access to XMLHttpRequest at 'https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/957?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&ts=1643944199199' from origin 'https://www.fiercepharma.com' has been blocked by CORS policy: No 'Access-Control-Allow-Origin' header is present on the requested resource.
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/957?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&ts=1643944199199
Message:
Failed to load resource: net::ERR_FAILED
javascript error URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Message:
Access to XMLHttpRequest at 'https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/957?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&ts=1643944199220' from origin 'https://www.fiercepharma.com' has been blocked by CORS policy: No 'Access-Control-Allow-Origin' header is present on the requested resource.
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/957?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&ts=1643944199220
Message:
Failed to load resource: net::ERR_FAILED
javascript error URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Message:
Access to XMLHttpRequest at 'https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/957?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&ts=1643944199255' from origin 'https://www.fiercepharma.com' has been blocked by CORS policy: No 'Access-Control-Allow-Origin' header is present on the requested resource.
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/957?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&ts=1643944199255
Message:
Failed to load resource: net::ERR_FAILED
javascript error URL: https://www.fiercepharma.com/pharma/gilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement?utm_source=nurture-email&utm_medium=email&utm_campaign=jan2022-fp-nurture-email4-what-you-missed&mkt_tok=Mjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis
Message:
Access to XMLHttpRequest at 'https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/957?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&ts=1643944199273' from origin 'https://www.fiercepharma.com' has been blocked by CORS policy: No 'Access-Control-Allow-Origin' header is present on the requested resource.
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/957?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&ts=1643944199273
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221643944199199%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199204%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221643944199199%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_all_%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_all_%5C%22%3A%5B%5C%222898354882%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199205%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&callback=bc_json961
Message:
Failed to load resource: the server responded with a status of 404 ()
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221643944199219%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199227%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221643944199219%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199228%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&callback=bc_json962
Message:
Failed to load resource: the server responded with a status of 404 ()
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221643944199255%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199264%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221643944199255%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199265%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&callback=bc_json963
Message:
Failed to load resource: the server responded with a status of 404 ()
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221643944199273%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199284%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221643944199273%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199285%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A09%3A59%2B00%3A00&callback=bc_json964
Message:
Failed to load resource: the server responded with a status of 404 ()
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221643944199273%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199284%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221643944199273%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199285%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A10%3A00%2B00%3A00&callback=bc_json968
Message:
Failed to load resource: the server responded with a status of 404 ()
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221643944199199%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199204%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221643944199199%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_all_%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_all_%5C%22%3A%5B%5C%222898354882%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199205%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A10%3A00%2B00%3A00&callback=bc_json965
Message:
Failed to load resource: the server responded with a status of 404 ()
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221643944199255%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199264%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221643944199255%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199265%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A10%3A00%2B00%3A00&callback=bc_json967
Message:
Failed to load resource: the server responded with a status of 404 ()
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221643944199219%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199227%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221643944199219%5C%22%5D%7D%7D%22%2C%22id%22%3A%221643944199228%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fgilead-to-fork-over-1-25-billion-pay-3-royalty-blockbuster-biktarvy-gsk-patent-settlement%3Futm_source%3Dnurture-email%26utm_medium%3Demail%26utm_campaign%3Djan2022-fp-nurture-email4-what-you-missed%26mkt_tok%3DMjk0LU1RRi0wNTYAAAGCYGthXKZOVMrMzUqVDQ1vKntNfZGELyrlh0OVoQRQR386JhDISaimqCj4Cja4LUQkeKwC32X3euWlQdEWlWi2CfyTOktPUgUN4PAFxc1M7dEH-MvBAis&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-04T03%3A10%3A00%2B00%3A00&callback=bc_json966
Message:
Failed to load resource: the server responded with a status of 404 ()

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
X-Content-Type-Options nosniff

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

1ded3c4c8da534897706a63a9c80e842.safeframe.googlesyndication.com
294-mqf-056.mktoresp.com
a.ad.gt
a.dpmsrv.com
ads.betweendigital.com
ads.servenobid.com
ads.spotible.com
ads.yieldmo.com
adservice.google.com
adservice.google.de
adtelligent-d.openx.net
ajax.googleapis.com
ap.lijit.com
apex.go.sonobi.com
api-52-43-59-220.b2c.com
api.fouanalytics.com
app-sj10.marketo.com
assets-tracking.crazyegg.com
aufp.io
bh.contextweb.com
bid.contextweb.com
bidder.criteo.com
c2shb.ssp.yahoo.com
c405.fiercepharma.com
cdn.blueconic.net
cdn.omeda.com
cdn.parsely.com
cdn.spotible.com
cm.g.doubleclick.net
code.jquery.com
colossusssp.com
creative.spotible.com
d1z2jf7jlzjs58.cloudfront.net
dm.hybrid.ai
fastlane.rubiconproject.com
fonts.googleapis.com
fonts.gstatic.com
ghb.adtelligent.com
ghb.hbmp.mediafuse.com
go.questexnetwork.com
googleads4.g.doubleclick.net
gum.criteo.com
hbopenbid.pubmatic.com
hostedcontent.dragonforms.com
htlb.casalemedia.com
ib.adnxs.com
id5-sync.com
ids.ad.gt
idsync.rlcdn.com
image2.pubmatic.com
in.ml314.com
inv-nets.admixer.net
match.adsrvr.org
ml314.com
mug.criteo.com
munchkin.marketo.net
olytics.omeda.com
onetag-sys.com
oqs.omeda.com
p.ad.gt
p1.parsely.com
pagead2.googlesyndication.com
pagestates-tracking.crazyegg.com
pbjs.e-planning.net
pixel-a.basis.net
pixel.sitescout.com
pixels.ad.gt
player.adtelligent.com
player.hbmp.mediafuse.com
player.mediafuse.com
prebid-us.creativecdn.com
prebid.a-mo.net
prebid.adnxs.com
prebid.deepintent.com
prebid.media.net
qtxasset.com
questex.blueconic.net
s.dpmsrv.com
s0.2mdn.net
sample.dragonforms.com
script.crazyegg.com
secure.adnxs.com
securepubads.g.doubleclick.net
static.addtoany.com
static.criteo.net
stats.g.doubleclick.net
sync.adtelligent.com
sync.go.sonobi.com
sync.medidexs.com
t.trafmag.com
tag.1rx.io
token.rubiconproject.com
tpc.googlesyndication.com
tracking.crazyegg.com
u.openx.net
v4-api-52-43-59-220.b2c.com
ws.zoominfo.com
www.fiercepharma.com
www.google-analytics.com
www.googletagmanager.com
www.googletagservices.com
ads.spotible.com
c405.fiercepharma.com
104.111.234.67
104.16.94.165
104.16.94.80
104.18.14.141
104.36.113.17
108.157.4.100
108.157.4.42
142.250.185.98
142.250.186.162
142.250.186.66
143.204.103.127
143.204.98.127
143.204.98.80
143.204.98.81
146.0.227.110
147.75.61.140
169.197.150.7
178.162.133.149
178.162.133.150
178.250.0.157
178.250.2.131
18.156.195.47
18.202.163.212
18.66.122.61
18.66.242.197
185.184.10.30
185.239.173.66
192.28.147.68
193.200.65.5
198.148.27.134
198.148.27.139
2.21.111.28
2001:4de0:ac18::1:a:2a
204.180.130.159
204.180.130.165
204.180.130.190
204.237.133.116
205.162.42.5
209.58.175.20
213.19.147.43
216.52.2.30
23.227.139.243
2602:803:c003:200::41
2606:4700:10::6816:47c5
2606:4700:20::681a:623
2606:4700:3030::6815:4b21
2606:4700:3033::6815:3a2a
2606:4700::6810:650c
2606:4700::6813:9408
2a00:1450:4001:801::2001
2a00:1450:4001:801::2002
2a00:1450:4001:802::2001
2a00:1450:4001:802::2002
2a00:1450:4001:802::2006
2a00:1450:4001:80e::200e
2a00:1450:4001:811::2002
2a00:1450:4001:812::2002
2a00:1450:4001:813::200a
2a00:1450:4001:828::2002
2a00:1450:4001:82f::2008
2a00:1450:4001:82f::200a
2a00:1450:4001:831::2003
2a00:1450:400c:c1b::9d
2a02:2638:1::13
2a02:2638::3
34.107.148.139
34.255.166.68
35.165.207.228
35.244.159.8
35.244.174.68
35.83.23.20
37.18.16.23
37.252.161.190
37.252.172.37
37.252.173.22
44.228.48.137
45.133.44.3
45.133.44.4
5.178.65.246
51.89.20.86
51.89.9.252
52.205.167.202
52.223.40.198
52.41.22.107
52.43.149.174
52.43.59.220
52.6.171.241
52.72.150.209
54.144.118.149
54.229.143.145
54.72.7.92
54.77.120.81
66.155.71.150
69.173.144.138
8.2.111.126
96.46.183.20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